ATTACHMENT A- TB in US 2011

ATTACHMENT A- TB in US 2011.pdf

Surveys of State, Tribal, Local and Territorial (STLT) Governmental Health Agencies

ATTACHMENT A- TB in US 2011

OMB: 0920-0879

⚠️ Notice: This form may be outdated. More recent filings and information on OMB 0920-0879 can be found here:
Document [pdf]
Download: pdf | pdf
Reported
Tuberculosis
in the
United States
2011

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination

For more information, contact
Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Centers for Disease Control and Prevention
1600 Clifton Road NE
MS E-10
Atlanta, GA 30333
Phone: (404) 639-8120
Fax: (404) 639-8959
E-mail: [email protected]
Web address: http://www.cdc.gov/tb/
Tuberculosis Applications Help Desk
Phone: (404) 639-8444
Email: [email protected]

Ordering Information
Copies of Reported Tuberculosis in the United States, 2011, are available from the Division of
Tuberculosis Elimination’s online ordering system at http://www.cdc.gov/tb/.
This report is also accessible via the internet at http://www.cdc.gov/tb/

Suggested Citation: CDC. Reported Tuberculosis in the United States, 2011. Atlanta, GA: U.S.
Department of Health and Human Services, CDC, October 2012.
All material in this report is in the public domain and may be reproduced or copied without permission. However, citation as to source is requested.

i

ii

Reported
Reported
Tuberculosis
Tuberculosis
in the
the
in
United
States
United States
2006

2011
Publication Year 2007
Publication Year 2012

iii

iv

Reported Tuberculosis in the United States, 2011
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
October 2012

Centers for Disease Control and Prevention...........................................Thomas R. Frieden, M.D., M.P.H.
	
Director
	
	

Office of Infectious Diseases................................................................................ Rima Khabbaz, M.D.
Director

	
	

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention...Kevin Fenton, M.D., Ph.D.
Director

	
	

Division of Tuberculosis Elimination......................................................... Kenneth G. Castro, M.D.
Director

	
	

Surveillance, Epidemiology, and Outbreak Investigations Branch........... Thomas R. Navin, M.D.
Chief

	
	

Surveillance Team........................................................ Roque Miramontes, P.A.-C., M.P.H.
Team Lead

	
	

Field Services and Evaluation Branch....................................................... Terence Chorba, M.D.
Chief

	
	

Data Management and Statistics Branch......................................José E. Becerra, M.D., M.P.H.
Chief

v

vi

This report was prepared by
Surveillance Team
Surveillance, Epidemiology, and Outbreak Investigations Branch
Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Centers for Disease Control and Prevention
Roque Miramontes, P.A.-C., M.P.H.
Carla Jeffries, M.P.H.1
Robert Pratt, B.S.
Rachel S. Yelk Woodruff, M.P.H.
Lori Armstrong, Ph.D.
Carla Winston, Ph.D.
Elvin Magee, M.P.H., M.S.
Lilia P. Manangan, R.N., M.P.H.
Glenda T. Newell
Kai Young, MPH
J. Scott Cope, B.S.
Others contributing to the production of this publication
Office of the Director
Philip LoBue, M.D., FACP, FCCP
Data Management and Statistics Branch
Sandy Price, P.M.P.1.
Vic Bowker1
Cynthia Adams1
Stacey Parker1
National Center for Health Marketing, Division of Creative Services
Brenda Holmes
Field Services and Evaluation Branch
All state and local health departments throughout the United States whose staff
collected and reported the data used in this publication.

1

CDC Information Management Systems Contractor

vii

viii

Preface

Reported Tuberculosis in the United States,
2011 presents summary data for tuberculosis
(TB) cases verified and counted in 2011. Report of Verified Case of Tuberculosis (RVCT)
forms are submitted to the Division of Tuberculosis Elimination (DTBE), Centers for Disease
Control and Prevention (CDC), by 60 reporting
areas (the 50 states, the District of Columbia,
New York City, Puerto Rico, and seven other
jurisdictions in the Pacific and Caribbean). First
released in 1993, the RVCT was expanded in
2009 to collect additional information for each
reported TB case in order to better monitor
trends in TB and TB control.
Reported Tuberculosis in the United States,
2011 is similar to previous publications (see
page xi, #19) and contains an Executive Commentary, Technical Notes, and six major sections. The Executive Commentary includes
highlights of the 2011 data, and the Technical
Notes section provides information about how
the data were collected and reported; these sections are included to help the reader interpret
the data. The 2011 report also includes a special supplement section on the U.S. Affiliated
Pacific Islands (USAPI).

case rates by metropolitan statistical areas (MSAs:
see Technical Notes, page 9, for further details)
with tables of selected demographic and clinical
characteristics. United States Affiliated Pacific
Islands, 2011 presents an overview of USAPI
TB programs and provides USAPI TB surveillance data highlights. Surveillance Slide Set, 2011
presents figures from the annual surveillance
slide set, which emphasize key recent trends in
TB epidemiology in the United States. The slides
with accompanying text can also be viewed and
downloaded from the DTBE website accessible at
http://www.cdc.gov/tb/.
The current Tuberculosis Case Definition for
Public Health Surveillance and Recommendations
for Reporting and Counting Tuberculosis Cases
are provided in Appendices A and B, respectively
(pages 139 and 140). National Surveillance for
Severe Adverse Events Associated with Treatment
for Latent Tuberculosis Infection - Reporting Information is provided in Appendix C (page 149).

Morbidity Trend Tables, United States present
trends in the overall TB case counts and case
rates by selected demographic and clinical
characteristics. Morbidity Tables, United States,
2011 present overall case counts and case rates
for the United States by selected demographic
characteristics. Morbidity Tables, Reporting
Areas, United States, 2011 present TB case
counts and case rates by state and other jurisdictions with tables of selected demographic
and clinical characteristics. Morbidity Tables,
Reporting Areas, United States, 2011 and 2009
present data for the most recent year for which
data are available on selected variables such as
completion of therapy by reporting area. Morbidity Tables, Cities and Metropolitan Statistical Areas, 2011 provide TB case counts and
ix

x

Previous Statistical Reports in this Series:
1.
2.
3.
4.
5.
6.
7.
8.

	
	
	
	
	
	
	
	

	
9. 	
10. 	
	
11. 	
	
12. 	
13. 	
	
14. 	
15. 	
16. 	
17. 	
	
18. 	
19. 	

Special Tuberculosis Projects, 1961–1965. Atlanta: CDC; 1966.
Special Tuberculosis Projects, December 1965. Atlanta: CDC; 1966.
Special Tuberculosis Projects, June 1966. Atlanta: CDC; 1967.
Special Tuberculosis Projects, December 1966. Atlanta: CDC; 1967.
Summary Report. Atlanta: CDC; 1967.
Special Tuberculosis Projects, June 1967. Atlanta: CDC; 1968.
Tuberculosis Program Reports, December 1967. Atlanta: CDC; 1968.
Tuberculin testing during 1966–1967 school year. In: Tuberculosis Program Reports. Atlanta: 		
CDC; 1968.
Tuberculosis Program Reports: Six Month Period Ending June 1968. Atlanta: CDC; 1969.
Program Performance Analyses, June–December 1968. In: Tuberculosis Program Reports.
	
Atlanta: CDC; 1970.
Tuberculin testing data, 1967–1968 school year. In: Tuberculosis Program Reports.
	
Atlanta: CDC; 1970.
The project years, 1961–1969, In: Tuberculosis Program Reports. Atlanta: CDC; 1970.
Tuberculosis programs (for years 1970–1973). In: Tuberculosis Program Reports. Atlanta:
	
CDC; 1971–1974.
Reported Tuberculosis Data (for years 1962–1973). Atlanta: CDC; 1963–1974.
Tuberculosis Statistics: States and Cities (for years 1974–1985). Atlanta: CDC; 1971–1986.
Tuberculosis in the United States (for years 1974–1986). Atlanta: CDC; 1976–1987.
Tuberculosis program management in the United States, 1984. In: Tuberculosis Program 		
Reports. Atlanta: CDC; 1986.
Tuberculosis Statistics in the United States (for years 1987–1992). Atlanta: CDC: 1989–1993.
Reported Tuberculosis in the United States (for years 1993–2010). Atlanta: CDC: 1994–2011.
Reports from 2006 through 2011 are available on the Internet at
http://www.cdc.gov/tb/statistics/

xi

State TB Resources on the Internet*
AL	
AK	
AR	
AZ	
CA	
CO	
CT	
DC	
DE	
FL	
GA	
HI	
IA	
ID	
IL	
IN	
KS	
KY	
LA	
MA	
MD	
ME	
MI	
MN	
MO	
MT	
MS	
ND	
NC	
NE	
NH	
NJ	
NM	
NYC	
NV	
NY	
OH	
OK	
	
OR	
PA	
RI	
PR	
SC	
SD	
TN	
TX	
UT	
VA	
VT	
WA	
WI	
WV	
WY	

http://www.adph.org/tb/
http://www.epi.alaska.gov/id/tb.stm
http://www.healthy.arkansas.gov/programsServices/infectiousDisease/tuberculosis
http://www.azdhs.gov/phs/oids/tuberculosis
http://www.cdph.ca.gov/programs/tb
http://www.cdphe.state.co.us/dc/tb/tbhome.html
http://www.ct.gov/dph/cwp/view.asp?a=3136&q=388584&dphNav_GID=1601&dphPNavCtr=|#47055
http://doh.dc.gov/doh/cwp/view,a,1374,q,580737.asp
http://dhss.delaware.gov/dph/dpc/tbelimination.html
http://www.doh.state.fl.us/disease_ctrl/tb/
http://health.state.ga.us/epi/tuber.asp
http://hawaii.gov/health/family-child-health/contagious-disease/tb/index.html
http://www.idph.state.ia.us/ImmTB/TB.aspx?prog=Tb&pg=TbHome
http://www.healthandwelfare.idaho.gov/Health/DiseasesConditions/Tuberculosis/tabid/378/Default.aspx
http://www.idph.state.il.us/health/infect/reportdis/tb.htm
http://www.in.gov/isdh/19662.htm
http://www.kdheks.gov/tb/
http://chfs.ky.gov/dph/epi/tb.htm
http://new.dhh.louisiana.gov/index.cfm/page/1005
http://www.mass.gov/dph/cdc/tb
http://ideha.dhmh.md.gov/OIDPCS/CTBCP/SitePages/Home.aspx
http://www.maine.gov/dhhs/boh/ddc/epi/tuberculosis/
http://www.michigan.gov/tb
http://www.health.state.mn.us/divs/idepc/diseases/tb/index.html
http://health.mo.gov/living/healthcondiseases/communicable/tuberculosis/index.php
http://www.dphhs.mt.gov/publichealth/tb/
http://www.msdh.state.ms.us/msdhsite/_static/14,0,125.html
http://www.ndhealth.gov/disease/tb/
http://epi.publichealth.nc.gov/cd/diseases/tb.html
http://dhhs.ne.gov/publichealth/Pages/cod_tuberculosis_tbindex.aspx
http://www.dhhs.nh.gov/dphs/cdcs/tb/index.htm
http://www.state.nj.us/health/tb/index.shtml
http://nmhealth.org/IDB/tb_program.shtml
http://www.nyc.gov/html/doh/html/tb/tb.shtml
http://www.health.nv.gov/CD_HIV_TBProgram.htm
http://www.nyhealth.gov/statistics/diseases/communicable/tuberculosis/
http://www.odh.ohio.gov/odhPrograms/hastpac/tcont/tcont1.aspx
http://www.ok.gov/health/Disease,_Prevention,_Preparedness/Acute_Disease_Service/Disease_Information/	
Tuberculosis.html
http://oregon.gov/DHS/ph/tb/
http://www.portal.state.pa.us/portal/server.pt?open=514&objID=557952&mode=2
http://www.health.ri.gov/disease/communicable/tb/index.php
http://www.salud.gov.pr/Programas/ProgramaTuberculosis
http://www.scdhec.net/health/disease/tb/index.htm
http://doh.sd.gov/TB/
http://health.state.tn.us/CEDS/TB/index.htm
http://www.dshs.state.tx.us/topicrelatedcontent.aspx?itemsid=1164
http://www.health.utah.gov/cdc/tb_home.htm
http://www.vdh.virginia.gov/Epidemiology/DiseasePrevention/Programs/Tuberculosis/
http://healthvermont.gov/prevent/tb/Tuberculosis.aspx
http://www.doh.wa.gov/cfh/tb
http://www.dhs.wisconsin.gov/tb/
http://www.wvtb.org
http://www.health.wyo.gov/phsd/tb/index.html

*Links to U.S. reporting area TB programs accessed as of September 2012. Includes responses from the reporting areas of New York
City (NYC) and Puerto Rico (PR).

xii

Contents
Acknowledgments................................................................................................................................ vii
Preface................................................................................................................................................... ix
Previous Statistical Reports in this Series............................................................................................. xi
State TB Statistics on the Internet........................................................................................................ xii
Executive Commentary...........................................................................................................................3
Technical Notes.......................................................................................................................................9
Morbidity Trend Tables, United States
Table 1. Tuberculosis Cases, Case Rates per 100,000 Population, Deaths, and Death Rates per
100,000 Population, and Percent Change: United States, 1953–2011............................................15
Table 2. Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Hispanic
Ethnicity and non-Hispanic Race: United States, 1993–2011........................................................16
Table 3. Tuberculosis Cases and Percentages by Hispanic Ethnicity and non-Hispanic Race, and
Origin of Birth: United States, 1993–2011.....................................................................................17
Table 4. Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Age
Group: United States, 1993–2011...................................................................................................18
Table 5. Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Origin of
Birth: United States, 1993–2011.....................................................................................................18
Table 6. Tuberculosis Cases and Percentages Among Foreign-born Persons by the Top 30
Countries of Birth: United States, 2007–2011................................................................................19
Table 7. Tuberculosis Cases and Percentages Among Foreign-born Persons by the Top 30
Countries of Birth and Years in the United States Before TB Diagnosis: United States, 2011......20
Table 8. Tuberculosis Cases and Percentages by Case Verification Criterion and Site of Disease:
United States, 1993–2011...............................................................................................................21
Table 9. Tuberculosis Cases and Percentages by Resistance to INH, Origin of Birth, and
Previous History of TB: United States, 1993–2011........................................................................22
Table 10. Tuberculosis Cases and Percentages, by Multidrug Resistance, Origin of Birth, and
Previous History of TB: United States, 1993–2011........................................................................23
Table 11. Percentages of Tuberculosis Cases by Initial Drug Regimen, Use of Directly Observed
Therapy (DOT), and Completion of Therapy (COT): United States, 1993–2011..........................24

xiii

Table 12. Tuberculosis Cases and Percentages in Persons with HIV Test Results and with HIV
Coinfection, by Age Group: United States, 1993–2011..................................................................24
Table 13. Tuberculosis Cases and Percentages by Reason Tuberculosis Therapy Stopped: United
States, 1993–2009...........................................................................................................................25
Morbidity Tables, United States, 2011
Table 14. Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age
Group: United States, 2011.............................................................................................................29
Table 15. Tuberculosis Case Rates per 100,000 Population by Hispanic Ethnicity and NonHispanic Race, Sex, and Age Group: United States, 2011.............................................................30
Table 16. Tuberculosis Cases in U.S.-born Persons by Hispanic Ethnicity and Non-Hispanic
Race, Sex, and Age Group: United States, 2011.............................................................................31
Table 17. Tuberculosis Cases in Foreign-born Persons by Hispanic Ethnicity and Non-Hispanic
Race, Sex, and Age Group: United States, 2011.............................................................................32
Table 18. Tuberculosis Cases Among Foreign-born Persons by Country of Birth: United States,
2011.................................................................................................................................................34
Morbidity Tables, Reporting Areas, 2011
Table 19. Tuberculosis Cases and Case Rates per 100,000 Population: Reporting Areas,
2011 and 2010.................................................................................................................................39
Table 20. Tuberculosis Cases and Case Rates per 100,000 Population, Ranked and Grouped by
Number of Cases: United States and the District of Columbia, 2011 and 2010.............................40
Table 21. Tuberculosis Cases and Percentages by Age Group: Reporting Areas, 2011................42
Table 22. Tuberculosis Cases and Percentages by Hispanic Ethnicity and Non-Hispanic Race,
U.S.-born and Foreign-born Persons: Reporting Areas, 2011........................................................44
Table 23. Tuberculosis Cases and Percentages, U.S.-born and Foreign-born Persons:
United States, 2011.........................................................................................................................46
Table 24. Tuberculosis Cases and Percentages in Foreign-born Persons by Top 7 Countries of
Birth: United States, 2011...............................................................................................................48
Table 25. Tuberculosis Cases and Percentages in Foreign-born Persons by Number of Years in
the United States: United States, 2011............................................................................................50
Table 26. Tuberculosis Cases and Percentages by Pulmonary and Extrapulmonary Disease:
Reporting Areas, 2011.....................................................................................................................51

xiv

Table 27. Extrapulmonary Tuberculosis Cases and Percentages by Site of Disease:
Reporting Areas, 2011.....................................................................................................................52
.

Morbidity Tables, Reporting Areas, 2011 and 2009
Table 28. Tuberculosis Cases and Percentages by Residence in Correctional Facilities, Age >15:
Reporting Areas, 2011.....................................................................................................................57
Table 29. Tuberculosis Cases and Percentages by Homeless Status, Age >15:
Reporting Areas, 2011.....................................................................................................................58
Table 30. Tuberculosis Cases and Percentages by Residence in Long-term Care Facilities,
Age >15: Reporting Areas, 2011....................................................................................................59
Table 31. Tuberculosis Cases and Percentages by Injecting Drug Use, Age >15:
Reporting Areas, 2011.....................................................................................................................60
Table 32. Tuberculosis Cases and Percentages by Noninjecting Drug Use, Age >15:
Reporting Areas, 2011 ...................................................................................................................61
Table 33. Tuberculosis Cases and Percentages by Excess Alcohol Use, Age >15:
Reporting Areas, 2011.....................................................................................................................62
Table 34. Tuberculosis Cases and Percentages by Primary Occupation, Age >15:
Reporting Areas, 2011 ...................................................................................................................63
Table 35. Tuberculosis Cases and Percentages by Initial Drug Regimen:
Reporting Areas, 2011 ...................................................................................................................64
Table 36. Culture-Positive Tuberculosis Cases and Percentages with Drug Susceptibility Results,
by Resistance to INH or Multidrug Resistance: Reporting Areas, 2011........................................65
Table 37. Tuberculosis Cases and Percentages by HIV Status: Reporting Areas, 2011................66
Table 38. Tuberculosis Cases and Percentages by Type of Health Care Provider:
Reporting Areas, 2009....................................................................................................................67
Table 39. Tuberculosis Cases and Percentages by Directly Observed Therapy (DOT):
Reporting Areas, 2009....................................................................................................................68
Table 40. Tuberculosis Cases and Percentages by Completion of Tuberculosis Therapy (COT):
Reporting Areas, 2009....................................................................................................................69
Table 41. Tuberculosis Cases and Percentages by Reason Therapy Stopped:
Reporting Areas, 2009...................................................................................................................70
Table 42. Completion of Tuberculosis Therapy (COT) Cases and Percentages by Hispanic
Ethnicity and Non-Hispanic Race: Reporting Areas, 2009............................................................72

xv

Table 43. Tuberculosis Cases and Percentages in Persons Completing Therapy for Whom
Therapy Was Indicated for One Year or Less: Reporting Areas, 2005–2009.................................74
Morbidity Tables, Cities and Metropolitan Statistical Areas, 2011
Table 44. Tuberculosis Cases in Selected Cities: 2011 and 2010...................................................77
Table 45. Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan Statistical
Areas with >500,000 Population, 2011 and 2010...........................................................................78
Table 46. Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with >500,000
Population, 2011.............................................................................................................................80
Table 47. Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race: Metropolitan Statistical Areas with >500,000 Population, 2011...................................................................................82
Table 48. Tuberculosis Cases and Percentages, U.S.-born Persons and Foreign-born Persons:
Metropolitan Statistical Areas with >500,000 Population, 2011....................................................84
Table 49. Tuberculosis Cases and Percentages by Homeless Status, Age >15:
Metropolitan Statistical Areas with >500,000 Population, 2011....................................................86
United States Affiliated Pacific Islands, 2011
Summary.........................................................................................................................................91
Slides...............................................................................................................................................93
Narrative.........................................................................................................................................99
Surveillance Slide Set, 2011
Slides.............................................................................................................................................103
Narrative.......................................................................................................................................132
Appendices
Appendix A: Tuberculosis Case Definition for Public Health Surveillance.................................139
Appendix B: Recommendations for Counting Reported Tuberculosis Cases..............................140
Appendix C: National Surveillance for Severe Adverse Events Associated with Treatment for
Latent Tuberculosis Infection - Reporting Information................................................................149
Index...................................................................................................................................................153

xvi

Executive Commentary

1
1

2

Executive Commentary
Highlights of 2011 Report
Since 1953, in cooperation with state and local health departments, the United States national tuberculosis program has collected information on each newly reported case of tuberculosis (TB) disease in the
United States. Currently, each individual TB case report (Report of Verified Case of Tuberculosis, or
RVCT) is submitted electronically. Following are the highlights of the 2011 report.
1.	 Updated case counts for each year from 1993 through 2010.
2.	 Case counts: 10,528 TB cases were reported to CDC from the 50 states and the District of Columbia
(DC) for 2011, representing a 5.8% decrease from 2010 (Table 1).
•	 Eighteen states reported increased case counts from 2010 (Table 20).
•	 California, Texas, New York, and Florida accounted for 50% of the national case total (Table 19).
•	 For the first time, Asians exceeded all other racial or ethnic groups with the largest percentage of total
cases (30%) (Table 2).
•	 Hispanics, who since 2004 had the largest percentage of total cases, now comprise the second largest
racial or ethnic group (29%) (Table 2).
•	 Blacks or African Americans born in the United States represented 39% of TB cases in U.S.-born
persons (Table 16) and accounted for approximately 15% of the national case total.
•	 Asians born outside the United States represented 46% of TB cases in foreign-born persons (Table
17) and accounted for 29% of the national case total.
3.	 Case rates: In 2011, the TB case rate declined from 3.6 to 3.4 per 100,000 persons, representing a
6.4% decrease from 2010.
•	 Twelve states and DC reported rates above the national average (Table 19).
•	 The TB case rate was 1.5 per 100,000 for U.S.-born persons and 17.2 for foreign-born persons
	 (Table 5).
•	 Asians continued to have the highest case rate (20.9 per 100,000 persons) among all racial or ethnic
groups (Table 2).
4.	 Burden among the foreign-born: In 2011, the percentage of cases occurring in foreign-born persons
increased to 62% of the national case total. This percentage has risen steadily since 1993.
•	 Foreign-born Hispanics and Asians together represented 80% of TB cases in foreign-born persons,
and accounted for 50% of the national case total (Table 17).
•	 In 34 states, ≥ 50% of TB cases occurred among foreign-born persons (Table 23).
•	 In 17 states, ≥ 70% of TB cases occurred among foreign-born persons (Table 23).
•	 In 10 states, ≥ 75% of TB cases occurred among foreign-born persons (Table 23).
•	 The top five countries of origin of foreign-born persons with TB were Mexico, the Philippines, Vietnam, India, and China (Table 6).
5.	 Drug resistance: 1.3% of reported cases had primary multidrug resistance, which is defined as no
previous history of TB disease and resistance to at least isoniazid and rifampin (Table 10).
6.	 HIV status: In 2011, 82% of persons with TB reported HIV test results.
•	 Among persons of all ages, the percentage with HIV test results increased from 67% in 2010 to 82%
in 2011; among persons 25–44 years of age, reporting of HIV test results increased from 75% to
90% (Table 12).

3

•	 The percentage of persons with TB who reported HIV-positive results has remained the
same (6%) since 2008 for persons of all ages.
Among persons 25–44 years of age, 10%
of persons with TB reported HIV-positive
results; this percentage has remained between
9%-10% since 2008(Table 12). The percentages have declined since 1993, when 15% of
persons with TB reported HIV-positive results
among persons of all ages, and 29% for persons between 25−44 years of age.
Tuberculosis in the United States
In 2011, the reported number of TB cases (10,528)
and case rate (3.4 cases per 100,000) both decreased; these represented declines of 5.8% and
6.4%, respectively, compared to 2010. Since the
1992 TB resurgence peak in the United States, the
number of TB cases reported annually has decreased by 61% (Table 1).
TB case rates vary by well-known factors such
as age, race and ethnicity, and country of origin.
The proportion of total cases occurring in foreignborn persons has been increasing since 1993. In
2011, 62% of TB cases occurred in foreign-born
persons. Foreign-born persons have accounted for
the majority of TB cases in the United States every
year since 2001. Moreover, the case rate among
foreign-born persons in 2011 was approximately
11 times higher than among U.S.-born persons
(Table 5).
Tuberculosis deaths decreased by 10%, from 590
deaths in 2008 to 529 deaths in 2009. The number
of TB deaths reported annually has decreased by
69% since 1992 (Table 1).
Age
Since 1993, TB case rates have declined annually
for almost all age groups. In 2011, TB case rates
continued the trend with declines in all age groups.
The highest burden of disease continues to be
among older adults. In 2011, adults aged 65 years
and older had a case rate of 5.4 cases per 100,000,
while children aged ≤ 14 years had the lowest rate
at 0.9 cases per 100,000 (Table 4).

4

Race and Ethnicity
In 2003, the race and ethnicity category “nonHispanic, Asian or Pacific Islander” was split into
“non-Hispanic Asian” and “non-Hispanic Native
Hawaiian or Other Pacific Islander.” In 2011,
Asians had the highest TB case rate at 20.9 cases
per 100,000, which was a slight decrease from 21.5
in 2010. Native Hawaiians or Other Pacific Islanders had the second-highest TB case rate at 15.9
cases per 100,000, which is a decrease compared
to 19.0 cases per 100,000 reported in 2010. Owing to low case numbers among Native Hawaiians
or other Pacific Islanders, case rates fluctuate and
must be interpreted with caution (Table 2).
Since 1993, TB case rates have declined between
60% and 78% in the following racial and ethnic
groups: among Hispanic or Latinos, from 19.9 to
5.8 cases per 100,000; among non-Hispanic blacks
or African Americans, from 28.5 to 6.3 cases per
100,000; among American Indian or Alaska Natives, from 14.0 to 5.6 cases per 100, 000; and
among non-Hispanic whites, from 3.6 to 0.8 cases
per 100,000. In 2011, the TB case rate for Asians
remained approximately three times higher than
that for Hispanics or blacks or African Americans
(Table 2).
Origin of Birth
Since 1993, the TB case rate among U.S.-born
persons has declined annually. In 2011, the TB
case rate for U.S.-born persons was 1.5 cases
per 100,000, representing a 80% decrease from
7.4 cases per 100,000 in 1993. The TB case rate
among foreign-born persons also declined during the same interval, though the decline was
less substantial. In 2011, the TB case rate among
foreign-born persons was 17.2 cases per 100,000,
representing a 49% decrease from 34.0 cases per
100,000 in 1993 (Table 5).
The proportion of TB cases among persons born in
the United States has also declined annually since
1993. In 2011, 38% of TB cases were among U.Sborn persons compared to 69% in 1993 (Table 5).
In 34 states, ≥ 50% of TB cases occurred among
foreign-born persons. In 17 states (California,
Colorado, Connecticut, Delaware, Hawaii, Iowa,
Maryland, Massachusetts, Minnesota, Nevada,

New Jersey, New York, North Dakota, Rhode
Island, Utah, Washington, Wyoming), ≥ 70% of TB
cases occurred among foreign-born persons (Table
23).
Country of Origin and World Region
From 2007 through 2011, the top five countries
of origin of foreign-born persons with TB were
Mexico, the Philippines, India, Vietnam and China
(Table 6). The distribution of TB cases by world
region of origin reflects immigration patterns
among persons settling in the United States.1 Of
the 6,510 TB cases reported among foreign-born
persons in 2011, 38% occurred among persons
born in the Americas region, and 31% occurred
among persons born in the Western Pacific region
(Table 18). From 1993 through 2011, the proportion of cases increased among persons born in the
Eastern Mediterranean region (3% in 1993 to 4%
in 2011), the Southeast Asia region (6% in 1993 to
14% in 2011), and the Africa region (2% in 1993
and 8% in 2011) (Table 18).
Multidrug-Resistant Tuberculosis
From 1993, when the RVCT was expanded to include drug-susceptibility results, the proportion of
patients with primary multidrug-resistant (MDR)
TB, which is defined as no previous history of
TB disease and resistance to at least isoniazid and
rifampin, decreased from 2.5% to 1.0% by 1998.
However, there has been a slight increase in the
percentage of primary MDR TB cases, from 0.9%
of the total number of reported TB cases in 2008
(88 cases), to 1.1% percent in 2009 (86 cases),
to 1.2% in 2010 (89 cases), to 1.3% in 2011 (98
cases). Since 1997, the percentage of U.S.-born patients with primary MDR TB has remained below
1.0%. However, of the total number of reported
primary MDR TB cases, the proportion occurring
in foreign-born persons increased from 25.3% (103
of 407) in 1993 to 82.7% (81 of 98) in 2011 (Table
10).

United States Department of Homeland Security. 2010
Yearbook of Immigration Statistics. In: U.S. Department of
Homeland Security, Office of Immigration Statistics; 2011.

1

Extensively Drug-Resistant Tuberculosis
CDC has included an updated case count of extensively drug-resistant (XDR) TB cases from 1993 to
2011 in the slide set that accompanies this report.
XDR TB is defined as resistance to isoniazid and
rifampin, plus resistance to any fluoroquinolone
and at least one of three injectable second-line
anti-TB drugs (i.e., amikacin, kanamycin, or
capreomycin).2,3 Six cases were reported as XDR
TB in 2011, compared with 1 case in 2010, 0 cases
in 2009, and 5 in 2008. Of the 12 XDR TB cases
reported since 2008, 11 were among foreign-born
persons.
Tuberculosis Therapy
The proportion of TB patients prescribed an initial
treatment regimen including at least isoniazid,
rifampin, and pyrazinamide increased from 72% in
1993 to 88% in 2011. The proportion of patients
who completed therapy within 1 year increased
from 64% in 1993 to 88% in 2009 (the latest year
for which complete outcome data are available).
The proportion of persons receiving directly observed therapy for at least a portion of the treatment duration also increased from 36% in 1993 to
90% in 2009, the latest year for which complete
outcome data are available (Table 11).
HIV Status
Between 2010 and 2011, the proportion of persons
with TB who reported HIV test results increased
by 20% for all ages and 22% for persons aged
25–44. This increase is attributed to new reporting
by states that were not previously reporting HIV
test results. The American Thoracic Society and
the Infectious Diseases Society of America recommend that all TB patients be counseled and tested
for HIV.4
2

Centers for Disease Control and Prevention. Revised
Definition of Extensively Drug-Resistant Tuberculosis.
MMWR Morb Mortal Wkly Rep 2006;55:1176.
3
Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec 2006;81:430-2.
4
CDC. Treatment of tuberculosis. American Thoracic
Society, CDC, and Infectious Diseases Society of America.
MMWR 2003;52(No. RR-11).

5

Summary
Both the absolute number of TB cases and the TB
case rate in the United States continued to decrease
in 2011. With 10,528 total cases, representing a
case rate of 3.4 cases per 100,000 persons, 2011
had the lowest number of reported TB cases since
reporting began in 1953. Furthermore, the number
of TB cases reported in 2011 and the corresponding case rate decreased by approximately 6% from
the previous year. However, despite successful
declines in TB cases and case rates over the past
60 years, it is unlikely that current TB control and
prevention efforts will result in TB elimination (<1
case per 1,000,000 population)5 in this century.6

treatment time may lead to better LTBI treatment
completion among foreign-born persons.8
Continuing the decline in TB cases in the United
States will require sustained focus on domestic TB
control activities and further support of global TB
control initiatives.9 Improving TB control among
racial/ethnic minorities and foreign-born persons is
imperative as the United States strives to prevent
TB transmission and meet TB elimination goals.10

Racial and ethnic minorities and foreign-born persons continue to be disproportionately affected by
TB. In 2011, 84% of all TB cases occurred among
persons who were Asian, black or African American, Hispanic, American Indian or Alaskan Native, or Native Hawaiian. The TB case rate among
Asians is 25 times higher than the TB case rate
among non-Hispanic whites. Asians accounted for
30% of all TB cases reported in 2011, the highest
percentage of any racial or ethnic group, and 96%
of Asian TB patients were foreign-born.
Since 2002, more than half of all TB cases reported
in the U.S. have occurred among foreign-born persons. The gap between the proportion of TB cases
among foreign-born and U.S.-born persons continued to widen in 2011, with 62% of all TB cases
occurring among foreign-born persons. TB control
strategies that have been successful in reducing
transmission among U.S.-born TB cases have had
less success in controlling TB among foreign-born
persons.7 Focusing on LTBI testing and treatment
of foreign-born persons would likely be more
successful in decreasing TB among this group.7
Additionally, a new LTBI regimen that reduces
Ending Neglect: The Elimination of Tuberculosis in the
United States. Washington, DC: National Academy Press;
2000.
6
Hill AN, Becerra JE, Castro KG. Modelling tuberculosis
trends in the USA. Epidemiol Infect 2012;140(10):186272.
5

Cain KP, Benoit SR, Winston CA, MacKenzie WR.
Tuberculosis among foreign-born persons in the United
States. JAMA. 2008;300(4):405-12.

7

6

8

Jereb JA, Goldberg SV, Powell K, Villarino E, LoBue
P. Recommendations for use of an Isoniazid-Rifapentine
regimen with direct observation to treat latent Mycobacterium tuberculosis Infection. MMWR Morb Mortal Wkly
Rep. 2011;60(48):1650-3.
9
Centers for Disease Control and Prevention. Trends in
tuberculosis – United States 2011. MMWR Morb Mortal
Wkly Rep 2012;61(11):181-5.
10
Centers for Disease Control and Prevention. CDC’s
response to ending neglect: the elimination of tuberculosis
in the United States 2002. http://www.cdc.gov/tb/publications/reportsarticles/iom/iomresponse/default.htm.

Technical Notes

7

8

Technical Notes
National Surveillance for Tuberculosis
Reporting areas (i.e., the 50 states, the District of Columbia, New York City, Puerto Rico, and other U.S. jurisdictions in the Pacific and Caribbean1) report tuberculosis
(TB) cases to CDC using a standard case report form,
Report of Verified Case of Tuberculosis (RVCT), through
2011. TB cases are verified according to the Tuberculosis
Case Definition for Public Health Surveillance in Appendix
A. TB cases are reported and counted according to the Recommendations for Reporting and Counting Tuberculosis
Cases in Appendix B.
The 2011 Report contains several new features:
•	 Race/ethnicity information on TB cases is displayed
by origin of birth (U.S.-born or foreign-born) (Table
3).
•	 Drug-resistance patterns are displayed in separate
tables with drug-resistance trend data by previous TB
status and origin of birth (Tables 9 and 10).
•	 California now reports HIV test results to CDC, resulting in a significant improvement in the completeness of HIV status reporting in 2011.
•	 TB case data are shown by homeless status among
those 15 years of age or older by MSA (Table 49).
TB Case Definition
In 2009, the case definition was modified. TB cases are
verified according to the following specified laboratory and
clinical criteria.
Laboratory criteria for diagnosis
A case may be verified by the laboratory case definition
with at least one of the following criteria: 1) isolation of
M. tuberculosis complex from a clinical specimen, OR 2)
demonstration of M. tuberculosis complex from a clinical
specimen by nucleic acid amplification test (NAAT), OR 3)
demonstration of acid-fast bacilli (AFB) in a clinical specimen when a culture has not been or cannot be obtained or
is falsely negative or contaminated.
Clinical case criteria
A case may be verified by the clinical case definition in
the presence of ALL of the following clinical criteria: 1) a
positive tuberculin skin test (TST) result or positive interferon gamma release assay (IGRA) result for M. tuberculosis, AND 2) other signs and symptoms compatible with TB
(e.g., abnormal chest radiograph, abnormal chest computerized tomography scan or other chest imaging study, or
clinical evidence of current disease, AND 3) treatment with
two or more anti-TB drugs, AND 4) a completed diagnostic
evaluation.

Provider Diagnosis
Provider diagnosis is not a component of the case definition for TB as described in Appendix A. However, when
cases of TB are diagnosed but do not meet either the clinical or laboratory case definition, reporting areas have the
option of verifying TB cases based on provider diagnosis
as described in Appendix B. Through 2008, the RVCT did
not collect information on IGRA results. If an IGRA was
performed in lieu of the TST, then the RVCT would have
indicated that the TST was not performed. Thus, cultureand smear-negative cases without a TST that are diagnosed
by a positive IGRA result prior to 2008 were considered
to have been confirmed by provider diagnosis. However,
starting in 2009, positive results for an IGRA are included
as part of the clinical case definition for TB confirmation.
Anergic patients with a clinical presentation consistent
with TB but without laboratory evidence of M. tuberculosis complex would also be an example of provider diagnosis and one which has not changed over time.
TB Case Verification Criteria Calculation
The software for TB surveillance developed by CDC includes a calculated variable for TB case verification called
“Vercrit,” which was modified in 2009. The new variables,
Nucleic Acid Amplification Test Result, Interferon
Gamma Release Assay (IGRA) for Mycobacterium
tuberculosis at Diagnosis, and Initial Chest CT Scan or
Other Chest Imaging Study were added in the Vercrit
calculation.
“Vercrit” is calculated by using the following criteria in
hierarchical order:
1.	 Positive culture
2.	 Positive nucleic acid amplification test
3.	 Positive acid-fast bacilli test
4.	 Clinical case confirmation
5.	 Provider diagnosis
Changes in Reporting and Counting TB Cases
In 2009, the Recommendations for Reporting and Counting Tuberculosis Cases in Appendix B were modified.
TB cases that are verified but not countable for morbidity
statistics can now be reported to CDC as a measure of programmatic and case management burden. However, data
on noncountable TB cases are incomplete and not included
in this report.
The recommendations for counting TB cases among immigrants, refugees,, and foreign visitors were revised based
on the recommendations in the 2007 Technical Instructions
for Tuberculosis Screening and Treatment for Panel Physicians.2 Regardless of of Panel Physician classification or
citizenship status, immigrants and refugees examined after
arriving in the United States and diagnosed with clinically

1
Other U.S. jurisdictions include American Samoa, the Commonwealth of the Northern Mariana Islands, the Federated States of Micronesia, Guam, the Republic of the Marshall Islands, the Republic of Palau, and U.S. Virgin Islands.
2
CDC. Immigration Requirements: Technical Instructions for Tuberculosis Screening and Treatment, 2007. Atlanta: CDC, Division of
Global Migration and Quarantine, revised September 2007; http://www.cdc.gov/ncidod/dq/pdf/ti_tb_8_9_2007.pdf.

9

active TB requiring anti-TB medications should be reported and counted by the locality of their current residence at
the time of diagnosis. Foreign visitors diagnosed with TB,
receiving anti-TB therapy, and planning to remain in the
United States for 90 days or more should be reported and
counted by the locality of current residence.
New and Expanded RVCT Variables
Data on demographic, clinical, laboratory, initial treatment,
and treatment outcomes are collected through the RVCT’s
three data collection reports:
1.	 Report of Verified Case of Tuberculosis: for all
patients with a verified case of TB.
2.	 Initial Drug Susceptibility Report (Follow-Up
Report 1): for all patients who had a culture that
was positive for M. tuberculosis complex.
3.	 Case Completion Report (Follow-Up Report 2):
for all patients who were alive when TB was
diagnosed.
In 2009, the RVCT was modified and expanded to include
11 additional variables. Modifications to the RVCT accommodate the changing epidemiology of TB in terms of
risk factors, new drug treatments, and enhanced laboratory
capacity for diagnostic tests. These new variables will be
made available in a future annual report.
The instructions for completing the RVCT forms and the
definitions for all data items are available at: CDC. Report
of Verified Case of Tuberculosis (RVCT) Instruction Manual. Atlanta, GA: U.S. Department of Health and Human
Services, CDC, 2009. http://www.cdc.gov/tb/programs/
rvct/InstructionManual.pdf.
Tabulation and Presentation of TB Data
This report presents summary data for TB cases reported
to CDC in 2011. TB cases are tabulated by year in which
the reporting area verified that the patient had TB and
included the patient in its official annual TB case count.
Since 2004, the published report has reflected updated
information on the numbers of cases of confirmed TB for
each year from 1993 onward. Totals for the United States
include data from the 50 states, the District of Columbia
(DC), and New York City.
Trend data are presented in Tables 1 through 13, except
Table 7, which now only presents number of years in the
United States for 2011. Age group tabulations are based
on the patient’s age in the month and year the patient was
reported to the health department as a suspected TB case.
State or metropolitan area data tabulations are based on the
patient’s residence at diagnosis of TB.
Rates
Rates are expressed as the number of cases reported each
calendar year per 100,000 population. Population de-

10

nominators used in calculating TB rates were based on
official census and midyear postcensal estimates from the
U.S. Census Bureau. In Tables 1, 19, and 20, the U.S.
total populations for 2000–2009 were taken from Annual Estimates of the Resident Population for the United
States, Regions, States, and Puerto Rico (April 1, 2000
to July 1, 2009); populations for 2010–2011 were taken
from Annual Estimates of the Population for the United
States, Regions, States, and Puerto Rico (April 1, 2010
to July 1, 2011). In 2003, two modifications were made
to the RVCT form: 1) entries for multiple race (two or
more races reported for a person) were allowed, and 2) the
previous category of “Asian/Pacific Islander” was divided into “Asian” and “Native Hawaiian or Other Pacific
Islander.” To calculate rates in Table 2, denominators for
2000–2011 were obtained from the Annual Estimates of
the Resident Population by Sex, Race, and Hispanic Origin
for the United States (April 1, 2000 to July 1, 2009) and
Annual Estimates of the Resident Population by Sex,
Race, and Hispanic Origin for the United States (April 1,
2010 to July 1, 2011). The population source for nativity
is the Current Population Survey and is used to calculate
case rates for U.S. and foreign-born TB. This population
source includes populations for the 50 states and D.C.,
those born abroad of U.S. parents, and those born in U.S.
outlying areas (the U.S.-affiliated areas) as the U.S-born
population.
To calculate rates for Table 4, denominators were obtained
from the Annual Estimates of the Resident Population by
Sex and Five-Year Age Groups for the United States (April
1, 2000 to July 1, 2009) and Annual Estimates of the
Resident Population by Sex and Five-Year Age Group for
the United States (April 1, 2010 to July 1, 2011). Denominators for computing 2011 rates in Table 15 were obtained
from Annual Estimates of the Population by Sex, Race,
and Hispanic or Latino Origin for the United States (April
1, 2000 to July 1, 2011). In 2004, the method for calculating the annual percentage change in the TB case rate was
modified. Unrounded figures are applied to calculate the
percentage change in the case rate.
In Table 5, the populations for U.S.-born and foreign-born
persons for 1993 and 1994 were obtained from Quarterly
Estimates of the United States Foreign-born and Native
Resident Populations: April 1, 1990–July 1, 1999. Denominators for computing the 1995–2011 rates were based
on extrapolations from the U.S. Census Current Population
Survey (March Supplement).
Mortality Data
Official TB mortality statistics for the United States are
compiled by the National Center for Health Statistics
(NCHS), CDC. The annual mortality rate is calculated as
the number of deaths due to TB in that year, divided by the
estimated population for the year, multiplied by 100,000

(Table 1). The number of deaths for 2009 was obtained
from the NCHS, National Vital Statistics Report, Vol.
60, No. 3, December 29, 2011. The finalized numbers of
deaths for 2010 and 2011 were not available at the time of
this publication.
Race and Ethnicity
Beginning with the 2011 report, Table 3 now includes
information on TB cases and percentages by race/ethnicity
and origin of birth (U.S.-born or foreign-born).
Drug Resistance
Beginning with the 2011 report, drug-resistance patterns
are displayed in separate tables with drug-resistance trend
data by previous TB status and origin of birth. Isoniazid
(INH) resistance and multidrug resistance (MDR) are
shown in Tables 9 and 10, respectively.
Completion of Tuberculosis Therapy
Tables 11, 40, 42, and 43 present rates of completion of
TB therapy (COT). Data collected by RVCT Follow Up
Report-2 on date and reason therapy stopped (e.g., patient
completed therapy) were used to calculate rates of COT.
Cases were stratified by the indicated length of therapy,
based on American Thoracic Society/CDC/Infectious
Diseases Society of America treatment guidelines3 in effect
during the period covered, and the patient’s initial drugsusceptibility test results, age, and site of disease.
In Table 40, the first column shows the total number of
cases reported during 2009. The remaining columns are
grouped under three headings: therapy of 1 year or less
indicated therapy, greater than 1 year indicated, and overall. Patients eligible to complete therapy within 1 year had
to have been alive at diagnosis, and initiated therapy with
at least one drug. Eligible patients did not have rifampin
resistance, did not die during therapy, did not move out of
country during treatment, and did not have meningeal TB,
regardless of age. In addition, TB patients under the age
of 15 were not eligible to complete therapy within 1 year if
they had disseminated disease (defined as miliary tuberculosis and/or a positive tuberculosis blood culture). Patients
with culture-negative disease, those with an unknown culture status, and those with culture-positive disease but unknown initial drug-susceptibility test results were included
under the category of 1 year or less of therapy indicated.
In Table 40, each group under an indicated length of
therapy has an initial column showing the number of cases
in persons who were alive at diagnosis and prescribed an
initial regimen of one or more drugs, and who did not die
during therapy. This number was used as the denominator
in COT rate calculations.
COT rates, shown as percentages, were only calculated
for areas reporting reason therapy stopped for at least 90%

of cases shown in the overall column. For the group with
an indicated length of therapy of 1 year or less, rates are
shown for both COT in 1 year or less (COT ≤1 year) and
for COT, regardless of duration (i.e., duration of therapy
≤1 year, >1 year, or unknown). For COT ≤1 year, the
numerator included only those patients completing therapy
in ≤366 days (based on the dates therapy started and
stopped). Patients with missing dates were classified as
“treatment not completed” for this calculation.
Rates of COT, regardless of duration, were calculated
by dividing the number of patients reported as having
completed therapy by the number of total eligible patients. Patients with an outcome other than completed
therapy (i.e., moved, lost, refused treatment, or other) were
classified as “treatment not completed.” Patients with an
unknown outcome were also classified as “treatment not
completed.” For the remaining two groups of indicated
therapy length (greater than 1 year and overall), only rates
of COT, regardless of duration, are presented. Table 12
provides rates for COT ≤1 year and for COT, regardless of
duration, only for the group with an indicated therapy of
1 year or less. Table 42 presents rates of COT by ethnicity and non-Hispanic race and by state for those in whom
therapy less than 1 year was indicated.
Because streptomycin is no longer being used as part of
the standard treatment for TB disease, streptomycin has
been removed from the calculated variable for initial drug
regimen. Consequently, a separate column for the treatment regimen of isoniazid, rifampin, pyrazinamide (IRZ),
ethambutol, streptomycin (E/S) is no longer reported in
Tables 11 and 35.
Site of TB Disease
Miliary disease is classified as both an extrapulmonary and
a pulmonary form of TB (Tables 8, 26, and 27). In publications prior to 1997, miliary disease was classified as
extrapulmonary TB unless pulmonary disease was reported
as the major site of TB disease. Beginning in 2009, miliary disease could not be classified as a site of TB disease
because it is a clinical or radiologic finding and should be
recorded under Initial Chest Radiograph, Initial Chest
CT Scan, or Other Chest Imaging Study.
Reporting of HIV Status
Information on HIV status for persons with TB is shown
in Tables 12 and 37; Table 12 additionally shows trend
data for persons aged 25–44 years. The completeness
of reporting on HIV status among persons with TB has
significantly improved to 90% of TB cases tested among
persons aged 25–44 years in 2011; however, this variable
is still underreported among jurisdictions. Data on the
HIV-infection status of persons with reported TB cases
should be interpreted with caution. These data are not
representative of all TB patients with HIV infection. HIV

3
CDC. Treatment of Tuberculosis, American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR
2003;52(No.RR-11):1-77.

11

testing is performed after a patient receives counseling
and gives informed consent. TB patients who are tested
anonymously may choose not to share the results of HIV
testing with their health care provider. TB patients managed in the private sector may receive confidential HIV
testing, but results may not be reported to the TB program
in the health department. In addition, many factors may
influence HIV testing of TB patients, including the extent
to which testing is targeted or routinely offered to specific
groups (e.g., 25- to 44-year-old males, injecting drug users, homeless persons), and the availability of and access
to HIV testing services. These data may overrepresent or
underrepresent the proportion of TB patients known to be
HIV infected in a reporting area.
Primary Occupation for the Past Year
Table 34 now reflects the new 2009 RVCT variable, Primary Occupation Within the Past Year, which replaces
the Occupation Within Past 24 months of TB Diagnosis
in previous reports. Following the 2009 RVCT revision,
“Multiple Occupation” was removed and the “Retired” and
“Not Seeking Employment” categories were added.
Reason Therapy Stopped
Tables 13 and 41 report a new 2009 RVCT data entry option; these tables now include a patient’s adverse reaction
to anti-TB drug therapy as an option for the reason therapy
stopped. The 2009 RVCT revision removed the option
of “Moved” as a valid response to the variable Reason
Therapy Stopped; however, in 2009 data, the “Moved”
option was still utilized by the following reporting areas:
Alaska, California, Georgia, Iowa, and New York City.
It is anticipated that future reports will not include the
“Moved” option from 2009 forward.
Metropolitan Statistical Areas
Tables 45 through 49 present data by metropolitan statistical areas (MSAs) with an estimated 2011 population of
500,000 or more. MSAs are defined by the federal Office
of Management and Budget, and the definitions effective
as of December 2009 were used for this publication (http://
www.whitehouse.gov/sites/default/files/omb/assets/bulletins/b10-02.pdf). Beginning with the 2011 report, Table
49 will show TB cases by homeless status among those 15
years of age or older by MSA.
On June 6, 2003, the OMB announced new MSA definitions based on Census 2000 data, and the information has
been updated annually. Some MSAs added or dropped
counties and some MSAs merged. The MSA definitions
apply to all areas except the six New England states; for
these states, the New England County Metropolitan Areas
(NECMAs) are used. MSAs are named for a central city
in the MSA or NECMA, may include several cities and
counties, and may cross state boundaries. For example,
the TB cases and case rates presented for the District of
Columbia in Table 19 include only persons residing within

12

the geographic boundaries of the District. However, the TB
cases and case rates for the Washington, D.C., MSA (Table
45) include persons residing within the several counties
in the metropolitan area, including counties in Maryland,
Virginia, and West Virginia.
A city/MSA with incomplete or unavailable data was not
included in the tables, and some cities’ or MSAs’ total
numbers may be underreported owing to missing information.

Morbidity Trend Tables
United States

13

14

Table 1. Tuberculosis Cases, Case Rates per 100,000 Population, Deaths, and Death Rates
per 100,000 Population, and Percent Change: United States, 1953–2011
Year
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
19742
1975
1976
1977
1978
19793
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
1

Number
84,304
79,775
77,368
69,895
67,149
63,534
57,535
55,494
53,726
53,315
54,042
50,874
49,016
47,767
45,647
42,623
39,120
37,137
35,217
32,882
30,998
30,122
33,989
32,105
30,145
28,521
27,669
27,749
27,373
25,520
23,846
22,255
22,201
22,768
22,517
22,436
23,495
25,701
26,283
26,673
25,103
24,205
22,727
21,210
19,751
18,287
17,500
16,309
15,944
15,055
14,835
14,499
14,068
13,727
13,278
12,895
11,528
11,171
10,528

Tuberculosis Cases
Percent Change
Rate
Rate
Number
52.6
--48.9
-5.4
-7.0
46.6
-3.0
-4.7
41.4
-9.7
-11.1
39.0
-3.9
-5.8
36.3
-5.4
-6.9
32.4
-9.4
-10.7
30.7
-3.5
-5.2
29.2
-3.2
-4.9
28.6
-0.8
-2.1
28.6
1.4
0.0
26.5
-5.9
-7.3
25.2
-3.7
-4.9
24.3
-2.5
-3.6
23.0
-4.4
-5.3
21.2
-6.6
-7.8
19.3
-8.2
-9.0
18.1
-5.1
-6.2
17.0
-5.2
-6.1
15.7
-6.6
-7.6
14.6
-5.7
-7.0
14.1
-2.8
-3.4
15.7
--14.7
-5.5
-6.4
13.7
-6.1
-6.8
12.8
-5.4
-6.6
12.3
-3.0
-3.9
12.2
0.3
-0.7
11.9
-1.4
-2.3
11.0
-6.8
-7.7
10.2
-6.6
-7.4
9.4
-6.7
-7.5
9.3
-0.2
-1.1
9.5
2.6
1.6
9.3
-1.1
-2.0
9.2
-0.4
-1.3
9.5
4.7
3.7
10.3
9.4
8.2
10.4
2.3
0.9
10.4
1.5
0.1
9.7
-5.9
-7.1
9.2
-3.6
-4.8
8.5
-6.1
-7.2
7.9
-6.7
-7.8
7.2
-6.9
-8.0
6.6
-7.4
-8.5
6.3
-4.3
-5.4
5.8
-6.8
-7.8
5.6
-2.2
-3.2
5.2
-5.6
-6.5
5.1
-1.5
-2.3
4.9
-2.3
-3.2
4.8
-3.0
-3.9
4.6
-2.4
-3.4
4.4
-3.3
-4.2
4.2
-2.9
-3.8
3.8
-10.6
-11.4
3.6
-3.1
-3.8
3.4
-5.8
-6.4

Number1
19,707
16,527
15,016
14,137
13,390
12,417
11,474
10,866
9,938
9,506
9,311
8,303
7,934
7,625
6,901
6,292
5,567
5,217
4,501
4,376
3,875
3,513
3,333
3,130
2,968
2,914
2,007
1,978
1,937
1,807
1,779
1,729
1,752
1,782
1,755
1,921
1,970
1,810
1,713
1,705
1,631
1,478
1,336
1,202
1,166
1,112
930
776
764
784
711
662
648
644
554
590
529
…
…

Tuberculosis Deaths
Percent Change
Rate1
Number
Rate
12.4
--10.2
-16.1
-17.7
9.1
-9.1
-10.8
8.4
-5.9
-7.7
7.8
-5.3
-7.1
7.1
-7.3
-9.0
6.5
-7.6
-8.5
6.0
-5.3
-7.7
5.4
-8.5
-10.0
5.1
-4.3
-5.6
4.9
-2.1
-3.9
4.3
-10.8
-12.2
4.1
-4.4
-4.7
3.9
-3.9
-4.9
3.5
-9.5
-10.3
3.1
-8.8
-11.4
2.8
-11.5
-9.7
2.6
-6.3
-7.1
2.2
-13.7
-15.4
2.1
-2.8
-4.5
1.8
-11.4
-14.5
1.7
-9.3
-5.6
1.6
-5.1
-5.9
1.5
-6.1
-6.3
1.4
-5.2
-6.7
1.3
-1.8
-7.1
0.9
-31.1
-30.8
0.9
-1.4
0.0
0.8
-2.1
-11.1
0.8
-6.7
0.0
0.8
-1.5
0.0
0.7
-2.8
-12.5
0.7
1.3
0.0
0.7
1.7
0.0
0.7
-1.5
0.0
0.8
9.5
14.3
0.8
2.6
0.0
0.7
-8.1
-12.5
0.7
-5.4
0.0
0.7
-0.5
0.0
0.6
-4.3
-14.3
0.6
-9.4
0.0
0.5
-9.6
-16.7
0.5
-10.0
0.0
0.4
-3.0
-20.0
0.4
-4.6
0.0
0.3
-16.4
-25.0
0.3
-16.6
0.0
0.3
-1.6
0.0
0.3
2.6
0.0
0.2
-10.2
-33.3
0.2
-6.9
0.0
0.2
-2.1
0.0
0.2
-0.6
0.0
0.2
-14.0
0.0
0.2
6.5
0.0
0.2
-10.3
0.0
…
…
…
…
…
…

Official tuberculosis mortality statistics were compiled by the National Center for Health Statistics, CDC, National Vital Statistics Reports.

2

Case data after 1974 are not comparable to prior years due to changes in the surveillance case definition that became effective in 1975.

3

The large decrease in death rate in 1979 occurred because late effects of tuberculosis (e.g., bronchiectasis or fibrosis) and pleurisy with effusion (without mention of cause) are

no longer included in tuberculosis deaths.
Percent change in tuberculosis death rates is calculated with rounded figures. See Technical Notes (page 9).
Note: 1993 to 2011 tuberculosis case counts and rates updated as of June 25, 2012, using Bridged-Race 1990–1999 Intercensal Population Estimates for 1990–1999 (ftp://
ftp.cdc.gov/pub/health_statistics/nchs/datasets/nvss/bridgepop/documentationbridgedintercena1.doc) (accessed July 20, 2012) and Annual Estimates of the Population for the
United States and States, and for Puerto Rico (July 1, 2000– July 1, 2010) (www.census.gov/popest/states/tables/NST-PEST2010-01.xls) (accessed July 20, 2012) and Annual
Estimates of the Population for the United States, Regions, States, and Puerto Rico: April 1, 2010 to July 1, 2011 (http://www.census.gov/popest/data/national/totals/2011/index.
html) (accessed August 8, 2012). Percentage change results reported to one decimal. Ellipses indicate data not available. See Surveillance Slides #2 and #3.

15

16

Total
Cases
25103
24205
22727
21210
19751
18287
17500
16309
15944
15055
14835
14499
14068
13727
13278
12895
11528
11171
10528

No.
272
327
320
287
264
254
242
232
226
185
179
157
152
164
133
137
101
152
129

(%)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
14.0
16.4
15.7
13.7
12.3
11.5
10.7
11.0
10.6
8.6
8.2
7.1
6.8
7.2
5.8
5.9
4.3
6.7
5.6

Rate
No.
3454
3639
3840
3666
3683
3516
3519
3392
3499
3323
3460
3336
3205
3297
3447
3396
3207
3167
3148

(%)
(14)
(15)
(17)
(17)
(19)
(19)
(20)
(21)
(22)
(22)
(23)
(23)
(23)
(24)
(26)
(26)
(28)
(28)
(30)

Asian1
Rate
41.2
41.5
41.8
38.1
36.6
33.5
32.1
31.3
31.2
28.6
29.9
28.0
26.1
26.1
26.5
25.4
23.4
21.5
20.9
No.
8947
8383
7554
7097
6604
5823
5550
5149
4782
4467
4159
4069
3958
3730
3474
3279
2872
2674
2408

(%)
(36)
(35)
(33)
(33)
(33)
(32)
(32)
(32)
(30)
(30)
(28)
(28)
(28)
(27)
(26)
(25)
(25)
(24)
(23)

Rate
28.5
26.2
23.2
21.5
19.7
17.0
16.0
15.0
13.7
12.7
11.7
11.4
10.9
10.2
9.4
8.8
7.6
7.0
6.3

Black or African
American
No.
…
…
…
…
…
…
…
…
…
…
64
63
54
52
95
69
75
95
81

(%)
…
…
…
…
…
…
…
…
…
…
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(1)

Rate
…
…
…
…
…
…
…
…
…
…
16.2
15.6
13.1
12.3
22.1
15.7
16.7
19.0
15.9

Native Hawaiian
or Other Pacific
Islander2
No.
6903
6572
5972
5487
4824
4475
4227
3638
3346
3042
2792
2631
2568
2387
2206
2143
1827
1769
1664

(%)
(27)
(27)
(26)
(26)
(24)
(24)
(24)
(22)
(21)
(20)
(19)
(18)
(18)
(17)
(17)
(17)
(16)
(16)
(16)

White
Rate
3.6
3.4
3.1
2.8
2.5
2.3
2.1
1.9
1.7
1.5
1.4
1.3
1.3
1.2
1.1
1.1
0.9
0.9
0.8

No. (%) Rate
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
…
37
(0) 1.0
34
(0) 0.9
45
(0) 1.1
39
(0) 0.9
24
(0) 0.6
41
(0) 0.9
39
(0) 0.9
32
(0) 0.6
37
(0) 0.6

Multiple Race3
No.
5138
5018
4834
4492
4218
4090
3864
3803
4008
3973
4105
4181
4045
4049
3875
3803
3375
3231
3008

(%)
20
21
21
21
21
22
22
23
25
26
28
29
29
29
29
29
29
29
29

Rate
19.9
18.6
17.2
15.2
13.7
12.6
11.4
10.7
10.8
10.3
10.3
10.2
9.5
9.2
8.5
8.1
7.0
6.4
5.8

Hispanic or Latino4

389
266
207
181
158
129
98
95
83
65
39
28
41
9
24
27
32
51
53

No.

(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)

(%)

Unknown or
Missing5

2

1

Asian race category reporting includes 	Pacific Islander from 1993–2002.
Native Hawaiian or Other Pacific Islander race first reported separately in 2003.
	3
Indicates two or more races reported for a person. Category first reported in 2003. Does not include persons of Hispanic or Latino origin.
4
Persons of Hispanic or Latino ethnicity may be of any race or multiple race.
	5
The higher count for unknown or missing race results for 1993 - 2001 reflect the impact of the transitional period of incorporating new race definitions for Asian, Native Hawaiian, and Multiple Race
in 2003.
	Note: Previously published rates for 1993–1999 have been updated using Bridged-Race 1990–1999 Intercensal Population Estimates for 1993–1999 (http://www.cdc.gov/nchs/nvss/bridged_race.
htm) (accessed Jully 20, 2012). Denominators for computing 2000–2011 case rates were obtained from the Annual Estimates of the Resident Population by Sex, Race, and Hispanic Origin for the
United States: April 1, 2000, to July 1, 2009 (http://www.census.gov/popest/data/historical/2000s/vintage_2009/index.html) (accessed July 20, 2012) and Annual Estimates of the Resident Population by Sex, Race, and Hispanic Origin for the United States: April 1, 2010 to July 1, 2011 (http://www.census.gov/popest/data/national/asrh/2011/index.html) (accessed July 20, 2012).
Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other Pacific Islander, and White) do not include persons of Hispanic
ethnicity or multiple race.
Data for all years updated through June 25, 2012.
Ellipses indicate data not available.
	See Technical Notes.
	See Surveillance Slide #8.
Zero % (0) denotes <0.5%.

Year
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011

American Indian or
Alaska Native

Non-Hispanic

	 able 2. Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Hispanic Ethnicity and non-Hispanic Race:
T
United States, 1993–2011

17

322 (98.5)

314 (98.1)

281 (97.9)

259 (98.5)

249 (98.0)

237 (97.9)

226 (97.4)

214 (95.1)

183 (98.9)

176 (98.3)

154 (98.1)

146 (96.1)

161 (98.2)

129 (97.0)

134 (97.8)

97

150 (98.7)

127 (98.5)

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2

2

4

3

4

3

6

3

3

2

11

6

5

(1.6)

(1.3)

(4.0)

(2.2)

(3.0)

(1.8)

(4.0)

(1.9)

(1.7)

(1.1)

(4.9)

(2.6)

(2.1)

(2.0)

(1.5)

4

5

(2.1)

(1.9)

(1.5)

(3.0)

6

6

5

8
(8.9)

(7.1)

133

133

151

153

135

133

122

147

152

(4.2) 3010 (95.8) 1533 (63.8) 871 (36.2)

59

79

68

(4.7) 3052 (95.3) 1929 (67.2) 941 (32.8)
(4.2) 3015 (95.8) 1769 (66.3) 901 (33.8)

52

72

(4.5) 3239 (95.5) 2238 (68.3) 1041 (31.8)

(3.9) 3302 (96.1) 2458 (71.0) 1003 (29.0)

38

41

(3.8) 3080 (96.2) 2876 (72.8) 1077 (27.3)
(4.0) 3161 (96.0) 2595 (69.6) 1132 (30.4)

55

50

…

…

…

…

…

…

…

…

…

…

(72.8)

(85.0)

(90.7)

(75.4)

(75.8)

(73.1)

(75.9)

(87.3)

(78.1)

…

…

…

…

…

…

…

…

…

…

22

14

7

17

23

14

13

8

14

…

…

…

…

…

…

…

…

…

…

(9.2)

(8.9)

(7.6)

(7.7)

2547 (83.9) 490 (16.1)

2787 (83.6) 547 (16.4)

3102 (85.3) 534 (14.7)

3637 (86.4) 575 (13.7)

3914 (87.6) 553 (12.4)

4255 (88.6) 546 (11.4)

4968 (90.8) 503

5427 (91.1) 529

6009 (92.4) 494

6317 (92.3) 528

(27.2) 1325 (79.9) 334 (20.1)

(15.1) 1423 (80.6) 343 (19.4)

(9.3) 1453 (79.6) 373 (20.4)

(24.6) 1755 (81.9) 387 (18.1)

(24.2) 1784 (81.2) 412 (18.8)

(26.9) 1959 (82.1) 426 (17.9)

(24.1) 2132 (83.1) 434 (16.9)

(12.7) 2211 (84.1) 418 (15.9)

22

15

16

16

9

16

23

15

9

…

…

…

…

…

…

…

…

…

…

(59.5)

(46.9)

(41.0)

(39.0)

(37.5)

(41.0)

(51.1)

(44.1)

(24.3)

…

…

…

…

…

…

…

…

…

…

15

17

23

25

15

23

22

19

28

…

…

…

…

…

…

…

…

…

…

No.

(%)

US-born

980 (24.8) 2973 (75.2)

1025 (25.7) 2964 (74.3)

1015 (26.8) 2770 (73.2)

1119 (29.2) 2717 (70.8)

1281 (31.5) 2785 (68.5)

1464 (34.9) 2727 (65.1)

1603 (35.9) 2859 (64.1)

(40.5) 764 (25.6) 2222 (74.4)

(53.1) 804 (25.0) 2415 (75.0)

(59.0) 850 (25.3) 2516 (74.8)

(61.0) 921 (24.3) 2877 (75.8)

(62.5) 877 (22.8) 2968 (77.2)

(59.0) 983 (24.4) 3051 (75.6)

(48.9) 955 (23.7) 3074 (76.3)

(55.9) 1064 (25.5) 3107 (74.5)

18

10

6

13

14

3

13

15

18

25

34

42

39

51

72

75

(34.6)

(19.6)

(19.4)

(48.2)

(77.8)

(37.5)

(35.1)

(55.6)

(52.9)

(48.1)

(46.6)

(50.6)

(54.2)

(44.4)

(47.7)

(46.0)

1907 (39.6) 2911 (60.4) 118 (60.8)

1989 (40.1) 2966 (59.9) 121 (57.1)

34

41

25

14

4

5

24

12

16

27

39

41

33

64

79

88

76

91

70

(65.4)

(80.4)

(80.7)

(51.9)

(22.2)

(62.5)

(64.9)

(44.4)

(47.1)

(51.9)

(53.4)

(49.4)

(45.8)

(55.7)

(52.3)

(54.0)

(39.2)

(42.9)

(22.7)

Foreignborn
No. (%)

Unknown or
Missing5

2235 (44.0) 2850 (56.1) 238 (77.3)

Hispanic or Latino4
US-born Foreignborn
No. (%) No. (%)

(75.7) 1000 (24.5) 3089 (75.5)

…

…

…

…

…

…

…

…

…

…

White
Multiple Race3
US-born
Foreign- US-born Foreignborn
born
No. (%) No. (%) No. (%) No. (%)

(21.9) 2369 (85.0) 418 (15.0)

…

…

…

…

…

…

…

…

…

…

Native Hawaiian
or Other Pacific
Islander2
US-born
Foreignborn
No. (%) No. (%)

(4.4) 3182 (95.6) 2971 (73.1) 1096 (27.0)

(4.4) 3297 (95.6) 3087 (74.4) 1064 (25.6)

(3.3) 3160 (96.7) 3401 (76.4) 1051 (23.6)

(3.0) 3320 (97.0) 3664 (76.7) 1114 (23.3)

102

109

(3.5) 3217 (96.6) 4107 (79.8) 1038 (20.2)

(3.5) 3336 (96.5) 4608 (83.3) 924 (16.7)

(3.3) 3329 (96.7) 4972 (85.5) 845 (14.5)

(3.6) 3494 (96.4) 5718 (86.7) 875 (13.3)

(3.7) 3479 (96.3) 6301 (88.8) 793 (11.2)

(3.0) 3665 (97.0) 6750 (89.4) 797 (10.6)

(3.7) 3443 (96.3) 7576 (91.1) 738

(3.0) 3299 (97.0) 8250 (92.9) 630

115

121

115

132

132

114

133

103

Black or African
Asian
American
US-born
ForeignUS-born Foreignborn
born
No. (%) No. (%) No. (%) No. (%)
1

1

Asian race category reporting includes 	Pacific Islander from 1993–2002.
2
Native Hawaiian or Other Pacific Islander race first reported separately in 2003.
	3
Indicates two or more races reported for a person. Category first reported in 2003. Does not include persons of Hispanic or Latino origin.
4
Persons of Hispanic or Latino ethnicity may be of any race or multiple race.
	5
The higher count for unknown or missing race results for 1993 - 2001 reflect the impact of the transitional period of incorporating new race definitions for Asian, Native Hawaiian, and Multiple
Race in 2003.
	Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other Pacific Islander, and White) do not include persons of Hispanic ethnicity or multiple race.
Data for all years updated through June 25, 2012.
Ellipses indicate data not available.
	See Technical Notes.
	See Surveillance Slide #13.

(96.0)

263 (97.1)

1993

Year

American Indian or
Alaska Native
US-born Foreignborn
No. (%) No. (%)

Non-Hispanic

	Table 3. Tuberculosis Cases and Percentages by Hispanic Ethnicity and non-Hispanic Race, and Origin of Birth:
United States, 1993–2011

	 able 4. Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Age
T
Group: United States, 1993–2011
Total
Year Cases
1993 25103
1994 24205
1995 22727
1996 21210
1997 19751
1998 18287
1999 17500
2000 16309
2001 15944
2002 15055
2003 14835
2004 14499
2005 14068
2006 13727
2007 13278
2008 12895
2009 11528
2010 11171
2011 10528

0–14
No.
1660
1659
1536
1356
1251
1077
1038
965
929
944
911
953
854
803
775
785
647
637
577

(%)
(7)
(7)
(7)
(6)
(6)
(6)
(6)
(6)
(6)
(6)
(6)
(7)
(6)
(6)
(6)
(6)
(6)
(6)
(5)

15–24
Rate
2.9
2.9
2.6
2.3
2.1
1.8
1.7
1.6
1.5
1.6
1.5
1.6
1.4
1.3
1.3
1.3
1.0
1.0
0.9

No.
1821
1832
1697
1637
1674
1543
1518
1618
1597
1498
1573
1603
1541
1532
1580
1444
1278
1199
1033

(%)
(7)
(8)
(7)
(8)
(8)
(8)
(9)
(10)
(10)
(10)
(11)
(11)
(11)
(11)
(12)
(11)
(11)
(11)
(10)

25–44
Rate
5.0
5.0
4.6
4.4
4.5
4.1
3.9
4.1
4.0
3.7
3.8
3.8
3.7
3.6
3.7
3.4
3.0
2.7
2.4

No.
9589
9043
8200
7564
6884
6335
6062
5576
5609
5288
5074
4939
4740
4689
4313
4241
3889
3672
3369

(%)
(38)
(37)
(36)
(36)
(35)
(35)
(35)
(34)
(35)
(35)
(34)
(34)
(34)
(34)
(32)
(33)
(34)
(33)
(32)

>65

45–64
Rate
11.5
10.7
9.7
8.9
8.0
7.4
7.1
6.6
6.6
6.3
6.1
5.9
5.7
5.6
5.2
5.1
4.7
4.5
4.1

No.
6196
6125
5960
5572
5278
4954
4860
4635
4515
4182
4283
4192
4124
4039
4036
3929
3424
3433
3297

(%)
(25)
(25)
(26)
(26)
(27)
(27)
(28)
(28)
(28)
(28)
(29)
(29)
(29)
(29)
(30)
(30)
(30)
(31)
(31)

Rate
12.4
11.9
11.3
10.2
9.4
8.5
8.1
7.4
7.0
6.3
6.3
5.9
5.7
5.4
5.3
5.0
4.3
4.2
4.0

No.
5820
5540
5329
5076
4663
4378
4020
3515
3293
3142
2994
2811
2809
2663
2574
2496
2283
2228
2247

(%)
(23)
(23)
(23)
(24)
(24)
(24)
(23)
(22)
(21)
(21)
(20)
(19)
(20)
(19)
(19)
(19)
(20)
(20)
(21)

Unk.1
Rate
17.7
16.6
15.8
14.9
13.6
12.6
11.6
10.0
9.3
8.8
8.3
7.8
7.7
7.2
6.8
6.4
5.8
5.5
5.4

No. (%)
17 (0)
6
(0)
5
(0)
5
(0)
1
(0)
0
(0)
2
(0)
0
(0)
1
(0)
1
(0)
0
(0)
1
(0)
0
(0)
1
(0)
0
(0)
0
(0)
7
(0)
2
(0)
5
(0)

Includes unknown and missing.
Note: Previously published rates for 1993–1999 have been updated using Bridged-Race 1990–1999 Intercensal Population Estimates for
1990–1999 (ftp://ftp.cdc.gov/pub/health_statistics/nchs/datasets/nvss/bridgepop/documentationbridgedintercena1.doc) (accessed August
30, 2011) Denominators for computing 2000–2011 case rates were obtained from the Annual Estimates of the Resident Population by
Sex and Five-Year Age Groups for the United States: April 1, 2000 to July 1, 2009 (http://www.census.gov/popest/data/historical/2000s/
vintage_2009/index.html), and Annual Estimates of the Resident Population by Sex and Five-Year Age Group for the United States: April 1,
2010 to July 1, 2011 (http://www.census.gov/popest/data/national/asrh/2011/index.html) (accessed July 20, 2012).
Data for all years updated through June 25, 2012.
See Technical Notes.
Zero % (0) denotes <0.5%.
See Surveillance Slides #5 and #6.

1

Table 5. Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Origin
of Birth: United States, 1993–2011
Year
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011

Total
Cases
25103
24205
22727
21210
19751
18287
17500
16309
15944
15055
14835
14499
14068
13727
13278
12895
11528
11171
10528

Foreign-born Persons1

U.S.-born Persons
No.
17435
16191
14676
13398
11935
10634
9806
8648
7872
7282
6861
6632
6308
5888
5478
5282
4570
4383
3981

(%)
(69)
(67)
(65)
(63)
(60)
(58)
(56)
(53)
(49)
(48)
(46)
(46)
(45)
(43)
(41)
(41)
(40)
(39)
(38)

Rate
7.4
6.9
6.2
5.6
5.0
4.4
4.0
3.5
3.2
2.9
2.7
2.6
2.5
2.3
2.1
2.0
1.7
1.6
1.5

No.
7402
7750
7998
7739
7742
7599
7602
7619
8009
7718
7929
7845
7730
7815
7731
7603
6941
6748
6510

(%)
(29)
(32)
(35)
(36)
(39)
(42)
(43)
(47)
(50)
(51)
(53)
(54)
(55)
(57)
(58)
(59)
(60)
(60)
(62)

Rate
34.0
34.4
34.9
31.5
30.0
28.9
29.2
27.3
26.9
25.4
23.5
23.2
22.4
22.0
20.7
20.4
18.9
18.2
17.2

Unknown or Missing
No.
266
264
53
73
74
54
92
42
63
55
45
22
30
24
69
10
17
40
37

(%)
(1)
(1)
(0)
(0)
(0)
(0)
(1)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(0)
(0)
(0)
(0)

Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin
Islands, and U.S. minor and outlying Pacific islands.
Note: Denominators for computing rates for years 1993–1994 were obtained from Quarterly Estimates of the United States Foreignborn and Native Resident Populations: April 1, 1990–July 1, 1999, located at http://www.census.gov/population/estimates/nation/nativity/
fbtab001.txt (accessed July 20, 2012). Denominators for computing the 1995–2011 rates are based on the U.S. Census Bureau, Current
Population Survey (March Supplement).
Data for all years updated through June 25, 2012.
	See Technical Notes.
Zero % (0) denotes <0.5%.
See Surveillance Slides #11, #12, #15, and #16.
1

18

	Table 6. Tuberculosis Cases and Percentages Among Foreign-born Persons1 by the Top 30
Countries2 of Birth: United States, 2007–2011
Year
2011
Country of Origin
Total Cases
Mexico
Philippines
India
Viet Nam
China
Guatemala
Haiti
Ethiopia
Honduras
Korea, Republic of
Somalia
El Salvador
Peru
Ecuador
Cambodia
Myanmar
Pakistan
Dominican Republic
Kenya
Nepal
Laos
Bangladesh
Thailand
Nigeria
Colombia
Indonesia
Cuba
Liberia
Taiwan
Russia
All Others3

2010

2009

2008

2007

No.

(%)

No.

(%)

No.

(%)

No.

(%)

No.

(%)

6510
1432
757
502
546
376
166
187
154
127
131
116
103
93
79
91
90
86
74
74
77
59
66
37
52
32
32
41
26
38
23
843

(100)
(22)
(12)
(8)
(8)
(6)
(3)
(3)
(2)
(2)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(0)
(1)
(0)
(1)
(0)
(13)

6748
1537
750
583
536
368
195
196
161
143
119
126
116
111
84
68
118
74
84
62
61
68
58
46
43
42
58
33
36
26
20
826

(100)
(23)
(11)
(9)
(8)
(5)
(3)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(1)
(0)
(0)
(12)

6941
1595
805
541
532
345
214
207
172
152
156
113
119
94
99
99
104
84
71
73
74
60
46
57
46
40
34
36
34
26
31
882

(100)
(23)
(12)
(8)
(8)
(5)
(3)
(3)
(2)
(2)
(2)
(2)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(1)
(0)
(0)
(0)
(13)

7603
1762
860
598
583
405
252
237
183
195
150
151
147
144
114
77
108
87
88
82
70
68
55
62
50
43
30
42
33
31
35
861

(100)
(23)
(11)
(8)
(8)
(5)
(3)
(3)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(1)
(0)
(0)
(0)
(11)

7731
1,841
951
625
570
386
243
173
178
181
155
176
158
139
116
95
65
79
89
69
53
79
56
47
44
56
52
41
46
38
40
890

(100)
(24)
(12)
(8)
(7)
(5)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(0)
(1)
(12)

Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin
Islands, and U.S. minor and outlying Pacific islands.
2
The top 30 countries were selected based on their ranked 5-year average number of TB cases.
3
Includes Not Specified for Country of Origin.
Note: Zero (0) denotes <0.5%.
Data for all years updated through June 25, 2012.
1

19

	Table 7. Tuberculosis Cases and Percentages Among Foreign-born Persons1 by the Top 30
Countries of Birth and Years in the United States Before TB Diagnosis: United States, 2011
No.Years in U.S.3
Total Cases
Country of Origin

< 1 Year

1 - 4 Years

≥ 5 Years

Unknown

No.

No.

(%)

No.

(%)

No.

(%)

No.

(%)

Mexico

1432

128

(9)

164

(11)

946

(66)

194

(14)

Philippines

757

112

(15)

101

(13)

462

(61)

82

(11)

Vietnam

546

57

(10)

68

(12)

336

(62)

85

(16)

India

502

85

(17)

122

(24)

255

(51)

40

(8)

China

376

54

(14)

59

(16)

242

(64)

21

(6)

Haiti

187

29

(16)

39

(21)

107

(57)

12

(6)

Guatemala

166

17

(10)

56

(34)

80

(48)

13

(8)

Ethiopia

154

30

(19)

64

(42)

57

(37)

3

(2)

2

Korea, Republic of

131

8

(6)

7

(5)

98

(75)

18

(14)

Honduras

127

23

(18)

21

(17)

75

(59)

8

(6)

Somalia

116

22

(19)

33

(28)

57

(49)

4

(3)

El Salvador

103

7

(7)

18

(17)

73

(71)

5

(5)

Peru

93

12

(13)

12

(13)

65

(70)

4

(4)

Cambodia

91

1

(1)

10

(11)

71

(78)

9

(10)

Myanmar

90

39

(43)

32

(36)

13

(14)

6

(7)

Pakistan

86

14

(16)

12

(14)

57

(66)

3

(3)

Ecuador

79

5

(6)

17

(22)

46

(58)

11

(14)

Nepal

77

22

(29)

37

(48)

17

(22)

1

(1)

Dominican Republic

74

22

(30)

10

(14)

42

(57)

0

(0)

Kenya

74

15

(20)

22

(30)

36

(49)

1

(1)

Bangladesh

66

16

(24)

16

(24)

26

(39)

8

(12)

Laos

59

0

(0)

3

(5)

48

(81)

8

(14)

Nigeria

52

18

(35)

16

(31)

16

(31)

2

(4)

Cuba

41

4

(10)

6

(15)

28

(68)

3

(7)

Bhutan

39

30

(77)

8

(21)

0

(0)

1

(3)

Taiwan

38

1

(3)

2

(5)

33

(87)

2

(5)

Korea, DPR

37

3

(8)

5

(14)

27

(73)

2

(5)

Thailand

37

6

(16)

6

(16)

24

(65)

1

(3)

Colombia

32

5

(16)

3

(9)

23

(72)

1

(3)

Indonesia

32

6

(19)

4

(13)

18

(56)

4

(13)

All Others4

816

134

(16)

131

(16)

460

(56)

91

(11)

Total

6510

925

(14)

1104

(17)

3838

(59)

643

(10)

Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin
Islands, and U.S. minor and outlying Pacific islands.
2
Ranked by total case count.
3
Among foreign-born persons, the number of years since arrival in the United States before diagnosis with tuberculosis.
4
Includes Not Specified for Country of Origin.
See Surveillance Slide #18
1

20

21

25103

24205

22727

21210

19751

18287

17500

16309

15944

15055

14835

14499

14068

13727

13278

12895

11528

11171

10528

Year

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

8042

8416

8861

10024

10425

10744

10955

11326

11683

11974

12749

13013

13995

14790

15979

17154

18266

19506

20307

No.

(76)

(75)

(77)

(78)

(79)

(78)

(78)

(78)

(79)

(80)

(80)

(80)

(80)

(81)

(81)

(81)

(80)

(81)

(81)

(%)

166

141

82

18

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

No.

NAA2

Culture

(2)

(1)

(1)

(0)

(0)

(0)

(0)

(0)

(0)

(0)

(0)

(0)

(0)

(0)

(0)

(0)

(0)

(0)

(0)

(%)

60

78

78

60

69

93

96

80

116

104

123

148

172

155

155

131

189

189

185

No.

Positive
Smear

(1)

(1)

(1)

(0)

(1)

(1)

(1)

(1)

(1)

(1)

(1)

(1)

(1)

(1)

(1)

(1)

(1)

(1)

(1)

(%)

1664

1875

1766

1546

1496

1629

1795

1824

1783

1822

1886

1951

2103

2253

2411

2607

2748

2916

3088

No.

(16)

(17)

(15)

(12)

(11)

(12)

(13)

(13)

(12)

(12)

(12)

(12)

(12)

(12)

(12)

(12)

(12)

(12)

(12)

(%)

Clinical
Case Definition

596

661

741

1247

1288

1261

1222

1269

1253

1155

1186

1197

1230

1089

1206

1318

1524

1594

1523

No.

(6)

(6)

(6)

(10)

(10)

(9)

(9)

(9)

(8)

(8)

(7)

(7)

(7)

(6)

(6)

(6)

(7)

(7)

(6)

(%)

Provider
Diagnosis

8333

8726

9012

10237

10587

10852

11126

11523

11805

11901

12724

13086

14066

14801

16239

17387

18887

20318

21154

2

1

(79)

(78)

(78)

(79)

(80)

(79)

(79)

(79)

(80)

(79)

(80)

(80)

(80)

(81)

(82)

(82)

(83)

(84)

(84)

(%)

2188

2435

2497

2650

2687

2872

2936

2972

3020

3148

3216

3211

3431

3484

3509

3814

3835

3885

3940

No.

(21)

(22)

(22)

(21)

(20)

(21)

(21)

(21)

(20)

(21)

(20)

(20)

(20)

(19)

(18)

(18)

(17)

(16)

(16)

(%)

Extrapulmonary4

Site of Disease5
Pulmonary3
No.

Based on the public health surveillance case definition for tuberculosis; see Appendix A .
Nucleic Acid Amplification test
3
Includes all cases among persons with pulmonary as the only site of disease, and persons with both pulmonary and extrapulmonary sites of disease.
4
Includes cases among persons with extrapulmonary TB disease only.
5
Excludes missing and unknowns.
Note: See Technical Notes.
Data for all years updated through June 25, 2012.

Total
Cases

Positive

Positive

Verification Criterion1

	Table 8.  Tuberculosis Cases and Percentages by Case Verification Criterion and Site of Disease: United States, 1993–2011

22

982

1534

1543

1350

1284

1195

1120

999

981

897

912

903

872

841

845

798

834

761

692

736

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

57

62

52

56

71

67

69

64

65

80

87

84

82

98

109

142

168

175

161

No.

Previous
TB

(17.1)

(17.5)

(15.2)

(13.1)

(14.3)

(13.6)

(13.7)

(11.9)

(12.4)

(14.1)

(13.8)

(13.3)

(12.3)

(13.1)

(14.7)

(16.5)

(17.5)

(16.9)

(16.4)

(%)

7335

7714

7689

9306

9645

9905

10064

10481

10751

10813

11509

11825

12655

13420

14448

15358

16022

16416

16601

Eligible

672

622

649

774

715

770

761

801

822

826

800

889

899

1011

1078

1133

1172

1352

1367

No.

No Previous
TB

Total INH-resistant

(9.2)

(8.1)

(8.4)

(8.3)

(7.4)

(7.8)

(7.6)

(7.6)

(7.6)

(7.6)

(7.0)

(7.5)

(7.1)

(7.5)

(7.5)

(7.4)

(7.3)

(8.2)

(8.2)

(%)

133

126

118

168

206

203

238

274

253

303

324

360

383

485

455

559

593

693

668

Eligible

8

12

6

12

(6.0)

(9.5)

(5.1)

(7.1)

(6.8)

(4.4)

9
14

(7.1)

(5.5)

(6.3)

(7.6)

(8.6)

(6.1)

(6.5)

(7.8)

(7.7)

(12.2)

(13.0)

(11.7)

(12.4)

(%)

17

15

16

23

28

22

25

38

35

68

77

81

83

No.

Previous
TB

2623

2935

3034

3677

3877

4144

4412

4698

4864

5069

5583

6144

7020

7712

8705

9646

10351

11019

11809

Eligible

170

164

186

189

164

173

188

214

214

206

242

269

283

366

435

496

555

709

789

No.

No Previous
TB

U.S.-born INH-resistant3

Isoniazid Resistant TB Cases

(6.5)

(5.6)

(6.1)

(5.1)

(4.2)

(4.2)

(4.3)

(4.6)

(4.4)

(4.1)

(4.3)

(4.4)

(4.0)

(4.7)

(5.0)

(5.1)

(5.4)

(6.4)

(6.7)

(%)

201

227

225

258

288

289

267

263

271

264

302

272

283

262

286

303

363

336

301

Eligible

49

50

46

44

57

57

52

49

49

57

59

(24.4)

(22.0)

(20.4)

(17.1)

(19.8)

(19.7)

(19.5)

(18.6)

(18.1)

(21.6)

(19.5)

(22.8)

(19.4)
62

(22.9)
55

(25.9)

(24.4)

(25.1)

(27.7)

(24.9)

(%)

60

74

74

91

93

75

No.

Previous
TB

4686

4752

4648

5623

5717

5745

5635

5773

5858

5703

5890

5652

5583

5675

5698

5665

5640

5280

4664

Eligible

500

454

463

584

547

596

567

587

605

619

557

617

614

643

640

636

616

631

564

No.

No Previous
TB

Foreign-born3,4 INH-resistant

(10.7)

(9.6)

(10.0)

(10.4)

(9.6)

(10.4)

(10.1)

(10.2)

(10.3)

(10.9)

(9.5)

(10.9)

(11.0)

(11.3)

(11.2)

(11.2)

(10.9)

(12.0)

(12.1)

(%)

1

Resistance to at least isoniazid. Isolates may be resistant to other drugs. Cases are culture positive with initial drug susceptibility testing done. Excludes cases with susceptibility testing not done or unknown for isoniazid.
2
This column provides an overall total of all INH-resistant cases, including those where previous history of TB is unknown and origin or birth is unknown.
3
Excludes cases where previous history of TB is unknown and cases where origin of birth is unknown.
4
Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto
Rico, the Republic of Palau, the U.S. Virgin Islands, and U.S. minor and outlying Pacific islands.
Note: Data for all years updated through June 25, 2012.

334

354

343

427

496

493

505

537

524

569

629

632

669

749

742

862

958

1033

Eligible

Year

All INHresistant2

Table 9. Tuberculosis Cases and Percentages, by Resistance to INH1, Origin of Birth, and Previous History of TB:
United States, 1993–2011

23

124

124

2004

2005

2006

334

354

343

427

496

493

505

537

524

569

629

632

669

749

742

862

958

1033

26

17

19

19

19

20

22

27

21

26

33

26

28

23

44

43

70

74

76

No.

Previous
TB

(7.8)

(4.8)

(5.5)

(4.4)

(3.8)

(4.1)

(4.4)

(5.0)

(4.0)

(4.6)

(5.2)

(4.1)

(4.2)

(3.1)

(5.9)

(5.0)

(7.3)

(7.2)

(7.7)

(%)

7335

7714

7689

9306

9645

9905

10064

10481

10751

10813

11509

11825

12655

13420

14448

15358

16022

16416

16601

98

89

86

88

101

103

98

100

94

132

115

120

127

132

155

207

254

353

407

No.

No Previous
TB
Eligible

Total MDR3

(1.3)

(1.2)

(1.1)

(0.9)

(1.0)

(1.0)

(1.0)

(1.0)

(0.9)

(1.2)

(1.0)

(1.0)

(1.0)

(1.0)

(1.1)

(1.3)

(1.6)

(2.2)

(2.5)

(%)

133

126

118

168

206

203

238

274

253

303

324

360

383

485

455

559

593

693

668

Eligible

1

2

1

3

(0.8)

(1.6)

(0.8)

(1.8)

(1.5)

(0.5)

1
3

(0.4)

(1.5)

(0.8)

(1.0)

(2.2)

(0.6)

(1.6)

(1.2)

(2.6)

(3.8)

(4.7)

(5.1)

(4.5)

(%)

1

4

2

3

7

2

6

6

12

21

28

35

30

No.

Previous
TB

2623

2935

3034

3677

3877

4144

4412

4698

4864

5069

5583

6144

7020

7712

8705

9646

10351

11019

11809

Eligible

17

13

11

21

19

19

20

26

24

35

34

40

39

55

76

105

169

238

301

No.

No Previous
TB

U.S.-born MDR3

Multidrug Resistant TB Cases

(0.6)

(0.4)

(0.4)

(0.6)

(0.5)

(0.5)

(0.5)

(0.6)

(0.5)

(0.7)

(0.6)

(0.7)

(0.6)

(0.7)

(0.9)

(1.1)

(1.6)

(2.2)

(2.5)

(%)

201

227

225

258

288

289

267

263

271

264

302

272

283

262

286

303

363

336

301

Eligible

25

15

18

16

16

19

21

23

19

23

26

(12.4)

(6.6)

(8.0)

(6.2)

(5.6)

(6.6)

(7.9)

(8.7)

(7.0)

(8.7)

(8.6)

(8.8)

(7.8)

22
24

(6.5)

(11.2)

(7.3)

(11.6)

(11.3)

(15.3)

(%)

17

32

22

42

38

46

No.

Previous
TB

4686

4752

4648

5623

5717

5745

5635

5773

5858

5703

5890

5652

5583

5675

5698

5665

5640

5280

4664

Eligible

81

75

75

67

82

84

77

74

70

97

81

80

88

76

79

101

85

110

103

No.

No Previous
TB

Foreign-born3,4 MDR

(1.7)

(1.6)

(1.6)

(1.2)

(1.4)

(1.5)

(1.4)

(1.3)

(1.2)

(1.7)

(1.4)

(1.4)

(1.6)

(1.3)

(1.4)

(1.8)

(1.5)

(2.1)

(2.2)

(%)

1

Resistance to at least isoniazid and rifampin. Isolates may be resistant to other drugs. Cases are culture positive with initial drug susceptibility testing done. Excludes cases with susceptibility testing not done or unknown for
isoniazid and rifampin.
2
This column provides an overall total of all MDR cases, including those where previous history of TB is unknown and origin or birth is unknown.
3
Excludes cases where previous history of TB is unknown and cases where origin of birth is unknown.
4
Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto
Rico, the Republic of Palau, the U.S. Virgin Islands, and U.S. minor and outlying Pacific islands.
Note: Data for all years updated through June 25, 2012.

107

128

2003

124

119

2002

2011

158

2001

2010

151

2000

112

146

1999

2009

157

1998

124

155

1997

107

201

1996

2007

250

1995

2008

327

1994

982

484

431

1993

Eligible

Year

All
MDR2

Table 10. Tuberculosis Cases and Percentages, by Multidrug Resistance1, Origin of Birth, and Previous History of TB:
United States, 1993–2011

	 able 11. Percentages of Tuberculosis Cases by Initial Drug Regimen, Use of Directly
T
Observed Therapy (DOT), and Completion of Therapy (COT): United States, 1993–2011
Directly Observed Therapy3
Initial Drug Regimen
Year

IR

IRZ

1,2

IRZE

DOT Only

Therapy <1 Year Indicated4

Both DOT and SelfAdministered

COT <1 Year

COT

1993
(12.9)
(31.2)
(40.3)
(21.7)
(14.4)
(64.1)
(87.5)
1994
(7.0)
(23.3)
(55.7)
(28.1)
(20.5)
(69.0)
(87.9)
1995
(5.2)
(20.3)
(62.7)
(37.3)
(21.5)
(74.0)
(89.8)
1996
(4.2)
(17.5)
(67.3)
(42.5)
(22.4)
(76.5)
(90.6)
1997
(3.2)
(15.1)
(71.9)
(47.0)
(23.8)
(78.3)
(91.4)
1998
(2.6)
(12.9)
(74.3)
(47.7)
(26.6)
(80.7)
(92.5)
1999
(2.2)
(11.2)
(76.9)
(49.4)
(27.6)
(80.9)
(92.4)
2000
(2.0)
(10.4)
(78.5)
(52.5)
(25.8)
(81.6)
(92.7)
2001
(1.7)
(9.6)
(79.8)
(53.6)
(27.5)
(81.8)
(92.8)
2002
(1.8)
(8.9)
(80.3)
(55.4)
(27.8)
(82.4)
(92.7)
2003
(1.4)
(8.1)
(81.3)
(56.5)
(28.5)
(83.0)
(92.9)
2004
(1.5)
(6.4)
(82.4)
(58.9)
(27.7)
(83.7)
(92.7)
2005
(1.3)
(5.5)
(83.7)
(57.9)
(29.6)
(83.2)
(92.6)
2006
(1.2)
(4.8)
(83.3)
(57.5)
(30.4)
(84.1)
(93.3)
2007
(1.1)
(4.6)
(83.6)
(56.3)
(32.9)
(84.8)
(94.0)
2008
(1.0)
(3.5)
(84.3)
(56.3)
(33.5)
(85.2)
(93.3)
2009
(1.0)
(3.1)
(84.2)
(59.5)
(30.3)
(87.7)
(95.3)
2010
(0.9)
(2.9)
(84.9)
...
...
...
...
20115
(0.7)
(2.7)
(85.6)
...
...
...
...
	1
Includes persons alive at diagnosis.
2
I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol. Excludes cases with no information on initial drug regimen; In 2011, 2.17% received no initial drug therapy, 0.12% were started on one drug, and 10.02% had an initial multidrug regimen other than IR, IRZ, or IRZE.
3
Includes persons alive at diagnosis with initial drug regimen of one or more drugs prescribed.
4
Includes persons alive at diagnosis, with initial drug regimen of one or more drugs prescribed, who did not die during therapy. Excludes
persons with initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or
positive blood culture.
5
Begining in 2011, those who moved out of country during treatment are excluded from the denominator of those eligible for COT.
Note: Data for all years updated through June 25, 2012.
See Technical Notes for description of COT calculation.
See Surveillance Slides #28 and #29..

	 able 12. Tuberculosis Cases and Percentages in Persons with HIV Test Results1 and with
T
HIV Coinfection by Age Group: United States, 1993–2011
25–44 Years Old
HIV Test
Results

All Ages
HIV Test
Results

HIV Positive

HIV Positive

Year

No.

(%)

No.

(%)

No.

(%)

No.

(%)

1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
20112

4382
4442
4276
4366
4141
3862
3810
3525
3576
3512
3424
3442
3277
3285
3160
3109
2857
2751
3042

(46)
(49)
(52)
(58)
(60)
(61)
(63)
(63)
(64)
(66)
(67)
(70)
(69)
(70)
(73)
(73)
(73)
(75)
(90)

2790
2669
2171
1856
1471
1240
1174
955
911
845
807
683
611
558
488
411
402
324
342

(29)
(30)
(26)
(25)
(21)
(20)
(19)
(17)
(16)
(16)
(16)
(14)
(13)
(12)
(11)
(10)
(10)
(9)
(10)

7457
7887
8178
8832
8771
8292
8419
8117
8095
8022
8117
8509
8231
8302
8353
8244
7398
7445
8683

(30)
(33)
(36)
(42)
(44)
(45)
(48)
(50)
(51)
(53)
(55)
(59)
(59)
(60)
(63)
(64)
(64)
(67)
(82)

3682
3601
3037
2615
2091
1831
1725
1464
1408
1390
1320
1195
1042
962
882
820
716
627
672

(15)
(15)
(13)
(12)
(11)
(10)
(10)
(9)
(9)
(9)
(9)
(8)
(7)
(7)
(7)
(6)
(6)
(6)
(6)

Includes persons with positive, negative, or indeterminate HIV test results and persons from California with co-diagnosis of TB and AIDS.
Rhode Island did not report HIV test results for years 1993–1997. HIV test results for Vermont are not included for years 2007–2010. HIV
test results for California are not included for years 2004 - 2010.
2
California began reporting HIV test results to CDC in 2011
Note: Data for all years updated through June 25, 2012.
See Surveillance Slides #24 and #25.
1

24

Table 13. Tuberculosis Cases and Percentages by Reason Tuberculosis Therapy Stopped:
United States, 1993–2009
Total
Cases1

Completed
Therapy

Adverse
Event

Moved2

Refused

Lost

Died3

Year

No.

No.

(%)

No.

(%)

No.

(%)

No.

(%)

No.

(%)

No.

1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009

23741
23051
21706
20298
18930
17584
16862
15785
15408
14564
14379
14081
13681
13316
12903
12551
11153

18044
17763
17306
16528
15673
14766
14234
13408
13241
12482
12418
12119
11735
11540
11343
10876
9790

(76.0)
(77.1)
(79.7)
(81.4)
(82.8)
(84.0)
(84.4)
(84.9)
(85.9)
(85.7)
(86.4)
(86.1)
(85.8)
(86.7)
(87.9)
(86.7)
(87.8)

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
20

(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.2)

1120
1194
969
783
667
534
456
408
378
336
313
337
323
292
241
257
99

(4.7)
(5.2)
(4.5)
(3.9)
(3.5)
(3.0)
(2.7)
(2.6)
(2.5)
(2.3)
(2.2)
(2.4)
(2.4)
(2.2)
(1.9)
(2.0)
(0.9)

1086
740
570
525
444
411
359
397
402
412
389
370
338
358
327
328
192

(4.6)
(3.2)
(2.6)
(2.6)
(2.3)
(2.3)
(2.1)
(2.5)
(2.6)
(2.8)
(2.7)
(2.6)
(2.5)
(2.7)
(2.5)
(2.6)
(1.7)

223
183
156
156
119
104
104
112
99
87
84
82
90
79
73
78
83

(0.9)
(0.8)
(0.7)
(0.8)
(0.6)
(0.6)
(0.6)
(0.7)
(0.6)
(0.6)
(0.6)
(0.6)
(0.7)
(0.6)
(0.6)
(0.6)
(0.7)

3053
2743
2396
1998
1755
1580
1437
1294
1121
1080
994
975
985
939
819
843
666

Unknown4

(%)

No.

(%)

(12.9)
(11.9)
(11.0)
(9.8)
(9.3)
(9.0)
(8.5)
(8.2)
(7.3)
(7.4)
(6.9)
(6.9)
(7.2)
(7.1)
(6.3)
(6.7)
(6.0)

215
428
309
308
272
189
272
166
167
167
181
198
210
108
100
163
303

(0.9)
(1.9)
(1.4)
(1.5)
(1.4)
(1.1)
(1.6)
(1.1)
(1.1)
(1.1)
(1.3)
(1.4)
(1.5)
(0.8)
(0.8)
(1.3)
(2.7)

Includes	all cases in persons reported as alive at diagnosis and taking one or more TB drugs.
In 2009 the moved variable was utilized by the following reporting areas: Alaska, California, Georgia, Iowa, and New York City.
3
Died = died of any cause (not only TB).
4
Includes cases in persons reporting reason therapy stopped = Other, Missing, or Unknown.
Note: Data for all years are updated through June 25, 2012.
Data complete through 2009 only. See Technical Notes for details.

1

2

25

This page intentionally left blank

26

Morbidity Tables
United States, 2011

27

28

Table 14. Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age
Group: United States, 2011
Age Group
Race/Ethnicity and Sex
Total Cases

All Ages

Under 5

5–14

15–24

25–44

45–64

>65

Unknown

10,528

350

227

1033

3369

3297

2247

5

Male

6413

197

114

572

1932

2267

1330

1

Female

4112

153

113

461

1437

1029

917

2

3

0

0

0

0

1

0

2

Hispanic or Latino1

3008

165

90

387

1100

799

465

2

Male

1969

98

47

246

730

571

276

1

Female

1039

67

43

141

370

228

189

1

0

0

0

0

0

0

0

0

American Indian or Alaska Native

129

7

4

8

26

53

31

0

Male

76

4

2

5

12

37

16

0

Female

53

3

2

3

14

16

15

0

Unknown

0

0

0

0

0

0

0

0

Asian

3148

52

37

311

1057

894

796

1

Male

1706

33

21

151

500

535

466

0

Female

1441

19

16

160

557

358

330

1

1

0

0

0

0

1

0

0

Black or African American

2408

82

75

232

821

852

346

0

Male

1440

37

31

121

479

582

190

0

Female

968

45

44

111

342

270

156

0

Unknown

0

0

0

0

0

0

0

0

Native Hawaiian or Other Pacific Islander

81

4

7

16

22

22

10

0

Male

45

2

6

11

11

13

2

0

Female

36

2

1

5

11

9

8

0

Unknown

0

0

0

0

0

0

0

0

White

1664

35

11

66

324

651

577

0

Male

1123

19

5

34

188

511

366

0

Female

541

16

6

32

136

140

211

0

Unknown

0

0

0

0

0

0

0

0

Multiple Race2

37

3

2

5

7

12

8

0

Male

26

2

2

2

4

10

6

0

Female

11

1

0

3

3

2

2

0

Unknown

0

0

0

0

0

0

0

0

Unknown

53

2

1

8

12

14

14

2

Male

28

2

0

2

8

8

8

0

Female

23

0

1

6

4

6

6

0

Unknown

2

0

0

0

0

0

0

2

Unknown

Unknown

Unknown

Persons of Hispanic or Latino ethnicity may be of any race or multiple race.													
Indicates two or more races reported for a person. 								
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other
Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple Race does
not include persons of Hispanic ethnicity.
See Technical Notes.																	
See Surveillance Slide #10.
1
2

29

Table 15. Tuberculosis Case Rates per 100,000 Population by Hispanic Ethnicity and NonHispanic Race, Sex, and Age Group: United States, 2011
Age Group
Race/Ethnicity and Sex

All Ages

Under 5

5–14

15–24

25–44

45 –64

>65

Total Rate

3.4

1.7

0.6

2.4

4.1

4.0

5.4

Male

4.2

1.9

0.5

2.5

4.7

5.6

7.4

Female

2.6

1.6

0.6

2.2

3.5

2.4

3.9

Hispanic or Latino1

5.8

3.2

0.9

4.3

6.8

8.7

15.7

Male

7.4

3.7

1.0

5.2

8.7

12.6

21.8

Female

4.1

2.6

0.9

3.3

4.8

4.9

11.1

American Indian or Alaska Native

5.6

4.0

1.1

2.1

4.3

9.3

16.1

Male

6.7

4.5

1.1

2.5

4.0

13.5

18.6

Female

4.6

3.5

1.1

1.6

4.5

5.4

14.1
53.3

Asian

20.9

5.8

2.0

15.1

21.0

23.9

Male

23.8

7.2

2.3

14.4

21.0

31.2

72.1

Female

18.2

4.3

1.8

15.9

20.9

17.7

38.9

Black or African American

6.3

2.9

1.3

3.6

7.9

9.0

9.9

Male

7.9

2.6

1.1

3.7

9.6

13.2

13.7

Female

4.8

3.3

1.6

3.5

6.2

5.3

7.3

Native Hawaiian or Other Pacific Islander

15.9

10.2

9.1

17.9

13.7

20.0

30.0

Male

17.5

10.0

15.1

24.0

13.5

24.0

13.1

Female

14.3

10.4

2.7

11.5

14.0

16.2

44.2

White

0.8

0.3

0.0

0.3

0.7

1.1

1.8

Male

1.2

0.4

0.0

0.3

0.8

1.8

2.5

Female

0.5

0.3

0.1

0.3

0.6

0.5

1.1

Multiple Race2

0.6

0.3

0.1

0.5

0.6

1.5

3.0

Male

0.9

0.4

0.3

0.4

0.7

2.6

5.2

Female

0.4

0.2

0.0

0.5

0.5

0.5

1.3

Persons of Hispanic or Latino origin may be of any race or multiple race.													
Indicates two or more races reported for a person. 								
Note: Denominators for computing 2000–2011 case rates were obtained from the Annual Estimates of the Population by Sex, Race, and
Hispanic or Latino Origin for the United States: April 1, 2000, to July 1, 2011 (http://www.census.gov/popest/data/national/asrh/2011/files/
NC-EST2011-ALLDATA-R-File04.csv) (accessed July 20, 2012).
Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other Pacific
Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple Race does not
include persons of Hispanic ethnicity.
See Technical Notes.																	
See Surveillance Slide #7.																	
1
2

30

Table 16. Tuberculosis Cases in U.S.-born Persons by Hispanic Ethnicity and Non-Hispanic
Race, Sex, and Age Group: United States, 2011
Age Group
Race/Ethnicity and Sex

All Ages

Under 5

5–14

15–24

25–44

45–64

>65

Unknown

Total Cases

3981

315

141

326

855

1,467

877

0

Male

2611

174

77

176

525

1,096

563

0

Female

1370

141

64

150

330

371

314

0

0

0

0

0

0

0

0

0

Hispanic or Latino1

764

158

65

131

171

150

89

0

Male

477

95

36

71

109

105

61

0

Female

287

63

29

60

62

45

28

0

0

0

0

0

0

0

0

0

American Indian or Alaska Native

127

7

4

8

25

53

30

0

Male

75

4

2

5

11

37

16

0

Female

52

3

2

3

14

16

14

0

Unknown

0

0

0

0

0

0

0

0

Unknown

Unknown

Asian

133

41

9

24

36

9

14

0

Male

74

22

6

14

18

5

9

0

Female

59

19

3

10

18

4

5

0

Unknown

0

0

0

0

0

0

0

0

Black or African American

1533

69

45

104

378

668

269

0

Male

991

31

22

57

239

482

160

0

Female

542

38

23

47

139

186

109

0

Unknown

0

0

0

0

0

0

0

0

Native Hawaiian or Other Pacific Islander

59

4

7

12

15

14

7

0

Male

31

2

6

8

7

7

1

0

Female

28

2

1

4

8

7

6

0

Unknown

0

0

0

0

0

0

0

0

White

1325

32

8

45

222

561

457

0

Male

935

17

3

21

134

452

308

0

Female

390

15

5

24

88

109

149

0

Unknown

0

0

0

0

0

0

0

0

Multiple Race2

22

3

2

2

4

6

5

0

Male

15

2

2

0

3

5

3

0

Female

7

1

0

2

1

1

2

0

Unknown

0

0

0

0

0

0

0

0

Unknown

18

1

1

0

4

6

6

0

Male

13

1

0

0

4

3

5

0

Female

5

0

1

0

0

3

1

0

Unknown

0

0

0

0

0

0

0

0

Persons of Hispanic or Latino origin may be of any race or multiple race.													
Indicates two or more races reported for a person. 								
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other
Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple race does
not include persons of Hispanic ethnicity.
See Technical Notes.
See Surveillance Slide #13.
1
2

31

Table 17. Tuberculosis Cases in Foreign-born Persons1 by Hispanic Ethnicity and NonHispanic Race, Sex, and Age Group: United States, 2011
Age Group

Not
Stated

All Ages

Under 5

5–14

15–24

25–44

45–64

>65

Total Cases
Male
Female
Unknown

6510
3780
2727
3

35
23
12
0

86
37
49
0

703
394
309
0

2509
1405
1104
0

1815
1160
654
1

1357
760
597
0

5
1
2
2

Hispanic or Latino2
Male
Female
Unknown

2222
1479
743
0

7
3
4
0

25
11
14
0

253
173
80
0

924
619
305
0

643
462
181
0

368
210
158
0

2
1
1
0

2
1
1
0

0
0
0
0

0
0
0
0

0
0
0
0

1
1
0
0

0
0
0
0

1
0
1
0

0
0
0
0

Asian
Male
Female
Unknown

3010
1629
1380
1

11
11
0
0

28
15
13
0

286
137
149
0

1021
482
539
0

883
529
353
1

780
455
325
0

1
0
1
0

Black or African American
Male
Female
Unknown

871
445
426
0

13
6
7
0

30
9
21
0

128
64
64
0

443
240
203
0

180
96
84
0

77
30
47
0

0
0
0
0

Native Hawaiian or Other Pacific Islander
Male
Female
Unknown

22
14
8
0

0
0
0
0

0
0
0
0

4
3
1
0

7
4
3
0

8
6
2
0

3
1
2
0

0
0
0
0

White
Male
Female
Unknown

334
187
147
0

3
2
1
0

3
2
1
0

21
13
8
0

102
54
48
0

88
58
30
0

117
58
59
0

0
0
0
0

Multiple Race3
Male
Female
Unknown

15
11
4
0

0
0
0
0

0
0
0
0

3
2
1
0

3
1
2
0

6
5
1
0

3
3
0
0

0
0
0
0

Unknown
Male
Female
Unknown

34
14
18
2

1
1
0
0

0
0
0
0

8
2
6
0

8
4
4
0

7
4
3
0

8
3
5
0

2
0
0
2

Race/Ethnicity and Sex

American Indian or Alaska Native
Male
Female
Unknown

Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin
Islands, and U.S. minor and outlying Pacific islands. 													
2
Persons of Hispanic or Latino ethnicity may be of any race or multiple race.												
3
Indicates two or more races reported for a person. 								
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other
Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple race does
not include persons of Hispanic ethnicity.
See Technical Notes.
See Surveillance Slide #13.
1

32

This page intentionally left blank

33

Table 18. Tuberculosis Cases Among Foreign-born Persons1 by Country of Birth2:
United States, 2011
African Region
Total Cases = 500
Algeria
Angola
Benin
Botswana
Burkina Faso
Burundi
Cameroon
Cape Verde
Central African Republic
Chad
Comoros
Congo, Republic of
Côte d’Ivoire
DR Congo
Equatorial Guinea
Eritrea

4
4
0
3
1
2
21
3
3
1
0
18
4
0
1
27

Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Kenya
Lesotho
Liberia
Madagascar
Malawi
Mali
Mauritania
Mauritius
Mozambique
Namibia

154
0
10
7
6
0
74
0
26
1
1
3
5
0
2
1

Niger
Nigeria
Rwanda
Sao Tome and Principe
Senegal
Seychelles
Sierra Leone
South Africa
Swaziland
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe

3
52
4
0
10
0
16
5
0
5
3
7
6
7

Netherland Antilles
Nicaragua
Panama
Paraguay
Peru
St. Kitts and Nevis
St. Lucia
St. Vincent & Grenadines
Suriname
Trinidad and Tobago
Turks and Caicos Islands
Uruguay
Venezuela

0
16
7
1
93
1
0
0
0
14
0
1
13

Sudan
Syrian Arab Republic
Tunisia
United Arab Emirates
West Bank and Gaza
Yemen

12
0
0
1
0
5

Americas Region
Total Cases = 2,483
Anguilla
Antigua and Barbuda
Argentina
Bahamas
Barbados
Belize
Bermuda
Bolivia
Brazil
British Virgin Islands
Canada
Cayman Islands
Chile
Colombia

0
0
5
1
1
7
1
18
17
0
1
0
2
32

Costa Rica
Cuba
Dominica
Dominican Republic
Ecuador
El Salvador
Grenada
Guatemala
Guyana
Haiti
Honduras
Jamaica
Mexico
Montserrat

3
41
0
74
79
103
2
166
16
187
127
22
1432
0

Eastern Mediterranean Region
Total Cases = 280
Afghanistan
Bahrain
Djibouti
Egypt
Iran, Islamic Republic of
Iraq
Jordan
Kuwait

34

17
0
0
2
15
11
1
2

Lebanon
Libyan Arab Jamahiriya
Morocco
Oman
Pakistan
Qatar
Saudi Arabia
Somalia

1
0
7
0
86
1
3
116

Table 18. (Cont’d) Tuberculosis Cases Among Foreign-born Persons1 by Country of Birth2:
United States, 2011
European Region
Total Cases = 221
Albania
Andorra
Armenia
Austria
Azerbaijan
Belarus
Belgium
Bosnia and Herzegovina
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Georgia
Germany

8
0
4
0
3
2
0
9
3
3
1
1
1
1
1
4
2
20

Greece
Hungary
Iceland
Ireland
Israel
Italy
Kazakhstan
Kyrgyzstan
Latvia
Lithuania
Luxembourg
Macedonia, TFYR
Malta
Moldova, Republic of
Monaco
Montenegro
Netherlands
Norway

3
4
0
2
2
9
4
1
1
1
0
2
0
2
0
1
0
0

Poland
Portugal
Romania
Russian Federation
San Marino
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Tajikistan
Turkey
Turkmenistan
Ukraine
United Kingdom
Uzbekistan

19
4
13
23
0
1
1
1
2
0
2
0
9
2
31
10
8

37
0
90
77

Sri Lanka
Thailand
Timor-Leste

2
37
0

0
131
59
17
11
0
0
0
0
0

Philippines
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Vietnam
Wallis and Futuna

757
5
1
0
0
7
0
0
546
0

Southeast Asia Region
Total Cases = 882
Bangladesh
Bhutan
India
Indonesia

66
39
502
32

Korea, DPR
Maldives
Myanmar
Nepal

Western Pacific Region
Total Cases = 2,048
Australia
Brunei Darussalam
Cambodia
China
China, Hong Kong SAR
China, Macao SAR
Cook Islands
Fiji
French Polynesia
Japan

1
0
91
376
24
0
0
3
0
19

Kiribati
Korea, Rep.
Lao, PDR
Malaysia
Mongolia
Nauru
New Caledonia
New Zealand
Niue
Papua New Guinea

Other3
Total Cases = 44
Unknown
Total Cases = 52

Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin
Islands, and U.S. minor and outlying Pacific islands
2
Country as reported by patient.
3
Includes country codes currently reported via the National Tuberculosis Surveillance System that are not represented by WHO member
states.
Note: Regional composition of countries based on WHO Report Global Tuberculosis Control 2011, World Health Organization
(WHO/HTM/TB/2011.16) (http://www.who.int/tb/publications/global_report/2011/en/).
1

35

This page intentionally left blank

36

Morbidity Tables
Reporting Areas, 2011

37

38

Table 19. Tuberculosis Cases and Case Rates per 100,000 Population:
Reporting Areas, 2011 and 2010
Cases

Case Rates

Rank According to Rate

Population Estimates
July 1, 2011
311,591,917

Reporting Area
United States

2011

2010

2011

2010

2011

2010

10,528

11,171

3.4

3.6

--

--

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia1
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

161
67
255
85
2,323
70
83
21
56
754
347
123
12
359
100
40
36
71
167
9
233
196
170
137
91
98
8
23
95
11
331
49
910
244
7
145
94
74
260
27
140
15
156
1,325
34
8
221
200
13
70
4

146
57
282
78
2,324
71
85
20
43
834
411
115
15
372
90
48
46
90
200
8
220
222
183
135
116
107
6
27
114
10
405
50
954
296
9
190
86
87
238
26
153
15
193
1,385
20
5
268
239
15
55
7

3.4
9.3
3.9
2.9
6.2
1.4
2.3
2.3
9.1
4.0
3.5
8.9
0.8
2.8
1.5
1.3
1.3
1.6
3.7
0.7
4.0
3.0
1.7
2.6
3.1
1.6
0.8
1.2
3.5
0.8
3.8
2.4
4.7
2.5
1.0
1.3
2.5
1.9
2.0
2.6
3.0
1.8
2.4
5.2
1.2
1.3
2.7
2.9
0.7
1.2
0.7

3.1
8.0
4.4
2.7
6.2
1.4
2.4
2.2
7.1
4.4
4.2
8.4
1.0
2.9
1.4
1.6
1.6
2.1
4.4
0.6
3.8
3.4
1.9
2.5
3.9
1.8
0.6
1.5
4.2
0.8
4.6
2.4
4.9
3.1
1.3
1.6
2.3
2.3
1.9
2.5
3.3
1.8
3.0
5.5
0.7
0.8
3.3
3.5
0.8
1.0
1.2

13
1
8
18
3
36
27
28
-7
11
2
47
19
35
37
40
34
10
50
6
16
32
22
14
33
46
41
12
45
9
26
5
23
44
39
24
30
29
21
15
31
25
4
43
38
20
17
49
42
48

19
2
9
22
3
39
26
29
-7
10
1
44
21
40
37
36
30
8
50
13
15
32
23
12
34
49
38
11
47
6
25
5
18
41
35
27
28
31
24
17
33
20
4
48
46
16
14
45
43
42

4,802,740
722,718
6,482,505
2,937,979
37,691,912
5,116,796
3,580,709
907,135
617,996
19,057,542
9,815,210
1,374,810
1,584,985
12,869,257
6,516,922
3,062,309
2,871,238
4,369,356
4,574,836
1,328,188
5,828,289
6,587,536
9,876,187
5,344,861
2,978,512
6,010,688
998,199
1,842,641
2,723,322
1,318,194
8,821,155
2,082,224
19,465,197
9,656,401
683,932
11,544,951
3,791,508
3,871,859
12,742,886
1,051,302
4,679,230
824,082
6,403,353
25,674,681
2,817,222
626,431
8,096,604
6,830,038
1,855,364
5,711,767
568,158

3
140
78
149
27
50
8
...

3
172
102
211
32
80
17
...

5.4
131.0
48.9
221.8
51.8
1.3
38.2
...

5.4
160.5
64.0
320.4
59.8
2.1
81.4
...

---------

---------

55,198
106,836
159,600
67,182
52,167
3,706,690
20,956
105,784

American Samoa1,2
Fed. States of Micronesia1,2
Guam1,2
Marshall Islands1,2
N. Mariana Islands1,2
Puerto Rico1,2
Republic of Palau1,2
U.S. Virgin Islands1,2

Not ranked with the states. See Table 20 for District of Columbia ranking among states.
Not included in U.S. totals.
Note: Denominators for computing 2010 and 2011 rates for states, the District of Columbia, and Puerto Rico were obtained from Annual
Estimates of the Population for the United States, Regions, States, and Puerto Rico (April 1, 2010– July 1, 2011) (http://www.census.gov/
popest/data/national/totals/2011/index.html) (accessed July 20, 2012); for all other areas, from IDB Summary Demographic Data (http://
www.census.gov/population/international/data/idb/informationGateway.php) (accessed July 20, 2012).
Ellipses indicate data not available.
See Technical Notes.
See Surveillance Slide #4.
1
2

39

Table 20. Tuberculosis Cases and Case Rates per 100,000 Population, Ranked and Grouped
by Number of Cases: United States and the District of Columbia, 2011 and 2010
No.

Rate

No.

Rate

No.

Rate

Overall
Rank by
2011 Rate

2,323
1,325
910
754

6.2
5.2
4.7
4.0

2,324
1,385
954
834

6.2
5.5
4.9
4.4

0.0
-4.3
-4.6
-9.6

0.0
-5.5
-4.1
-9.1

3
4
5
7

100 - 499 cases in 2011
Illinois
Georgia
New Jersey
Pennsylvania
Arizona
North Carolina
Maryland
Virginia
Washington
Massachusetts
Michigan
Louisiana
Alabama
Tennessee
Ohio
South Carolina
Minnesota
Hawaii
Indiana

359
347
331
260
255
244
233
221
200
196
170
167
161
156
145
140
137
123
100

2.8
3.5
3.8
2.0
3.9
2.5
4.0
2.7
2.9
3.0
1.7
3.7
3.4
2.4
1.3
3.0
2.6
8.9
1.5

372
411
405
238
282
296
220
268
239
222
183
200
146
193
190
153
135
115
90

2.9
4.2
4.6
1.9
4.4
3.1
3.8
3.3
3.5
3.4
1.9
4.4
3.1
3.0
1.6
3.3
2.5
8.4
1.4

-3.5
-15.6
-18.3
9.2
-9.6
-17.6
5.9
-17.5
-16.3
-11.7
-7.1
-16.5
10.3
-19.2
-23.7
-8.5
1.5
7.0
11.1

-3.4
-16.7
-17.4
5.3
-11.4
-19.4
5.3
-18.2
-17.1
-11.8
-10.5
-15.9
9.7
-20.0
-18.8
-9.1
4.0
6.0
7.1

19
11
9
29
8
23
6
20
17
16
32
10
13
25
39
15
22
2
35

< 100 cases in 2011
Missouri
Nevada
Oklahoma
Mississippi
Arkansas
Connecticut
Oregon
Kentucky
Colorado
Wisconsin
Alaska
District of Columbia
New Mexico
Iowa
Kansas
Utah
Rhode Island
Nebraska
Delaware
South Dakota
West Virginia
Idaho
New Hampshire
Maine
Montana
Vermont
North Dakota
Wyoming

98
95
94
91
85
83
74
71
70
70
67
56
49
40
36
34
27
23
21
15
13
12
11
9
8
8
7
4

1.6
3.5
2.5
3.1
2.9
2.3
1.9
1.6
1.4
1.2
9.3
9.1
2.4
1.3
1.3
1.2
2.6
1.2
2.3
1.8
0.7
0.8
0.8
0.7
0.8
1.3
1.0
0.7

107
114
86
116
78
85
87
90
71
55
57
43
50
48
46
20
26
27
20
15
15
15
10
8
6
5
9
7

1.8
4.2
2.3
3.9
2.7
2.4
2.3
2.1
1.4
1.0
8.0
7.1
2.4
1.6
1.6
0.7
2.5
1.5
2.2
1.8
0.8
1.0
0.8
0.6
0.6
0.8
1.3
1.2

-8.4
-16.7
9.3
-21.6
9.0
-2.4
-14.9
-21.1
-1.4
27.3
17.5
30.2
-2.0
-16.7
-21.7
70.0
3.8
-14.8
5.0
0.0
-13.3
-20.0
10.0
12.5
33.3
60.0
-22.2
-42.9

-11.1
-16.7
8.7
-20.5
7.4
-4.2
-17.4
-23.8
0.0
20.0
16.3
28.2
0.0
-18.8
-18.8
71.4
4.0
-20.0
4.5
0.0
-12.5
-20.0
0.0
16.7
33.3
62.5
-23.1
-41.7

33
12
24
14
18
27
30
34
36
42
1
-26
37
40
43
21
41
28
31
49
47
45
50
46
38
44
48

10,528

3.4

11,171

3.6

-5.8

-5.6

2011
Reporting Area
>= 500 cases in 2011
California
Texas
New York1
Florida

Total

2010–2011 % Change

2010

Includes New York City.
Note: Denominators for computing 2010 and 2011 rates for states, the District of Columbia, and Puerto Rico were obtained from Annual
Estimates of the Population for the United States, Regions, States, and Puerto Rico (April 1, 2010 to July 1, 2011) (www.census.gov/
popest/data/national/totals/2011/index.html) (accessed July 20, 2012).
See Table 20 for ranking of states without the District of Columbia.

1

40

This page intentionally left blank

41

42

40

36

71

167

Iowa

Kansas

Kentucky

Louisiana

331

New Jersey

8

Montana

11

98

Missouri

New Hampshire

91

Mississippi

23

137

Minnesota

95

170

Michigan

Nebraska

196

Massachusetts

Nevada

233

Maryland

9

100

Indiana

Maine

12

359

123

Hawaii

Illinois

347

Georgia

Idaho

754

Florida

0

83

Connecticut

21

70

Colorado

56

2,323

California

Delaware

85

Arkansas

District of Columbia

2

255

Arizona

7

0

6

1

0

2

2

4

6

8

9

0

5

1

1

0

3

6

0

1

16

21

1

5

81

1

8

4

67

7

161

350

Alaska

10,528

United States

No.

Alabama

Total
Cases

Reporting Area

(2.1)

(0.0)

(6.3)

(4.3)

(0.0)

(2.0)

(2.2)

(2.9)

(3.5)

(4.1)

(3.9)

(0.0)

(3.0)

(1.4)

(2.8)

(0.0)

(3.0)

(1.7)

(0.0)

(0.8)

(4.6)

(2.8)

(1.8)

(0.0)

(2.4)

(7.1)

(3.5)

(1.2)

(3.1)

(6.0)

(4.3)

(3.3)

(%)

Under 5

7

0

4

1

0

3

0

6

1

0

6

0

3

0

0

1

4

11

1

0

10

22

0

0

1

3

46

3

5

2

4

227

No.

(2.1)

(0.0)

(4.2)

(4.3)

(0.0)

(3.1)

(0.0)

(4.4)

(0.6)

(0.0)

(2.6)

(0.0)

(1.8)

(0.0)

(0.0)

(2.5)

(4.0)

(3.1)

(8.3)

(0.0)

(2.9)

(2.9)

(0.0)

(0.0)

(1.2)

(4.3)

(2.0)

(3.5)

(2.0)

(3.0)

(2.5)

(2.2)

(%)

5–14

35

1

7

5

0

11

5

25

15

27

19

3

12

6

3

9

10

31

1

12

39

59

9

4

11

6

180

6

27

6

14

1,033

No.

(%)

(10.6)

(9.1)

(7.4)

(21.7)

(0.0)

(11.2)

(5.5)

(18.2)

(8.8)

(13.8)

(8.2)

(33.3)

(7.2)

(8.5)

(8.3)

(22.5)

(10.0)

(8.6)

(8.3)

(9.8)

(11.2)

(7.8)

(16.1)

(19.0)

(13.3)

(8.6)

(7.7)

(7.1)

(10.6)

(9.0)

(8.7)

(9.8)

15–24

124

2

28

6

2

33

23

53

41

70

105

1

51

21

9

14

33

104

3

26

121

217

18

13

36

25

625

21

95

19

49

3,369

No.

(37.5)

(18.2)

(29.5)

(26.1)

(25.0)

(33.7)

(25.3)

(38.7)

(24.1)

(35.7)

(45.1)

(11.1)

(30.5)

(29.6)

(25.0)

(35.0)

(33.0)

(29.0)

(25.0)

(21.1)

(34.9)

(28.8)

(32.1)

(61.9)

(43.4)

(35.7)

(26.9)

(24.7)

(37.3)

(28.4)

(30.4)

(32.0)

(%)

25–44

Table 21. Tuberculosis Cases and Percentages by Age Group: Reporting Areas, 2011

86

4

28

8

4

28

39

28

65

47

56

0

71

29

13

9

25

115

4

46

115

292

18

2

24

22

774

30

58

29

62

3,297

No.
(%)

(26.0)

(36.4)

(29.5)

(34.8)

(50.0)

(28.6)

(42.9)

(20.4)

(38.2)

(24.0)

(24.0)

(0.0)

(42.5)

(40.8)

(36.1)

(22.5)

(25.0)

(32.0)

(33.3)

(37.4)

(33.1)

(38.7)

(32.1)

(9.5)

(28.9)

(31.4)

(33.3)

(35.3)

(22.7)

(43.3)

(38.5)

(31.3)

45–64

72

4

22

2

2

19

22

21

42

44

38

5

25

14

10

7

25

92

3

38

46

143

10

2

9

9

614

24

62

7

25

2,247

No.

>65

(21.8)

(36.4)

(23.2)

(8.7)

(25.0)

(19.4)

(24.2)

(15.3)

(24.7)

(22.4)

(16.3)

(55.6)

(15.0)

(19.7)

(27.8)

(17.5)

(25.0)

(25.6)

(25.0)

(30.9)

(13.3)

(19.0)

(17.9)

(9.5)

(10.8)

(12.9)

(26.4)

(28.2)

(24.3)

(10.4)

(15.5)

(21.3)

(%)

0

0

0

0

0

2

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

3

0

0

0

0

5

No.

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(2.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.1)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(%)

Unknown
or Missing

43

1

221

200

13

70
4
3

Virginia

Washington

West Virginia

Wisconsin

Wyoming

American Samoa1

1

50

…

U.S. Virgin Islands1

Not included in U.S. totals.

8

Republic of Palau1

1

Puerto Rico

0

27

N. Mariana Islands1

3

…

0

18

78

149

Marshall Islands1

15

0

0

4

1

0

1

Guam1

140

4

8

Vermont

Fed. States of Micronesia1

2

34

Utah

66

5

1

5

156

15

South Dakota

1,325

140

South Carolina

2

Texas

27

Rhode Island

8

0

9

4

1

Tennessee

74

260

Pennsylvania

94

Oklahoma

Oregon

145

7

North Dakota

Ohio

244

11

18

910

New York

North Carolina

No.
0

Total
Cases

49

New Mexico

Reporting Area
(%)

(4.5)

(2.0)

(0.0)

…

(0.0)

(2.0)

(0.0)

(12.1)

(3.8)

(10.7)

(0.0)

(0.0)

(5.7)

(7.7)

(2.0)

(0.9)

(0.0)

(2.9)

(5.0)

(3.2)

(6.7)

(3.6)

(7.4)

(3.1)

(0.0)

(9.6)

(2.8)

(14.3)

Under 5

…

0

0

1

23

8

26

0

0

3

0

8

6

1

1

32

3

0

2

0

3

1

3

3

0

5

11

1

No.

(%)

(2.9)

(2.4)

(1.9)

(0.0)

(1.4)

(0.0)

(1.2)

(1.4)

(3.2)

(2.1)

(0.0)

(2.0)

(1.2)

(2.0)

…

(0.0)

(0.0)

(3.7)

(15.4)

(10.3)

(18.6)

(0.0)

(0.0)

(4.3)

(0.0)

(4.0)

(2.7)

(12.5)

5–14

…

0

2

0

27

6

30

0

3

10

1

25

22

1

5

145

18

4

11

3

25

9

6

15

4

24

102

2

No.

(%)

…

(0.0)

(4.0)

(0.0)

(18.1)

(7.7)

(21.4)

(0.0)

(75.0)

(14.3)

(7.7)

(12.5)

(10.0)

(12.5)

(14.7)

(10.9)

(11.5)

(26.7)

(7.9)

(11.1)

(9.6)

(12.2)

(6.4)

(10.3)

(57.1)

(9.8)

(11.2)

(4.1)

15–24

…

1

16

5

42

14

36

1

0

17

1

62

94

2

12

458

49

3

36

12

92

30

26

52

1

78

345

11

No.

(%)

…

(12.5)

(32.0)

(18.5)

(28.2)

(17.9)

(25.7)

(33.3)

(0.0)

(24.3)

(7.7)

(31.0)

(42.5)

(25.0)

(35.3)

(34.6)

(31.4)

(20.0)

(25.7)

(44.4)

(35.4)

(40.5)

(27.7)

(35.9)

(14.3)

(32.0)

(37.9)

(22.4)

25–44

…

6

21

18

34

32

27

2

0

22

5

46

58

2

7

412

47

4

51

8

77

20

31

31

1

70

256

18

No.

…

(75.0)

(42.0)

(66.7)

(22.8)

(41.0)

(19.3)

(66.7)

(0.0)

(31.4)

(38.5)

(23.0)

(26.2)

(25.0)

(20.6)

(31.1)

(30.1)

(26.7)

(36.4)

(29.6)

(29.6)

(27.0)

(33.0)

(21.4)

(14.3)

(28.7)

(28.1)

(36.7)

(%)

45–64

Table 21. (Cont’d) Tuberculosis Cases and Percentages by Age Group: Reporting Areas, 2011

…

1

10

3

5

15

6

0

1

14

5

55

39

2

8

212

34

3

35

2

55

14

19

40

0

56

178

17

No.

>65
(%)

…

(12.5)

(20.0)

(11.1)

(3.4)

(19.2)

(4.3)

(0.0)

(25.0)

(20.0)

(38.5)

(27.5)

(17.6)

(25.0)

(23.5)

(16.0)

(21.8)

(20.0)

(25.0)

(7.4)

(21.2)

(18.9)

(20.2)

(27.6)

(0.0)

(23.0)

(19.6)

(34.7)

…

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

No.

…

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(%)

Unknown
or Missing

44
137

255

85

2,323

70

83

21

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

1
1

347

123

Georgia

Hawaii

8

11

331

New Hampshire

New Jersey

8

23

9

98

Missouri

Montana

95

8

91

Nebraska

15

137

Minnesota

Mississippi

Nevada

12

170

Michigan

105

0

33

3

1

28

196

Massachusetts

47

233

0

21

13

15

Maryland

9

167

Maine

Louisiana

9

36

71

Kansas

40

Kentucky

6

100

Indiana

Iowa

99

12

359

Idaho

Illinois

71

198

56

754

District of Columbia

Florida

3

19

20

848

7

3

67

18

161

3,008

Alabama

10,528

United States

No.

Alaska

Total
Cases

Reporting Area

(31.7)

(0.0)

(34.7)

(13.0)

(12.5)

(9.2)

(8.8)

(10.9)

(7.1)

(14.3)

(20.2)

(0.0)

(12.6)

(18.3)

(25.0)

(15.0)

(15.0)

(27.6)

(8.3)

(0.8)

(20.5)

(26.3)

(14.3)

(14.3)

(22.9)

(28.6)

(36.5)

(8.2)

(53.7)

(4.5)

(11.2)

(28.6)

(%)

Hispanic
or Latino1

0

0

0

0

2

0

1

3

1

0

0

0

2

0

1

0

0

0

1

0

0

2

0

0

0

0

4

1

20

45

0

129

No.

(0.0)

(0.0)

(0.0)

(0.0)

(25.0)

(0.0)

(1.1)

(2.2)

(0.6)

(0.0)

(0.0)

(0.0)

(1.2)

(0.0)

(2.8)

(0.0)

(0.0)

(0.0)

(8.3)

(0.0)

(0.0)

(0.3)

(0.0)

(0.0)

(0.0)

(0.0)

(0.2)

(1.2)

(7.8)

(67.2)

(0.0)

(1.2)

(%)

American Indian
or Alaska Native

112

3

37

5

0

20

8

40

46

81

74

1

22

9

10

13

22

114

3

98

61

91

7

6

30

23

1,096

11

41

9

19

3,148

No.

(33.8)

(27.3)

(38.9)

(21.7)

(0.0)

(20.4)

(8.8)

(29.2)

(27.1)

(41.3)

(31.8)

(11.1)

(13.2)

(12.7)

(27.8)

(32.5)

(22.0)

(31.8)

(25.0)

(79.7)

(17.6)

(12.1)

(12.5)

(28.6)

(36.1)

(32.9)

(47.2)

(12.9)

(16.1)

(13.4)

(11.8)

(29.9)

(%)

Asian

71

3

13

8

0

37

56

66

60

48

86

3

75

16

11

10

23

90

2

1

164

293

39

9

17

16

135

32

19

1

71

2,408

No.

(21.5)

(27.3)

(13.7)

(34.8)

(0.0)

(37.8)

(61.5)

(48.2)

(35.3)

(24.5)

(36.9)

(33.3)

(44.9)

(22.5)

(30.6)

(25.0)

(23.0)

(25.1)

(16.7)

(0.8)

(47.3)

(38.9)

(69.6)

(42.9)

(20.5)

(22.9)

(5.8)

(37.6)

(7.5)

(1.5)

(44.1)

(22.9)

(%)

Black or
African American

0

0

1

1

0

1

0

0

1

0

0

0

0

1

0

0

0

0

0

21

0

6

0

0

0

1

25

6

0

1

1

81

No.

(0.0)

(0.0)

(1.1)

(4.3)

(0.0)

(1.0)

(0.0)

(0.0)

(0.6)

(0.0)

(0.0)

(0.0)

(0.0)

(1.4)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(17.1)

(0.0)

(0.8)

(0.0)

(0.0)

(0.0)

(1.4)

(1.1)

(7.1)

(0.0)

(1.5)

(0.6)

(0.8)

(%)

Native Hawaiian
or Other Pacific
Islander

43

5

11

6

5

28

18

13

46

32

26

5

46

32

5

10

40

55

4

1

51

164

2

3

17

10

196

28

38

6

52

1,664

No.

(13.0)

(45.5)

(11.6)

(26.1)

(62.5)

(28.6)

(19.8)

(9.5)

(27.1)

(16.3)

(11.2)

(55.6)

(27.5)

(45.1)

(13.9)

(25.0)

(40.0)

(15.3)

(33.3)

(0.8)

(14.7)

(21.8)

(3.6)

(14.3)

(20.5)

(14.3)

(8.4)

(32.9)

(14.9)

(9.0)

(32.3)

(15.8)

(%)

White

0

0

0

0

0

0

0

0

0

1

0

0

1

0

0

1

0

0

1

1

0

0

0

0

0

0

6

0

0

0

0

37

No.

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.5)

(0.0)

(0.0)

(0.6)

(0.0)

(0.0)

(2.5)

(0.0)

(0.0)

(8.3)

(0.8)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.3)

(0.0)

(0.0)

(0.0)

(0.0)

(0.4)

(%)

Multiple Race2

Table 22. Tuberculosis Cases and Percentages by Hispanic Ethnicity and Non-Hispanic Race: Reporting Areas, 2011

0

0

0

0

0

3

0

0

4

6

0

0

0

0

0

0

0

1

0

0

0

0

0

0

0

0

13

0

0

2

0

53

No.

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(3.1)

(0.0)

(0.0)

(2.4)

(3.1)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.3)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.6)

(0.0)

(0.0)

(3.0)

(0.0)

(0.5)

(%)

Unknown or
Missing

45

8

221

200

13

70

4

3

Vermont

Virginia

Washington

West Virginia

Wisconsin

Wyoming

American Samoa3

27

50

8

…

Marshall Islands3

N. Mariana Islands3

Puerto Rico3

Republic of Palau3

U.S. Virgin Islands3
…

0

50

0

1

1

2

0

1

17

1

0

10

697

…

(0.0)

(0.0)

(0.7)

(1.3)

(1.4)

(0.0)

(25.0)

(24.3)

(7.7)

(9.0)

(19.0)

(0.0)

(29.4)

(52.6)

(16.7)

(0.0)

(11.4)

(22.2)

(17.3)

(17.6)

(17.0)

(6.2)

(0.0)

(19.3)

(27.9)

(%)
(65.3)

…

0

0

0

0

0

0

0

0

0

0

3

0

0

3

1

0

5

0

0

0

2

16

0

0

7

0

No.
9

…

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(1.5)

(0.0)

(0.0)

(8.8)

(0.1)

(0.0)

(33.3)

(0.0)

(0.0)

(0.0)

(2.7)

(17.0)

(0.0)

(0.0)

(2.9)

(0.0)

(%)
(18.4)

American Indian
or Alaska Native

…

1

0

17

1

39

4

2

2

32

2

94

86

2

11

214

19

3

19

10

84

29

15

37

2

42

332

No.
1

…

(12.5)

(0.0)

(63.0)

(0.7)

(50.0)

(2.9)

(66.7)

(50.0)

(45.7)

(15.4)

(47.0)

(38.9)

(25.0)

(32.4)

(16.2)

(12.2)

(20.0)

(13.6)

(37.0)

(32.3)

(39.2)

(16.0)

(25.5)

(28.6)

(17.2)

(36.5)

(%)
(2.0)

Asian

…

0

0

0

0

0

0

0

0

13

1

42

47

3

4

248

54

2

78

7

69

10

10

51

5

91

194

No.
4

…

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(18.6)

(7.7)

(21.0)

(21.3)

(37.5)

(11.8)

(18.7)

(34.6)

(13.3)

(55.7)

(25.9)

(26.5)

(13.5)

(10.6)

(35.2)

(71.4)

(37.3)

(21.3)

(%)
(8.2)

Black or
African American

…

6

0

7

147

37

132

1

0

0

0

5

0

0

2

2

0

0

0

0

0

2

3

0

0

1

0

No.
0

…

(75.0)

(0.0)

(25.9)

(98.7)

(47.4)

(94.3)

(33.3)

(0.0)

(0.0)

(0.0)

(2.5)

(0.0)

(0.0)

(5.9)

(0.2)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(2.7)

(3.2)

(0.0)

(0.0)

(0.4)

(0.0)

(%)
(0.0)

Native Hawaiian
or Other Pacific
Islander

…

0

0

0

0

0

0

0

1

8

9

35

44

3

4

162

56

5

27

4

59

18

24

48

0

44

112

No.
3

White

…

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(25.0)

(11.4)

(69.2)

(17.5)

(19.9)

(37.5)

(11.8)

(12.2)

(35.9)

(33.3)

(19.3)

(14.8)

(22.7)

(24.3)

(25.5)

(33.1)

(0.0)

(18.0)

(12.3)

(%)
(6.1)

…

0

0

0

0

0

1

0

0

0

0

3

2

0

0

1

1

0

0

0

3

0

1

0

0

12

3

No.
0

…

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.7)

(0.0)

(0.0)

(0.0)

(0.0)

(1.5)

(0.9)

(0.0)

(0.0)

(0.1)

(0.6)

(0.0)

(0.0)

(0.0)

(1.2)

(0.0)

(1.1)

(0.0)

(0.0)

(4.9)

(0.3)

(%)
(0.0)

Multiple Race2

…

1

0

3

0

1

1

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

9

0

0

0

15

No.
0

…

(12.5)

(0.0)

(11.1)

(0.0)

(1.3)

(0.7)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(9.6)

(0.0)

(0.0)

(0.0)

(1.6)

(%)
(0.0)

Unknown or
Missing

2

1

Persons of Hispanic origin may be of any race or multiple race.
Indicates two or more races reported for a person.
3
Not included in U.S. totals.
	Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other Pacific Islander, and White) are mutually exclusive
and do not include persons of Hispanic ethnicity or multiple race. Multiple Race does not include persons of Hispanic ethnicity.
See Technical Notes.

78

149

Guam3

140

18

34

Fed. States of Micronesia3

42

1,325

Texas

Utah

0
26

15

156

16

South Dakota

140

South Carolina

6

45

Tennessee

27

Rhode Island

13

74

260

94

Oregon

9
16

145

Ohio

Oklahoma

Pennsylvania

0

7

47

North Dakota

254

910

244

New York

No.
32

Total
Cases
49

North Carolina

Reporting Area
New Mexico

Hispanic
or Latino1

Table 22. (Cont’d) Tuberculosis Cases and Percentages by Hispanic Ethnicity and Non-Hispanic Race: Reporting Areas, 2011

Table 23. Tuberculosis Cases and Percentages, U.S.-born and Foreign-born Persons1:
United States, 2011
Reporting Area

Total
Cases

U.S.-born Persons

Foreign-born Persons1

Unknown Origin

No.

(%)

No.

(%)

No.

(%)

United States

10,528

3,981

(37.8)

6,510

(61.8)

37

(0.4)

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

161
67
255
85
2,323
70
83
21
56
754
347
123
12
359
100
40
36
71
167
9
233
196
170
137
91
98
8
23
95
11
331
49
910
244
7
145
94
74
260
27
140
15
156
1,325
34
8
221
200
13
70
4

113
52
85
66
513
21
18
5
26
362
188
32
6
133
57
11
16
48
128
3
66
32
82
21
73
60
7
9
26
5
85
24
203
137
0
63
70
24
104
6
107
9
101
625
10
3
69
45
8
23
1

(70.2)
(77.6)
(33.3)
(77.6)
(22.1)
(30.0)
(21.7)
(23.8)
(46.4)
(48.0)
(54.2)
(26.0)
(50.0)
(37.0)
(57.0)
(27.5)
(44.4)
(67.6)
(76.6)
(33.3)
(28.3)
(16.3)
(48.2)
(15.3)
(80.2)
(61.2)
(87.5)
(39.1)
(27.4)
(45.5)
(25.7)
(49.0)
(22.3)
(56.1)
(0.0)
(43.4)
(74.5)
(32.4)
(40.0)
(22.2)
(76.4)
(60.0)
(64.7)
(47.2)
(29.4)
(37.5)
(31.2)
(22.5)
(61.5)
(32.9)
(25.0)

48
15
170
19
1,782
49
65
16
30
392
159
91
6
226
43
29
20
23
39
5
167
164
83
116
18
38
1
13
69
6
246
25
706
107
7
82
24
50
156
21
33
6
55
700
24
5
152
155
5
46
3

(29.8)
(22.4)
(66.7)
(22.4)
(76.7)
(70.0)
(78.3)
(76.2)
(53.6)
(52.0)
(45.8)
(74.0)
(50.0)
(63.0)
(43.0)
(72.5)
(55.6)
(32.4)
(23.4)
(55.6)
(71.7)
(83.7)
(48.8)
(84.7)
(19.8)
(38.8)
(12.5)
(56.5)
(72.6)
(54.5)
(74.3)
(51.0)
(77.6)
(43.9)
(100.0)
(56.6)
(25.5)
(67.6)
(60.0)
(77.8)
(23.6)
(40.0)
(35.3)
(52.8)
(70.6)
(62.5)
(68.8)
(77.5)
(38.5)
(65.7)
(75.0)

0
0
0
0
28
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
5
0
0
0
0
1
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0

(0.0)
(0.0)
(0.0)
(0.0)
(1.2)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(11.1)
(0.0)
(0.0)
(2.9)
(0.0)
(0.0)
(0.0)
(0.0)
(4.3)
(0.0)
(0.0)
(0.0)
(0.0)
(0.1)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(1.4)
(0.0)

Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin
Islands, and U.S. minor and outlying Pacific islands.
Note: See Surveillance Slide #14.

1

46

This page intentionally left blank

47

48

19

1,782

49

California

Colorado

6
0
5
7

30

392

159

91

6

226

43

29

20

District of Columbia

Florida

Georgia

Hawaii

Idaho

Illinois

Indiana

Iowa

Kansas

4

7

18

38

1

Mississippi

Missouri

Montana

83

116

Michigan

6
2

167

164

Maryland

Massachusetts

Minnesota

0

5

Maine

0

1

6

8

6

23

39

Kentucky

Louisiana

66

1

0

41

45

1

2

65

16

Connecticut

Delaware

12

498

4

104

170

Arizona

Arkansas

9
1

48

1,432

15

United States

No.

Alabama

6,510

Reporting Area

(0.0)

(2.6)

(33.3)

(6.9)

(8.4)

(1.2)

(3.6)

(0.0)

(15.4)

(30.4)

(25.0)

(0.0)

(14.0)

(29.2)

(16.7)

(0.0)

(25.8)

(11.5)

(3.3)

(12.5)

(6.2)

(24.5)

(27.9)

(21.1)

(61.2)

(6.7)

(18.8)

(22.0)

(%)

Mexico

Alaska

Total
Cases

0

0

2

3

12

3

15

0

4

2

2

0

5

26

2

68

6

26

1

2

6

2

375

1

14

7

2

757

No.

(0.0)

(0.0)

(11.1)

(2.6)

(14.5)

(1.8)

(9.0)

(0.0)

(10.3)

(8.7)

(10.0)

(0.0)

(11.6)

(11.5)

(33.3)

(74.7)

(3.8)

(6.6)

(3.3)

(12.5)

(9.2)

(4.1)

(21.0)

(5.3)

(8.2)

(46.7)

(4.2)

(11.6)

(%)

Philippines

0

8

2

9

7

16

11

0

13

0

4

3

0

8

0

8

8

21

0

1

5

3

240

6

5

0

5

546

No.

(0.0)

(21.1)

(11.1)

(7.8)

(8.4)

(9.8)

(6.6)

(0.0)

(33.3)

(0.0)

(20.0)

(10.3)

(0.0)

(3.5)

(0.0)

(8.8)

(5.0)

(5.4)

(0.0)

(6.3)

(7.7)

(6.1)

(13.5)

(31.6)

(2.9)

(0.0)

(10.4)

(8.4)

(%)

Vietnam

0

4

3

7

10

17

17

0

2

2

1

3

7

37

0

0

19

20

1

1

10

4

89

2

4

0

11

502

No.

(0.0)

(10.5)

(16.7)

(6.0)

(12.0)

(10.4)

(10.2)

(0.0)

(5.1)

(8.7)

(5.0)

(10.3)

(16.3)

0

3

0

0

3

15

3

0

1

0

0

0

0

16

1

(16.4)

5

(0.0)

0

7

0

0

0

1

121

0

4

0

1

376

(0.0)

(7.9)

(0.0)

(0.0)

(3.6)

(9.1)

(1.8)

(0.0)

(2.6)

(0.0)

(0.0)

(0.0)

(0.0)

(7.1)

(16.7)

(5.5)

(0.0)

(1.8)

(0.0)

(0.0)

(0.0)

(2.0)

(6.8)

(0.0)

(2.4)

(0.0)

(2.1)

(5.8)

(%)

China
No.

(0.0)

(11.9)

(5.1)

(3.3)

(6.3)

(15.4)

(8.2)

(5.0)

(10.5)

(2.4)

(0.0)

(22.9)

(7.7)

(%)

India

Country of Origin

0

1

0

0

0

15

1

0

0

0

0

0

0

2

0

0

2

101

0

0

7

0

3

0

0

0

0

187

No.

(0.0)

(2.6)

(0.0)

(0.0)

(0.0)

(9.1)

(0.6)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.9)

(0.0)

(0.0)

(1.3)

(25.8)

(0.0)

(0.0)

(10.8)

(0.0)

(0.2)

(0.0)

(0.0)

(0.0)

(0.0)

(2.9)

(%)

Haiti

0

1

1

1

1

2

3

0

1

2

0

0

1

3

0

0

14

13

1

1

2

0

36

1

4

0

7

166

No.

(0.0)

(2.6)

(5.6)

(0.9)

(1.2)

(1.2)

(1.8)

(0.0)

(2.6)

(8.7)

(0.0)

(0.0)

(2.3)

(1.3)

(0.0)

(0.0)

(8.8)

(3.3)

(3.3)

(6.3)

(3.1)

(0.0)

(2.0)

(5.3)

(2.4)

(0.0)

(14.6)

(2.5)

(%)

Guatemala

1

15

4

88

43

81

111

5

12

10

8

8

23

67

2

10

69

159

26

9

31

27

418

5

35

5

13

2,492

No.

0

5
(100.0)

0
(39.5)

0

0

13

0

0

0

0

0

15

1

1

0

0

0

0

0

0

0

0

2

0

0

2

0

52

No.

(0.0)

(13.2)

(0.0)

(0.0)

(0.0)

(7.9)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(51.7)

(2.3)

(0.4)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.1)

(0.0)

(0.0)

(13.3)

(0.0)

(0.8)

(%)

Unknown or
Missing

(22.2)

(75.9)

(51.8)

(49.4)

(66.5)

(100.0)

(30.8)

(43.5)

(40.0)

(27.6)

(53.5)

(29.6)

(33.3)

(11.0)

(43.4)

(40.6)

(86.7)

(56.3)

(47.7)

(55.1)

(23.5)

(26.3)

(20.6)

(33.3)

(27.1)

(38.3)

(%)

All Others2

Table 24. Tuberculosis Cases and Percentages in Foreign-born Persons1 by Top 7 Countries of Birth: United States, 2011

49

0

3

Wyoming

0

11

1

15

8

0

6

352

17

0

8

(0.0)

(23.9)

(20.0)

(9.7)

(5.3)

(0.0)

(25.0)

(50.3)

(30.9)

(0.0)

(24.2)

(0.0)

(5.1)

(14.0)

(33.3)

(2.4)

(0.0)

(21.5)

(7.9)

(84.0)

(11.0)

(0.0)

(27.5)

(%)
(7.7)

0

0

0

25

14

0

1

25

1

1

2

2

11

4

1

5

0

5

24

1

25

1

23

No.
0

(0.0)

(0.0)

(0.0)

(16.1)

(9.2)

(0.0)

(4.2)

(3.6)

(1.8)

(16.7)

(6.1)

(9.5)

(7.1)

(8.0)

(4.2)

(6.1)

(0.0)

(4.7)

(3.4)

(4.0)

(10.2)

(16.7)

(33.3)

(%)
(0.0)

Philippines

0

1

0

26

13

0

1

62

1

0

5

1

16

10

1

3

0

10

5

0

5

0

2

No.
1

(0.0)

(2.2)

(0.0)

(16.8)

(8.6)

(0.0)

(4.2)

(8.9)

(1.8)

(0.0)

(15.2)

(4.8)

(10.3)

(20.0)

(4.2)

(3.7)

(0.0)

(9.3)

(0.7)

(0.0)

(2.0)

(0.0)

(2.9)

(%)
(7.7)

Vietnam

0

5

1

9

19

0

4

36

7

1

3

2

21

1

2

13

0

7

45

0

53

0

1

No.
1
2

(0.0)

(10.9)

(20.0)

(5.8)

(12.5)

(0.0)

(16.7)

(5.1)

(12.7)

0

4

0

5

8

0

1

15

1

0

3

(16.7)

1

(9.1)

14

6

1

7

0

4

111

0

9

2

(0.0)

(8.7)

(0.0)

(3.2)

(5.3)

(0.0)

(4.2)

(2.1)

(1.8)

(0.0)

(9.1)

(4.8)

(9.0)

(12.0)

(4.2)

(8.5)

(0.0)

(3.7)

(15.7)

(0.0)

(3.7)

(33.3)

(2.9)

(%)
(7.7)

China
No.
1

(9.5)

(13.5)

(2.0)

(8.3)

(15.9)

(0.0)

(6.5)

(6.4)

(0.0)

(21.5)

(0.0)

(1.4)

(%)
(7.7)

India

0

0

0

0

1

0

0

0

0

0

0

0

0

0

0

0

0

2

37

0

15

0

0

No.
0

(0.0)

(0.0)

(0.0)

(0.0)

(0.7)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(1.9)

(5.2)

(0.0)

(6.1)

(0.0)

(0.0)

(%)
(0.0)

Haiti

0

0

0

2

5

0

0

14

7

0

1

0

5

1

1

4

0

6

10

0

13

0

2

No.
0

(0.0)

(0.0)

(0.0)

(1.3)

(3.3)

(0.0)

(0.0)

(2.0)

(12.7)

(0.0)

(3.0)

(0.0)

(3.2)

(2.0)

(4.2)

(4.9)

(0.0)

(5.6)

(1.4)

(0.0)

(5.3)

(0.0)

(2.9)

(%)
(0.0)

Guatemala

3

25

3

73

84

5

11

196

21

4

11

15

81

21

10

48

7

40

417

3

97

3

20

No.
9

(100.0)

(54.3)

(60.0)

(47.1)

(55.3)

(100.0)

(45.8)

(28.0)

(38.2)

(66.7)

(33.3)

(71.4)

(51.9)

(42.0)

(41.7)

(58.5)

(100.0)

(37.4)

(59.1)

(12.0)

(39.4)

(50.0)

(29.0)

(%)
(69.2)

All Others2

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

10

1

0

2

0

0

No.
0

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(0.0)

(9.3)

(0.1)

(0.0)

(0.8)

(0.0)

(0.0)

(%)
(0.0)

Unknown or
Missing

1

Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the Marshall Islands, Midway Island, the Commonwealth
of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin Islands, and U.S. minor outlying and Pacific islands.
2
Includes 143 countries.
Note: See Surveillance Slide #17.

5

46

West Virginia

155

Washington

Wisconsin

5

152

24

Vermont

700

Texas

Utah

Virginia

6

55

South Dakota

Tennessee

21

33

Rhode Island

7
8

50

156

Oregon

Pennsylvania

South Carolina

8

24

Oklahoma

0
2

7

82

North Dakota

Ohio

23

56

706

107

New York

North Carolina

21

25

27

246

0

19

New Mexico

6

No.
1

Mexico

New Jersey

69

Nevada

13

New Hampshire

Nebraska

Reporting Area

Total
Cases

Country of Origin

Table 24. (Cont’d) Tuberculosis Cases and Percentages in Foreign-born Persons1 by Top 7 Countries of Birth: United States, 2011

Table 25. Tuberculosis Cases and Percentages in Foreign-born Persons1 by Number of Years
in the United States: United States, 2011
Reporting Area
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

<1 Year

1–4

5–9

10–19

Unknown or
Missing

>20

Total
Cases
6,510

No.
925

(%)
(14.2)

No.
1,104

(%)
(17.0)

No.
1,032

(%)
(15.9)

No.
1,302

(%)
(20.0)

No.
1,503

(%)
(23.1)

No.
644

(%)
(9.9)

48
15
170
19
1,782
49
65
16
30
392
159
91
6
226
43
29
20
23
39
5
167
164
83
116
18
38
1
13
69
6
246
25
706
107
7
82
24
50
156
21
33
6
55
700
24
5
152
155
5
46
3

3
2
38
5
174
13
6
4
4
60
26
21
2
31
11
1
2
8
3
0
24
35
10
21
3
2
0
2
10
1
28
5
100
22
3
15
4
7
25
3
4
2
11
108
6
3
21
25
1
10
0

(6.3)
(13.3)
(22.4)
(26.3)
(9.8)
(26.5)
(9.2)
(25.0)
(13.3)
(15.3)
(16.4)
(23.1)
(33.3)
(13.7)
(25.6)
(3.4)
(10.0)
(34.8)
(7.7)
(0.0)
(14.4)
(21.3)
(12.0)
(18.1)
(16.7)
(5.3)
(0.0)
(15.4)
(14.5)
(16.7)
(11.4)
(20.0)
(14.2)
(20.6)
(42.9)
(18.3)
(16.7)
(14.0)
(16.0)
(14.3)
(12.1)
(33.3)
(20.0)
(15.4)
(25.0)
(60.0)
(13.8)
(16.1)
(20.0)
(21.7)
(0.0)

17
2
21
6
181
10
21
7
13
64
33
9
0
33
9
3
5
9
8
1
35
36
10
24
6
3
0
7
7
2
46
5
153
19
1
12
2
8
29
7
10
3
12
134
4
1
29
33
2
9
3

(35.4)
(13.3)
(12.4)
(31.6)
(10.2)
(20.4)
(32.3)
(43.8)
(43.3)
(16.3)
(20.8)
(9.9)
(0.0)
(14.6)
(20.9)
(10.3)
(25.0)
(39.1)
(20.5)
(20.0)
(21.0)
(22.0)
(12.0)
(20.7)
(33.3)
(7.9)
(0.0)
(53.8)
(10.1)
(33.3)
(18.7)
(20.0)
(21.7)
(17.8)
(14.3)
(14.6)
(8.3)
(16.0)
(18.6)
(33.3)
(30.3)
(50.0)
(21.8)
(19.1)
(16.7)
(20.0)
(19.1)
(21.3)
(40.0)
(19.6)
(100.0)

15
1
21
3
190
5
13
3
8
59
41
10
1
37
7
1
2
2
12
2
43
22
12
27
3
0
0
2
11
1
40
1
123
21
2
14
5
7
33
3
7
1
11
138
4
1
35
24
0
8
0

(31.3)
(6.7)
(12.4)
(15.8)
(10.7)
(10.2)
(20.0)
(18.8)
(26.7)
(15.1)
(25.8)
(11.0)
(16.7)
(16.4)
(16.3)
(3.4)
(10.0)
(8.7)
(30.8)
(40.0)
(25.7)
(13.4)
(14.5)
(23.3)
(16.7)
(0.0)
(0.0)
(15.4)
(15.9)
(16.7)
(16.3)
(4.0)
(17.4)
(19.6)
(28.6)
(17.1)
(20.8)
(14.0)
(21.2)
(14.3)
(21.2)
(16.7)
(20.0)
(19.7)
(16.7)
(20.0)
(23.0)
(15.5)
(0.0)
(17.4)
(0.0)

7
3
30
2
315
5
16
2
2
102
29
17
3
57
1
1
1
3
7
1
38
34
18
28
2
0
0
2
11
0
45
3
170
15
0
24
0
9
39
5
5
0
10
149
6
0
41
36
0
8
0

(14.6)
(20.0)
(17.6)
(10.5)
(17.7)
(10.2)
(24.6)
(12.5)
(6.7)
(26.0)
(18.2)
(18.7)
(50.0)
(25.2)
(2.3)
(3.4)
(5.0)
(13.0)
(17.9)
(20.0)
(22.8)
(20.7)
(21.7)
(24.1)
(11.1)
(0.0)
(0.0)
(15.4)
(15.9)
(0.0)
(18.3)
(12.0)
(24.1)
(14.0)
(0.0)
(29.3)
(0.0)
(18.0)
(25.0)
(23.8)
(15.2)
(0.0)
(18.2)
(21.3)
(25.0)
(0.0)
(27.0)
(23.2)
(0.0)
(17.4)
(0.0)

6
3
34
3
585
11
9
0
3
84
27
22
0
62
0
0
9
1
8
1
27
36
13
16
4
0
1
0
29
1
44
11
131
11
0
13
2
4
28
3
6
0
11
171
4
0
26
33
0
10
0

(12.5)
(20.0)
(20.0)
(15.8)
(32.8)
(22.4)
(13.8)
(0.0)
(10.0)
(21.4)
(17.0)
(24.2)
(0.0)
(27.4)
(0.0)
(0.0)
(45.0)
(4.3)
(20.5)
(20.0)
(16.2)
(22.0)
(15.7)
(13.8)
(22.2)
(0.0)
(100.0)
(0.0)
(42.0)
(16.7)
(17.9)
(44.0)
(18.6)
(10.3)
(0.0)
(15.9)
(8.3)
(8.0)
(17.9)
(14.3)
(18.2)
(0.0)
(20.0)
(24.4)
(16.7)
(0.0)
(17.1)
(21.3)
(0.0)
(21.7)
(0.0)

0
4
26
0
337
5
0
0
0
23
3
12
0
6
15
23
1
0
1
0
0
1
20
0
0
33
0
0
1
1
43
0
29
19
1
4
11
15
2
0
1
0
0
0
0
0
0
4
2
1
0

(0.0)
(26.7)
(15.3)
(0.0)
(18.9)
(10.2)
(0.0)
(0.0)
(0.0)
(5.9)
(1.9)
(13.2)
(0.0)
(2.7)
(34.9)
(79.3)
(5.0)
(0.0)
(2.6)
(0.0)
(0.0)
(0.6)
(24.1)
(0.0)
(0.0)
(86.8)
(0.0)
(0.0)
(1.4)
(16.7)
(17.5)
(0.0)
(4.1)
(17.8)
(14.3)
(4.9)
(45.8)
(30.0)
(1.3)
(0.0)
(3.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(2.6)
(40.0)
(2.2)
(0.0)

Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin
Islands, and U.S. minor and outlying Pacific islands.
																	
1

50

Table 26. Tuberculosis Cases and Percentages by Pulmonary and Extrapulmonary Disease:
Reporting Areas, 2011

Reporting Area
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
American Samoa4
Fed. States of Micronesia4
Guam4
Marshall Islands4
N. Mariana Islands4
Puerto Rico4
Republic of Palau4
U.S. Virgin Islands4

Pulmonary1

Extrapulmonary2

Pulmonary and
Extrapulmonary Cases
Total3
Miliary
No.
(%)
No.
1,309
(12.4)
428

Total
Cases
10,528

No.
7,024

(%)
(66.7)

No.
2,188

(%)
(20.8)

161
67
255
85
2,323
70
83
21
56
754
347
123
12
359
100
40
36
71
167
9
233
196
170
137
91
98
8
23
95
11
331
49
910
244
7
145
94
74
260
27
140
15
156
1,325
34
8
221
200
13
70
4

126
57
204
59
1,564
44
47
14
38
518
234
93
10
225
72
22
31
52
134
5
149
118
106
60
66
68
2
15
74
8
199
32
570
164
3
90
54
40
167
15
79
10
104
952
13
6
147
97
12
51
4

(78.3)
(85.1)
(80.0)
(69.4)
(67.3)
(62.9)
(56.6)
(66.7)
(67.9)
(68.7)
(67.4)
(75.6)
(83.3)
(62.7)
(72.0)
(55.0)
(86.1)
(73.2)
(80.2)
(55.6)
(63.9)
(60.2)
(62.4)
(43.8)
(72.5)
(69.4)
(25.0)
(65.2)
(77.9)
(72.7)
(60.1)
(65.3)
(62.6)
(67.2)
(42.9)
(62.1)
(57.4)
(54.1)
(64.2)
(55.6)
(56.4)
(66.7)
(66.7)
(71.8)
(38.2)
(75.0)
(66.5)
(48.5)
(92.3)
(72.9)
(100.0)

24
7
34
14
465
19
20
6
14
159
68
18
1
84
15
11
5
12
22
3
59
53
58
58
15
20
5
7
18
1
80
13
207
43
3
33
26
25
62
11
32
4
30
169
16
2
48
73
1
15
0

(14.9)
(10.4)
(13.3)
(16.5)
(20.0)
(27.1)
(24.1)
(28.6)
(25.0)
(21.1)
(19.6)
(14.6)
(8.3)
(23.4)
(15.0)
(27.5)
(13.9)
(16.9)
(13.2)
(33.3)
(25.3)
(27.0)
(34.1)
(42.3)
(16.5)
(20.4)
(62.5)
(30.4)
(18.9)
(9.1)
(24.2)
(26.5)
(22.7)
(17.6)
(42.9)
(22.8)
(27.7)
(33.8)
(23.8)
(40.7)
(22.9)
(26.7)
(19.2)
(12.8)
(47.1)
(25.0)
(21.7)
(36.5)
(7.7)
(21.4)
(0.0)

11
3
17
12
294
7
16
1
4
77
43
12
1
50
13
6
0
7
11
1
25
24
6
19
10
8
1
1
3
2
52
4
133
37
0
22
14
9
31
1
29
1
22
204
5
0
26
30
0
4
0

(6.8)
(4.5)
(6.7)
(14.1)
(12.7)
(10.0)
(19.3)
(4.8)
(7.1)
(10.2)
(12.4)
(9.8)
(8.3)
(13.9)
(13.0)
(15.0)
(0.0)
(9.9)
(6.6)
(11.1)
(10.7)
(12.2)
(3.5)
(13.9)
(11.0)
(8.2)
(12.5)
(4.3)
(3.2)
(18.2)
(15.7)
(8.2)
(14.6)
(15.2)
(0.0)
(15.2)
(14.9)
(12.2)
(11.9)
(3.7)
(20.7)
(6.7)
(14.1)
(15.4)
(14.7)
(0.0)
(11.8)
(15.0)
(0.0)
(5.7)
(0.0)

5
2
9
4
87
2
1
1
3
41
18
7
0
22
6
4
0
3
6
1
8
7
6
8
3
0
0
0
2
2
13
3
36
13
0
7
7
2
9
0
13
1
9
47
0
0
5
5
0
0
0

3
140
78
149
27
50
8
...

0
106
60
75
23
42
8
...

(0.0)
(75.7)
(76.9)
(50.3)
(85.2)
(84.0)
(100.0)
...

0
20
8
50
0
8
0
...

(0.0)
(14.3)
(10.3)
(33.6)
(0.0)
(16.0)
(0.0)
...

3
14
10
24
4
0
0
...

(100.0)
(10.0)
(12.8)
(16.1)
(14.8)
(0.0)
(0.0)
...

3
8
4
3
3
0
0
...

Includes cases with pulmonary listed as the only site of disease.
Includes cases with pleural, lymphatic, bone and/or joint, meningeal, peritoneal, genitourinary, or other site, excluding pulmonary, listed
as site of disease.
3
Includes cases with evidence of miliary disease.
4
Not included in U.S. totals.
51
Note: 7 cases had missing and/or unknown site of disease.
1
2

52

2,188

24
7
34
14
465
19
20
6
14
159
68
18
1
84
15
11
5
12
22
3
59
53
58
58
15
20
5
7
18
1
80

United States

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey

Reporting Area

Total
Extrapulmonary
Cases1

25
7
35
14
479
20
22
6
14
164
69
18
1
95
16
13
5
13
22
3
61
58
61
64
15
21
5
7
18
1
84

2,298

Total
Extrapulmonary
Sites2

6
1
5
5
71
3
2
0
6
24
16
7
0
19
1
1
0
4
12
0
12
12
11
8
8
3
1
1
1
0
19

389

No.

(24.0)
(14.3)
(14.3)
(35.7)
(14.8)
(15.0)
(9.1)
(0.0)
(42.9)
(14.6)
(23.2)
(38.9)
(0.0)
(20.0)
(6.3)
(7.7)
(0.0)
(30.8)
(54.5)
(0.0)
(19.7)
(20.7)
(18.0)
(12.5)
(53.3)
(14.3)
(20.0)
(14.3)
(5.6)
(0.0)
(22.6)

(16.9)

(%)

Pleural

7
1
10
2
190
5
13
2
4
58
21
3
0
25
6
6
2
5
4
3
27
19
11
28
2
9
1
4
9
1
35

856
(28.0)
(14.3)
(28.6)
(14.3)
(39.7)
(25.0)
(59.1)
(33.3)
(28.6)
(35.4)
(30.4)
(16.7)
(0.0)
(26.3)
(37.5)
(46.2)
(40.0)
(38.5)
(18.2)
(100.0)
(44.3)
(32.8)
(18.0)
(43.8)
(13.3)
(42.9)
(20.0)
(57.1)
(50.0)
(100.0)
(41.7)

(37.2)

(%)

Lymphatic
No.

1
1
5
0
51
0
3
1
1
20
8
2
0
16
2
2
0
2
1
0
3
6
14
10
2
2
1
1
2
0
11

256

No.

(4.0)
(14.3)
(14.3)
(0.0)
(10.6)
(0.0)
(13.6)
(16.7)
(7.1)
(12.2)
(11.6)
(11.1)
(0.0)
(16.8)
(12.5)
(15.4)
(0.0)
(15.4)
(4.5)
(0.0)
(4.9)
(10.3)
(23.0)
(15.6)
(13.3)
(9.5)
(20.0)
(14.3)
(11.1)
(0.0)
(13.1)

(11.1)

(%)

Bone and/or Joint

0
1
3
0
25
4
2
1
0
9
0
1
0
5
0
0
1
0
2
0
2
4
2
5
0
0
0
0
1
0
3

114

No.

(0.0)
(14.3)
(8.6)
(0.0)
(5.2)
(20.0)
(9.1)
(16.7)
(0.0)
(5.5)
(0.0)
(5.6)
(0.0)
(5.3)
(0.0)
(0.0)
(20.0)
(0.0)
(9.1)
(0.0)
(3.3)
(6.9)
(3.3)
(7.8)
(0.0)
(0.0)
(0.0)
(0.0)
(5.6)
(0.0)
(3.6)

(5.0)

(%)

Genitourinary

Site of Disease

2
1
2
0
15
0
1
0
1
14
6
0
0
7
2
3
0
0
0
0
6
4
0
3
0
1
0
0
0
0
5

132

No.

(8.0)
(14.3)
(5.7)
(0.0)
(3.1)
(0.0)
(4.5)
(0.0)
(7.1)
(8.5)
(8.7)
(0.0)
(0.0)
(7.4)
(12.5)
(23.1)
(0.0)
(0.0)
(0.0)
(0.0)
(9.8)
(6.9)
(0.0)
(4.7)
(0.0)
(4.8)
(0.0)
(0.0)
(0.0)
(0.0)
(6.0)

(5.7)

(%)

Meningeal

1
1
2
1
33
3
1
0
1
8
3
1
0
5
2
1
0
1
0
0
5
2
1
3
1
1
1
0
1
0
3

124

No.

(4.0)
(14.3)
(5.7)
(7.1)
(6.9)
(15.0)
(4.5)
(0.0)
(7.1)
(4.9)
(4.3)
(5.6)
(0.0)
(5.3)
(12.5)
(7.7)
(0.0)
(7.7)
(0.0)
(0.0)
(8.2)
(3.4)
(1.6)
(4.7)
(6.7)
(4.8)
(20.0)
(0.0)
(5.6)
(0.0)
(3.6)

(5.4)

(%)

Peritoneal

Table 27. Extrapulmonary Tuberculosis Cases and Percentages by Site of Disease: Reporting Areas, 2011

8
1
8
6
94
5
0
2
1
31
15
4
1
18
3
0
2
1
3
0
6
11
22
7
2
5
1
1
4
0
8

427

(%)

(32.0)
(14.3)
(22.9)
(42.9)
(19.6)
(25.0)
(0.0)
(33.3)
(7.1)
(18.9)
(21.7)
(22.2)
(100.0)
(18.9)
(18.8)
(0.0)
(40.0)
(7.7)
(13.6)
(0.0)
(9.8)
(19.0)
(36.1)
(10.9)
(13.3)
(23.8)
(20.0)
(14.3)
(22.2)
(0.0)
(9.5)

(18.6)

Other
No.

53

...
20
8
50
...
8
...
...

American Samoa3
Fed. States of Micronesia3
Guam3
Marshall Islands3
N. Mariana Islands3
Puerto Rico3
Republic of Palau3
U.S. Virgin Islands3
...
...
8
52
...
8
...
...

13
217
47
3
36
26
27
64
13
34
5
32
179
20
2
50
76
1
17
0

Total
Extrapulmonary
Sites2

...
...
2
21
...
1
...
...

6
31
12
0
2
3
4
12
1
11
0
7
16
3
0
6
12
0
4
0

No.

...
...
(25.0)
(40.4)
...
(12.5)
...
...

(46.2)
(14.3)
(25.5)
(0.0)
(5.6)
(11.5)
(14.8)
(18.8)
(7.7)
(32.4)
(0.0)
(21.9)
(8.9)
(15.0)
(0.0)
(12.0)
(15.8)
(0.0)
(23.5)
(0.0)

2

1

(%)

Pleural

Excludes cases with pulmonary site of disease.
Patient may have more than one extrapulmonary site of disease.
3
Not included in U.S. totals.
Note: Ellipses indicate data not available.
See Technical Notes.

13
207
43
3
33
26
25
62
11
32
4
30
169
16
2
48
73
1
15
0

New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennyslvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

Reporting Area

Total
Extrapulmonary
Cases1

...
...
3
23
...
2
...
...

2
92
12
1
14
16
8
25
3
11
0
14
70
8
2
24
32
1
8
0

No.

...
...
(37.5)
(44.2)
...
(25.0)
...
...

(15.4)
(42.4)
(25.5)
(33.3)
(38.9)
(61.5)
(29.6)
(39.1)
(23.1)
(32.4)
(0.0)
(43.8)
(39.1)
(40.0)
(100.0)
(48.0)
(42.1)
(100.0)
(47.1)
(0.0)

(%)

Lymphatic

...
...
1
0
...
0
...
...

0
20
4
2
4
0
2
8
0
2
2
1
22
3
0
4
13
0
1
0

No.

...
...
(12.5)
(0.0)
...
(0.0)
...
...

(0.0)
(9.2)
(8.5)
(66.7)
(11.1)
(0.0)
(7.4)
(12.5)
(0.0)
(5.9)
(40.0)
(3.1)
(12.3)
(15.0)
(0.0)
(8.0)
(17.1)
(0.0)
(5.9)
(0.0)

(%)

Bone and/or Joint

...
...
0
0
...
0
...
...

3
12
3
0
2
2
0
2
3
1
0
1
9
1
0
1
2
0
1
0

No.

...
...
(0.0)
(0.0)
...
(0.0)
...
...

(23.1)
(5.5)
(6.4)
(0.0)
(5.6)
(7.7)
(0.0)
(3.1)
(23.1)
(2.9)
(0.0)
(3.1)
(5.0)
(5.0)
(0.0)
(2.0)
(2.6)
(0.0)
(5.9)
(0.0)

(%)

Genitourinary

Site of Disease

...
...
0
0
...
3
...
...

0
12
4
0
2
3
2
4
0
3
0
4
19
1
0
3
1
0
1
0

No.

...
...
(0.0)
(0.0)
...
(37.5)
...
...

(0.0)
(5.5)
(8.5)
(0.0)
(5.6)
(11.5)
(7.4)
(6.3)
(0.0)
(8.8)
(0.0)
(12.5)
(10.6)
(5.0)
(0.0)
(6.0)
(1.3)
(0.0)
(5.9)
(0.0)

(%)

Meningeal

...
...
0
8
...
0
...
...

0
8
2
0
4
0
2
4
1
1
0
2
9
0
0
2
7
0
0
0

No.

...
...
(0.0)
(15.4)
...
(0.0)
...
...

(0.0)
(3.7)
(4.3)
(0.0)
(11.1)
(0.0)
(7.4)
(6.3)
(7.7)
(2.9)
(0.0)
(6.3)
(5.0)
(0.0)
(0.0)
(4.0)
(9.2)
(0.0)
(0.0)
(0.0)

(%)

Peritoneal

Table 27. (Cont’d) Extrapulmonary Tuberculosis Cases and Percentages by Site of Disease: Reporting Areas, 2011

...
...
2
0
...
2
...
...

2
42
10
0
8
2
9
9
5
5
3
3
34
4
0
10
9
0
2
0

No.

(%)

...
...
(25.0)
(0.0)
...
(25.0)
...
...

(15.4)
(19.4)
(21.3)
(0.0)
(22.2)
(7.7)
(33.3)
(14.1)
(38.5)
(14.7)
(60.0)
(9.4)
(19.0)
(20.0)
(0.0)
(20.0)
(11.8)
(0.0)
(11.8)
(0.0)

Other

This page intentionally left blank

54

Morbidity Tables
Reporting Areas, 2011 and 2009

55

56

Table 28. Tuberculosis Cases and Percentages by Residence in Correctional Facilities,1
Age > 15: Reporting Areas, 2011
Cases with Information on Residence
in Correctional Facilities

Cases Reported As Residents
of Correctional Facilities2
No.
(%)

Reporting Area

Total
Cases

No.

(%)

United States

9,946

9,884

(99.4)

424

(4.3)

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York State3
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

150
61
242
81
2,193
62
80
21
55
711
321
122
11
342
93
39
35
70
159
9
218
188
163
127
89
91
8
21
85
11
317
48
206
675
228
6
138
82
73
249
25
133
14
148
1,227
32
7
213
188
12
63
4

150
60
242
81
2,167
62
76
21
55
711
320
122
11
341
91
39
35
70
159
9
218
188
160
127
89
86
8
21
85
11
317
48
206
661
228
6
135
81
73
249
25
133
14
148
1,227
32
7
213
188
12
62
4

(100.0)
(98.4)
(100.0)
(100.0)
(98.8)
(100.0)
(95.0)
(100.0)
(100.0)
(100.0)
(99.7)
(100.0)
(100.0)
(99.7)
(97.8)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(98.2)
(100.0)
(100.0)
(94.5)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(97.9)
(100.0)
(100.0)
(97.8)
(98.8)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(98.4)
(100.0)

11
1
64
3
75
2
0
0
1
21
31
2
0
4
4
0
1
5
8
0
2
4
1
2
1
3
0
0
1
0
1
3
5
9
6
0
1
4
2
9
0
2
0
7
116
0
0
9
2
0
1
0

(7.3)
(1.7)
(26.4)
(3.7)
(3.5)
(3.2)
(0.0)
(0.0)
(1.8)
(3.0)
(9.7)
(1.6)
(0.0)
(1.2)
(4.4)
(0.0)
(2.9)
(7.1)
(5.0)
(0.0)
(0.9)
(2.1)
(0.6)
(1.6)
(1.1)
(3.5)
(0.0)
(0.0)
(1.2)
(0.0)
(0.3)
(6.3)
(2.4)
(1.4)
(2.6)
(0.0)
(0.7)
(4.9)
(2.7)
(3.6)
(0.0)
(1.5)
(0.0)
(4.7)
(9.5)
(0.0)
(0.0)
(4.2)
(1.1)
(0.0)
(1.6)
(0.0)

American Samoa4
3
3
(100.0)
0
(0.0)
Fed. States of Micronesia4
99
99
(100.0)
1
(1.0)
Guam4
67
67
(100.0)
1
(1.5)
Marshall Islands4
108
108
(100.0)
0
(0.0)
N. Mariana Islands4
26
26
(100.0)
0
(0.0)
49
49
(100.0)
2
(4.1)
Puerto Rico4
Republic of Palau4
8
8
(100.0)
0
(0.0)
U.S. Virgin Islands4
...
...
...
...
...
1
Resident of correctional facility at time of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2
Percent of those with known status.
3
Excludes New York City.
4
Not included in U.S. totals.
Note: Ellipses indicate data not available.
See Surveillance Slide #26

57

Table 29. Tuberculosis Cases and Percentages by Homeless Status,1 Age >15:
Reporting Areas, 2011
Reporting Area
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York State3
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
American Samoa4
Fed. States of Micronesia4
Guam4
Marshall Islands4
N. Mariana Islands4
Puerto Rico4
Republic of Palau4
U.S. Virgin Islands4

Cases with Information
on Homeless Status

Cases Reported As
Being Homeless2

Total
Cases
9,946

No.
9,814

(%)
(98.7)

No.
565

(%)
(5.8)

150
61
242
81
2,193
62
80
21
55
711
321
122
11
342
93
39
35
70
159
9
218
188
163
127
89
91
8
21
85
11
317
48
206
675
228
6
138
82
73
249
25
133
14
148
1,227
32
7
213
188
12
63
4

150
60
209
81
2,167
62
76
21
55
704
319
107
11
339
93
39
35
70
159
9
217
187
160
127
89
86
8
21
85
11
316
48
202
661
227
6
133
79
73
248
25
132
14
148
1,227
32
7
213
188
12
62
4

(100.0)
(98.4)
(86.4)
(100.0)
(98.8)
(100.0)
(95.0)
(100.0)
(100.0)
(99.0)
(99.4)
(87.7)
(100.0)
(99.1)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(99.5)
(99.5)
(98.2)
(100.0)
(100.0)
(94.5)
(100.0)
(100.0)
(100.0)
(100.0)
(99.7)
(100.0)
(98.1)
(97.9)
(99.6)
(100.0)
(96.4)
(96.3)
(100.0)
(99.6)
(100.0)
(99.2)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(98.4)
(100.0)

9
14
15
8
124
4
0
0
2
64
32
9
0
33
9
2
1
6
12
1
13
8
17
2
11
4
0
2
4
1
7
4
3
16
15
0
3
6
7
5
2
8
0
11
59
2
0
1
9
0
0
0

(6.0)
(23.3)
(7.2)
(9.9)
(5.7)
(6.5)
(0.0)
(0.0)
(3.6)
(9.1)
(10.0)
(8.4)
(0.0)
(9.7)
(9.7)
(5.1)
(2.9)
(8.6)
(7.5)
(11.1)
(6.0)
(4.3)
(10.6)
(1.6)
(12.4)
(4.7)
(0.0)
(9.5)
(4.7)
(9.1)
(2.2)
(8.3)
(1.5)
(2.4)
(6.6)
(0.0)
(2.3)
(7.6)
(9.6)
(2.0)
(8.0)
(6.1)
(0.0)
(7.4)
(4.8)
(6.3)
(0.0)
(0.5)
(4.8)
(0.0)
(0.0)
(0.0)

3
99
67
108
26
49
8
...

3
99
67
108
26
49
8
...

(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
...

0
7
3
0
0
3
0
...

(0.0)
(7.1)
(4.5)
(0.0)
(0.0)
(6.1)
(0.0)
...

Homeless within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the District of
Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2
Percent of those with known status.
3
Excludes New York City.
4
Not included in U.S. totals.
Note: Ellipses indicate data not available.
See Surveillance Slide #27
1

58

Table 30. Tuberculosis Cases and Percentages by Residence in Long-term Care Facilities,1
Age >15: Reporting Areas, 2011
Reporting Area
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York State3
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
American Samoa4
Fed. States of Micronesia4
Guam4
Marshall Islands4
N. Mariana Islands4
Puerto Rico4
Republic of Palau4
U.S. Virgin Islands4

Total
Cases
9,946

Cases with Information on
Residence in Long-term Care Facilities

Cases Reported As Residents of
Long-term Care Facilities2

No.
9,883

(%)
(99.4)

No.
224

(%)
(2.3)

150
61
242
81
2,193
62
80
21
55
711
321
122
11
342
93
39
35
70
159
9
218
188
163
127
89
91
8
21
85
11
317
48
206
675
228
6
138
82
73
249
25
133
14
148
1,227
32
7
213
188
12
63
4

150
61
242
81
2,167
62
76
21
55
711
320
122
11
340
91
39
35
70
159
9
218
188
161
127
89
86
8
21
85
11
316
48
205
663
228
6
134
82
73
248
25
133
14
148
1,227
32
7
213
187
12
62
4

(100.0)
(100.0)
(100.0)
(100.0)
(98.8)
(100.0)
(95.0)
(100.0)
(100.0)
(100.0)
(99.7)
(100.0)
(100.0)
(99.4)
(97.8)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(98.8)
(100.0)
(100.0)
(94.5)
(100.0)
(100.0)
(100.0)
(100.0)
(99.7)
(100.0)
(99.5)
(98.2)
(100.0)
(100.0)
(97.1)
(100.0)
(100.0)
(99.6)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(99.5)
(100.0)
(98.4)
(100.0)

1
0
8
3
43
0
5
1
2
5
4
3
0
12
3
0
0
2
2
0
6
4
5
2
2
3
0
2
1
1
6
2
5
37
3
0
3
3
1
6
0
3
3
3
23
0
0
0
5
1
0
0

(0.7)
(0.0)
(3.3)
(3.7)
(2.0)
(0.0)
(6.6)
(4.8)
(3.6)
(0.7)
(1.3)
(2.5)
(0.0)
(3.5)
(3.3)
(0.0)
(0.0)
(2.9)
(1.3)
(0.0)
(2.8)
(2.1)
(3.1)
(1.6)
(2.2)
(3.5)
(0.0)
(9.5)
(1.2)
(9.1)
(1.9)
(4.2)
(2.4)
(5.6)
(1.3)
(0.0)
(2.2)
(3.7)
(1.4)
(2.4)
(0.0)
(2.3)
(21.4)
(2.0)
(1.9)
(0.0)
(0.0)
(0.0)
(2.7)
(8.3)
(0.0)
(0.0)

3
99
67
108
26
49
8
...

3
99
67
107
24
49
8
...

(100.0)
(100.0)
(100.0)
(99.1)
(92.3)
(100.0)
(100.0)
...

0
4
1
0
0
4
0
...

(0.0)
(4.0)
(1.5)
(0.0)
(0.0)
(8.2)
(0.0)
...

Resident of long-term care facility at time of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2
Percent of those with known status.
3
Excludes New York City.
4
Not included in U.S. totals.
Note: Ellipses indicate data not available.
1

59

Table 31. Tuberculosis Cases and Percentages by Injecting Drug Use,1 Age >15:
Reporting Areas, 2011
Reporting Area
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York State2
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

Cases with Information on
Injecting Drug Use

Cases Reporting Injecting Drug Use

Total
Cases
9,946

No.
9,692

(%)
(97.4)

No.
146

(%)
(1.5)

150
61
242
81
2,193
62
80
21
55
711
321
122
11
342
93
39
35
70
159
9
218
188
163
127
89
91
8
21
85
11
317
48
206
675
228
6
138
82
73
249
25
133
14
148
1,227
32
7
213
188
12
63
4

149
58
200
81
2,139
62
72
21
55
702
317
81
11
336
93
39
35
70
158
9
217
186
156
127
89
86
8
20
85
11
316
48
196
662
228
6
130
75
73
244
25
128
14
148
1,213
32
7
213
185
12
61
3

(99.3)
(95.1)
(82.6)
(100.0)
(97.5)
(100.0)
(90.0)
(100.0)
(100.0)
(98.7)
(98.8)
(66.4)
(100.0)
(98.2)
(100.0)
(100.0)
(100.0)
(100.0)
(99.4)
(100.0)
(99.5)
(98.9)
(95.7)
(100.0)
(100.0)
(94.5)
(100.0)
(95.2)
(100.0)
(100.0)
(99.7)
(100.0)
(95.1)
(98.1)
(100.0)
(100.0)
(94.2)
(91.5)
(100.0)
(98.0)
(100.0)
(96.2)
(100.0)
(100.0)
(98.9)
(100.0)
(100.0)
(100.0)
(98.4)
(100.0)
(96.8)
(75.0)

6
3
8
0
21
0
1
0
0
13
5
-0
3
5
0
1
2
5
0
1
2
7
1
1
0
0
0
0
0
3
2
1
9
1
0
2
5
1
1
1
2
0
4
26
0
0
1
2
0
0
0

(4.0)
(5.2)
(4.0)
(0.0)
(1.0)
(0.0)
(1.4)
(0.0)
(0.0)
(1.9)
(1.6)
-(0.0)
(0.9)
(5.4)
(0.0)
(2.9)
(2.9)
(3.2)
(0.0)
(0.5)
(1.1)
(4.5)
(0.8)
(1.1)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.9)
(4.2)
(0.5)
(1.4)
(0.4)
(0.0)
(1.5)
(6.7)
(1.4)
(0.4)
(4.0)
(1.6)
(0.0)
(2.7)
(2.1)
(0.0)
(0.0)
(0.5)
(1.1)
(0.0)
(0.0)
(0.0)

Amercian Samoa3
3
3
(100.0)
0
(0.0)
Fed. States of Micronesia3
99
99
(100.0)
0
(0.0)
Guam3
67
65
(97.0)
0
(0.0)
Marshall Islands3
108
108
(100.0)
1
(0.9)
3
N. Mariana Islands
26
26
(100.0)
0
(0.0)
Puerto Rico3
49
49
(100.0)
9
(18.4)
Republic of Palau3
8
8
(100.0)
0
(0.0)
U.S. Virgin Islands3
...
...
...
...
...
1
Injecting drug use within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2
Excludes New York City.
3
Not included in U.S. totals.
Note: Ellipses indicate data not available.

60

Table 32. Tuberculosis Cases and Percentages by Noninjecting Drug Use,1 Age >15:
Reporting Areas, 2011
Reporting Area

Total
Cases

Cases with Information on
Noninjecting Drug Use

Cases Reporting Noninjecting Drug Use

No.

(%)

No.

(%)

United States

9,946

9,686

(97.4)

735

(7.6)

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York State2
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

150
61
242
81
2,193
62
80
21
55
711
321
122
11
342
93
39
35
70
159
9
218
188
163
127
89
91
8
21
85
11
317
48
206
675
228
6
138
82
73
249
25
133
14
148
1,227
32
7
213
188
12
63
4

149
58
200
81
2,138
62
72
21
55
703
318
80
11
337
93
39
35
70
158
9
217
185
154
127
89
86
8
20
85
11
316
48
197
657
228
6
130
74
73
244
25
128
14
148
1,213
32
7
213
184
12
62
4

(99.3)
(95.1)
(82.6)
(100.0)
(97.5)
(100.0)
(90.0)
(100.0)
(100.0)
(98.9)
(99.1)
(65.6)
(100.0)
(98.5)
(100.0)
(100.0)
(100.0)
(100.0)
(99.4)
(100.0)
(99.5)
(98.4)
(94.5)
(100.0)
(100.0)
(94.5)
(100.0)
(95.2)
(100.0)
(100.0)
(99.7)
(100.0)
(95.6)
(97.3)
(100.0)
(100.0)
(94.2)
(90.2)
(100.0)
(98.0)
(100.0)
(96.2)
(100.0)
(100.0)
(98.9)
(100.0)
(100.0)
(100.0)
(97.9)
(100.0)
(98.4)
(100.0)

23
8
25
2
118
1
2
1
4
74
27
-0
32
11
1
3
5
26
0
5
5
24
3
10
10
0
0
6
0
14
7
7
38
18
0
13
17
5
8
3
15
1
12
129
0
0
13
3
0
3
1

(15.4)
(13.8)
(12.5)
(2.5)
(5.5)
(1.6)
(2.8)
(4.8)
(7.3)
(10.5)
(8.5)
-(0.0)
(9.5)
(11.8)
(2.6)
(8.6)
(7.1)
(16.5)
(0.0)
(2.3)
(2.7)
(15.6)
(2.4)
(11.2)
(11.6)
(0.0)
(0.0)
(7.1)
(0.0)
(4.4)
(14.6)
(3.6)
(5.8)
(7.9)
(0.0)
(10.0)
(23.0)
(6.8)
(3.3)
(12.0)
(11.7)
(7.1)
(8.1)
(10.6)
(0.0)
(0.0)
(6.1)
(1.6)
(0.0)
(4.8)
(25.0)

American Samoa3
3
3
(100.0)
0
(0.0)
Fed. States of Micronesia3
99
99
(100.0)
7
(7.1)
3
Guam
67
65
(97.0)
0
(0.0)
Marshall Islands3
108
108
(100.0)
1
(0.9)
N. Mariana Islands3
26
26
(100.0)
0
(0.0)
Puerto Rico3
49
49
(100.0)
12
(24.5)
3
Republic of Palau
8
8
(100.0)
0
(0.0)
U.S. Virgin Islands3
...
...
...
...
...
1
Noninjecting drug use within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and
the District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2
Excludes New York City.
3
Not included in U.S. totals.
Note: Ellipses indicate data not available.

61

Table 33. Tuberculosis Cases and Percentages by Excess Alcohol Use,1 Age >15:
Reporting Areas, 2011
Reporting Area
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York State2
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

Cases with Information on
Excess Alcohol Use

Cases Reporting
Excess Alcohol Use

Total
Cases
9,946

No.
9,732

(%)
(97.8)

No.
1,208

(%)
(12.4)

150
61
242
81
2,193
62
80
21
55
711
321
122
11
342
93
39
35
70
159
9
218
188
163
127
89
91
8
21
85
11
317
48
206
675
228
6
138
82
73
249
25
133
14
148
1,227
32
7
213
188
12
63
4

148
59
199
81
2,141
62
75
21
55
703
318
110
11
337
93
39
35
70
158
9
218
185
154
127
89
86
8
19
85
11
316
48
199
663
228
6
129
78
73
244
25
130
13
147
1,214
32
6
213
184
12
62
4

(98.7)
(96.7)
(82.2)
(100.0)
(97.6)
(100.0)
(93.8)
(100.0)
(100.0)
(98.9)
(99.1)
(90.2)
(100.0)
(98.5)
(100.0)
(100.0)
(100.0)
(100.0)
(99.4)
(100.0)
(100.0)
(98.4)
(94.5)
(100.0)
(100.0)
(94.5)
(100.0)
(90.5)
(100.0)
(100.0)
(99.7)
(100.0)
(96.6)
(98.2)
(100.0)
(100.0)
(93.5)
(95.1)
(100.0)
(98.0)
(100.0)
(97.7)
(92.9)
(99.3)
(98.9)
(100.0)
(85.7)
(100.0)
(97.9)
(100.0)
(98.4)
(100.0)

36
28
34
3
209
3
6
0
9
119
43
15
0
48
16
8
4
9
36
1
12
15
25
5
13
13
1
1
7
1
25
13
20
12
32
0
15
16
4
21
1
28
1
21
241
3
0
16
13
1
4
1

(24.3)
(47.5)
(17.1)
(3.7)
(9.8)
(4.8)
(8.0)
(0.0)
(16.4)
(16.9)
(13.5)
(13.6)
(0.0)
(14.2)
(17.2)
(20.5)
(11.4)
(12.9)
(22.8)
(11.1)
(5.5)
(8.1)
(16.2)
(3.9)
(14.6)
(15.1)
(12.5)
(5.3)
(8.2)
(9.1)
(7.9)
(27.1)
(10.1)
(1.8)
(14.0)
(0.0)
(11.6)
(20.5)
(5.5)
(8.6)
(4.0)
(21.5)
(7.7)
(14.3)
(19.9)
(9.4)
(0.0)
(7.5)
(7.1)
(8.3)
(6.5)
(25.0)

American Samoa3
3
3
(100.0)
2
(66.7)
Fed. States of Micronesia3
99
98
(99.0)
1
(1.0)
Guam3
67
65
(97.0)
3
(4.6)
Marshall Islands3
108
105
(97.2)
20
(19.0)
N. Mariana Islands3
26
26
(100.0)
0
(0.0)
Puerto Rico3
49
49
(100.0)
4
(8.2)
Republic of Palau3
8
8
(100.0)
0
(0.0)
U.S. Virgin Islands3
...
...
...
...
...
1
Excess alcohol use within past 12 months of TB diagnosis. Percentage based on 52 reporting areas (50 states, New York City, and the
District of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
2
Excludes New York City.
3
Not included in U.S. totals.
Note: Ellipses indicate data not available.

62

Table 34. Tuberculosis Cases and Percentages by Primary Occupation, Age >15:
Reporting Areas, 2011

Reporting Area
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York State2
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
American Samoa3
Fed. States of Micronesia3
Guam3
Marshall Islands3
N. Mariana Islands3
Puerto Rico3
Republic of Palau3
U.S. Virgin Islands3

Cases with
Information on
Occupation

Total
Cases
9,946

No.
9,587

(%)
96.4

150
61
242
81
2,193
62
80
21
55
711
321
122
11
342
93
39
35
70
159
9
218
188
163
127
89
91
8
21
85
11
317
48
206
675
228
6
138
82
73
249
25
133
14
148
1,227
32
7
213
188
12
63
4

150
55
205
81
2,158
62
72
21
55
696
312
111
11
336
92
38
35
70
157
9
216
188
152
127
89
0
8
21
84
11
317
48
197
616
228
4
134
67
73
249
25
132
14
148
1,199
32
7
213
185
12
61
4

3
99
67
108
26
49
8
...

3
98
67
108
26
49
8
...

Percentage of Cases by Occupation1
Unemployed Health Care

Retired

Correctional

Migrant

Worker

Employee

Worker

Not Seeking

(30.4)

(3.7)

(0.1)

(1.6)

(16.1)

(13.9)

(34.2)

100
90.2
84.7
100
98.4
100
90
100
100
97.9
97.2
91
100
98.2
98.9
97.4
100
100
98.7
100
99.1
100
93.3
100
100
0
100
100
98.8
100
100
100
95.6
91.3
100
66.7
97.1
81.7
100
100
100
99.2
100
100
97.7
100
100
100
98.4
100
96.8
100

(23.3)
(58.2)
(35.6)
(21.0)
(26.7)
(14.5)
(25.0)
(9.5)
(81.8)
(64.7)
(35.6)
(18.9)
(18.2)
(18.8)
(20.7)
(13.2)
(28.6)
(14.3)
(34.4)
(11.1)
(18.5)
(29.3)
(65.1)
(16.5)
(46.1)
-(0.0)
(19.0)
(6.0)
(27.3)
(20.5)
(41.7)
(24.4)
(46.3)
(31.6)
-(23.1)
(23.9)
(20.5)
(23.7)
(12.0)
(34.1)
(0.0)
(29.7)
(29.1)
(15.6)
(0.0)
(0.0)
(10.3)
(8.3)
(21.3)
(25.0)

(1.3)
(1.8)
(4.9)
(4.9)
(3.7)
(8.1)
(6.9)
(14.3)
(0.0)
(2.6)
(3.2)
(1.8)
(0.0)
(2.7)
(4.3)
(2.6)
(2.9)
(1.4)
(3.2)
(0.0)
(6.9)
(4.3)
(4.6)
(7.9)
(3.4)
-(12.5)
(0.0)
(4.8)
(0.0)
(5.0)
(0.0)
(6.6)
(3.2)
(3.5)
-(1.5)
(0.0)
(4.1)
(5.2)
(8.0)
(2.3)
(7.1)
(3.4)
(3.2)
(3.1)
(0.0)
(3.3)
(4.3)
(0.0)
(1.6)
(0.0)

(0.7)
(0.0)
(0.0)
(1.2)
(0.1)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.6)
(0.0)
(0.0)
(0.3)
(0.0)
(0.0)
(0.0)
(0.0)
(0.6)
(0.0)
(0.5)
(0.0)
(0.0)
(0.0)
(0.0)
-(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.5)
(0.0)
(0.4)
-(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.2)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)

(3.3)
(0.0)
(9.3)
(0.0)
(2.5)
(0.0)
(1.4)
(0.0)
(0.0)
(1.7)
(0.0)
(0.9)
(0.0)
(0.9)
(1.1)
(2.6)
(0.0)
(5.7)
(2.5)
(0.0)
(1.4)
(1.1)
(1.3)
(0.0)
(0.0)
-(0.0)
(0.0)
(0.0)
(0.0)
(0.9)
(2.1)
(0.5)
(1.5)
(1.3)
-(1.5)
(1.5)
(0.0)
(0.0)
(0.0)
(1.5)
(0.0)
(4.1)
(0.7)
(0.0)
(0.0)
(0.0)
(0.5)
(0.0)
(1.6)
(0.0)

(13.3)
(9.1)
(14.1)
(21.0)
(20.5)
(9.7)
(9.7)
(14.3)
(5.5)
(3.4)
(11.5)
(23.4)
(27.3)
(22.6)
(22.8)
(21.1)
(20.0)
(18.6)
(17.2)
(55.6)
(13.9)
(21.8)
(0.0)
(16.5)
(16.9)
-(25.0)
(19.0)
(10.7)
(36.4)
(16.4)
(22.9)
(18.8)
(15.1)
(20.2)
-(26.1)
(23.9)
(19.2)
(20.1)
(8.0)
(22.0)
(7.1)
(14.9)
(13.5)
(18.8)
(0.0)
(9.9)
(17.3)
(33.3)
(16.4)
(0.0)

(26.7)
(5.5)
(13.2)
(13.6)
(13.9)
(29.0)
(15.3)
(0.0)
(0.0)
(0.7)
(8.7)
(18.0)
(9.1)
(15.8)
(21.7)
(26.3)
(22.9)
(22.9)
(7.6)
(11.1)
(10.6)
(12.8)
(0.0)
(31.5)
(7.9)
-(12.5)
(9.5)
(40.5)
(0.0)
(14.8)
(6.3)
(10.7)
(1.9)
(8.3)
-(17.9)
(6.0)
(28.8)
(14.9)
(36.0)
(9.1)
(78.6)
(15.5)
(17.0)
(21.9)
(85.7)
(33.3)
(36.8)
(50.0)
(24.6)
(25.0)

(31.3)
(25.5)
(22.9)
(38.3)
(32.5)
(38.7)
(41.7)
(61.9)
(12.7)
(26.9)
(40.4)
(36.9)
(45.5)
(39.0)
(29.3)
(34.2)
(25.7)
(37.1)
(34.4)
(22.2)
(48.1)
(30.9)
(28.9)
(27.6)
(25.8)
-(50.0)
(52.4)
(38.1)
(36.4)
(42.3)
(27.1)
(38.6)
(32.0)
(34.6)
-(29.9)
(44.8)
(27.4)
(36.1)
(36.0)
(31.1)
(7.1)
(32.4)
(36.4)
(40.6)
(14.3)
(53.5)
(30.8)
(8.3)
(34.4)
(50.0)

100
99
100
100
100
100
100
...

(0.0)
(55.1)
(26.9)
(48.1)
(30.8)
(44.9)
(12.5)
...

(0.0)
(0.0)
(3.0)
(1.9)
(0.0)
(4.1)
(0.0)
...

(0.0)
(3.1)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
...

(0.0)
(1.0)
(0.0)
(0.0)
(30.8)
(0.0)
(25.0)
...

(33.3)
(3.1)
(22.4)
(3.7)
(3.8)
(8.2)
(37.5)
...

(0.0)
(16.3)
(6.0)
(18.5)
(0.0)
(16.3)
(0.0)
...

(66.7)
(21.4)
(41.8)
(27.8)
(34.6)
(26.5)
(25.0)
...

Other

Employment

Occupation within past 12 months of TB diagnosis. Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and
the District of Columbia). Percentages shown only for reporting areas with information reported for >75% of cases.
2
Excludes New York City.
3
Not included in U.S. totals.
Note: Ellipses indicate data not available.
1

63

Table 35. Tuberculosis Cases and Percentages by Initial Drug Regimen:
Reporting Areas, 2011

Reporting Area
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York State4
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

Total
Cases
10,528

Cases in
Persons
Alive at
Diagnosis
10,279

161
67
255
85
2,323
70
83
21
56
754
347
123
12
359
100
40
36
71
167
9
233
196
170
137
91
98
8
23
95
11
331
49
221
689
244
7
145
94
74
260
27
140
15
156
1,325
34
8
221
200
13
70
4

156
65
246
82
2,272
68
81
21
56
737
332
122
12
351
98
40
34
69
164
8
228
191
168
133
89
95
8
23
93
11
322
46
218
674
235
7
143
89
74
252
27
134
15
149
1,300
34
8
218
196
12
69
4

Cases with Information on
Initial Drug Regimen1

Percentage of Cases in Persons with
Initial Drug Regimen2

No.
10,183

(%)
(99.1)

IR
(0.7)

IRZ
(2.7)

IRZE3
(86.2)

156
64
238
82
2,254
68
76
21
55
735
331
122
11
347
98
40
34
69
161
8
227
191
166
133
88
92
8
23
92
11
318
46
218
654
235
7
141
88
74
251
27
134
15
149
1,287
34
8
216
196
12
68
4

(100.0)
(98.5)
(96.7)
(100.0)
(99.2)
(100.0)
(93.8)
(100.0)
(98.2)
(99.7)
(99.7)
(100.0)
(91.7)
(98.9)
(100.0)
(100.0)
(100.0)
(100.0)
(98.2)
(100.0)
(99.6)
(100.0)
(98.8)
(100.0)
(98.9)
(96.8)
(100.0)
(100.0)
(98.9)
(100.0)
(98.8)
(100.0)
(100.0)
(97.0)
(100.0)
(100.0)
(98.6)
(98.9)
(100.0)
(99.6)
(100.0)
(100.0)
(100.0)
(100.0)
(99.0)
(100.0)
(100.0)
(99.1)
(100.0)
(100.0)
(98.6)
(100.0)

(0.6)
(0.0)
(0.0)
(0.0)
(0.6)
(0.0)
(0.0)
(0.0)
(0.0)
(0.8)
(2.1)
(0.8)
(0.0)
(1.2)
(2.0)
(0.0)
(0.0)
(0.0)
(0.6)
(0.0)
(2.2)
(0.5)
(0.0)
(0.8)
(2.3)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.9)
(0.0)
(0.0)
(0.3)
(0.9)
(0.0)
(0.0)
(15.9)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.5)
(2.9)
(0.0)
(0.0)
(0.0)
(0.0)
(1.5)
(0.0)

(7.1)
(1.6)
(2.9)
(7.3)
(1.6)
(0.0)
(1.3)
(4.8)
(0.0)
(3.3)
(0.0)
(1.6)
(0.0)
(3.7)
(2.0)
(0.0)
(0.0)
(0.0)
(5.6)
(0.0)
(4.8)
(2.6)
(5.4)
(6.0)
(8.0)
(5.4)
(0.0)
(17.4)
(1.1)
(0.0)
(1.6)
(0.0)
(2.3)
(2.6)
(0.9)
(0.0)
(2.8)
(12.5)
(4.1)
(2.4)
(3.7)
(4.5)
(6.7)
(2.7)
(2.5)
(5.9)
(0.0)
(0.5)
(2.0)
(0.0)
(10.3)
(0.0)

(82.7)
(79.7)
(92.0)
(86.6)
(88.1)
(83.8)
(25.0)
(81.0)
(92.7)
(86.3)
(94.6)
(89.3)
(100.0)
(87.6)
(86.7)
(90.0)
(97.1)
(82.6)
(90.7)
(100.0)
(83.3)
(76.4)
(79.5)
(86.5)
(80.7)
(75.0)
(100.0)
(69.6)
(95.7)
(81.8)
(87.4)
(91.3)
(86.7)
(84.6)
(81.3)
(100.0)
(84.4)
(60.2)
(91.9)
(62.9)
(88.9)
(86.6)
(86.7)
(91.9)
(90.9)
(82.4)
(62.5)
(95.4)
(88.3)
(91.7)
(79.4)
(100.0)

American Samoa5
3
3
3
(100.0)
(0.0)
(0.0)
(66.7)
Fed. States of Micronesia5
140
140
140
(100.0)
(0.0)
(0.7)
(97.1)
Guam5
78
78
76
(97.4)
(0.0)
(2.6)
(89.5)
Marshall Islands5
149
149
149
(100.0)
(0.0)
(0.0)
(81.9)
N. Mariana Islands5
27
27
27
(100.0)
(0.0)
(0.0)
(74.1)
Puerto Rico5
50
47
39
(83.0)
(0.0)
(0.0)
(97.4)
5
Republic of Palau
8
8
8
(100.0)
(0.0)
(0.0)
(100.0)
U.S. Virgin Islands5
...
...
...
...
...
...
...
1
Includes persons who were alive at diagnosis and started on one or more drug.
2
Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the District of Columbia). Counts and percentages
shown only for reporting areas with information reported for >75% of cases.
3
I=isoniazid; R=rifampin; Z=pyrazinamide; E=ethambutol.
4
Excludes New York City.
5
Not included in U.S. totals.
Note: Excluding cases with no information on drug regimen, 226 (2.17%) persons were not started on any drugs, 13 (0.12%) were
started on one drug, and 1,045 (10.02%) had an initial multidrug regimen other than IR, IRZ, or IRZE.

64

Table 36. Culture-Positive Tuberculosis Cases and Percentages with Drug-Susceptibility
Results, by Resistance to INH or Multidrug Resistance: Reporting Areas, 2011

Reporting Area
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York State3
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
American Samoa4
Fed. States of Micronesia4
Guam4
Marshall Islands4
N. Mariana Islands4
Puerto Rico4
Republic of Palau4
U.S. Virgin Islands4

Total
Culture
Positive
Cases
8,070

Cases with Initial DrugSusceptibility Testing
Performed1

Resistance2
Isoniazid and Rifampin1

Isoniazid1

No.
7,727

(%)
(95.7)

No.
736

(%)
(9.5)

No.
124

(%)
(1.6)

119
60
193
60
1,840
52
69
19
46
604
240
76
10
274
74
31
36
53
137
8
166
144
123
101
66
75
5
18
65
10
267
43
172
495
183
4
112
68
59
199
20
107
7
109
1,009
24
6
175
160
13
60
4

108
59
190
59
1,773
52
66
19
46
567
237
75
9
248
73
8
35
53
128
8
165
137
122
101
66
34
5
18
60
10
262
43
169
481
174
0
110
67
59
177
20
101
7
106
982
24
6
174
158
12
60
4

(90.8)
(98.3)
(98.4)
(98.3)
(96.4)
(100.0)
(95.7)
(100.0)
(100.0)
(93.9)
(98.8)
(98.7)
(90.0)
(90.5)
(98.6)
(25.8)
(97.2)
(100.0)
(93.4)
(100.0)
(99.4)
(95.1)
(99.2)
(100.0)
(100.0)
(45.3)
(100.0)
(100.0)
(92.3)
(100.0)
(98.1)
(100.0)
(98.3)
(97.2)
(95.1)
(0.0)
(98.2)
(98.5)
(100.0)
(88.9)
(100.0)
(94.4)
(100.0)
(97.2)
(97.3)
(100.0)
(100.0)
(99.4)
(98.8)
(92.3)
(100.0)
(100.0)

5
14
15
4
192
7
6
2
3
42
23
7
2
22
8
-4
5
10
0
13
14
9
12
6
-0
0
8
1
34
0
18
56
14
-7
2
5
22
1
4
1
7
88
3
0
15
14
1
6
0

(4.6)
(23.7)
(7.9)
(6.8)
(10.8)
(13.5)
(9.1)
(10.5)
(6.5)
(7.4)
(9.7)
(9.3)
(22.2)
(8.9)
(11.0)
-(11.4)
(9.4)
(7.8)
(0.0)
(7.9)
(10.2)
(7.4)
(11.9)
(9.1)
-(0.0)
(0.0)
(13.3)
(10.0)
(13.0)
(0.0)
(10.7)
(11.6)
(8.0)
-(6.4)
(3.0)
(8.5)
(12.4)
(5.0)
(4.0)
(14.3)
(6.6)
(9.0)
(12.5)
(0.0)
(8.6)
(8.9)
(8.3)
(10.0)
(0.0)

2
4
1
1
34
1
0
0
0
6
1
1
0
3
2
-0
2
0
0
2
0
1
3
0
-0
0
0
0
8
0
6
14
2
-2
1
1
4
0
0
0
0
16
1
0
2
1
0
2
0

(1.9)
(6.8)
(0.5)
(1.7)
(1.9)
(1.9)
(0.0)
(0.0)
(0.0)
(1.1)
(0.4)
(1.3)
(0.0)
(1.2)
(2.7)
-(0.0)
(3.8)
(0.0)
(0.0)
(1.2)
(0.0)
(0.8)
(3.0)
(0.0)
-(0.0)
(0.0)
(0.0)
(0.0)
(3.1)
(0.0)
(3.6)
(2.9)
(1.1)
-(1.8)
(1.5)
(1.7)
(2.3)
(0.0)
(0.0)
(0.0)
(0.0)
(1.6)
(4.2)
(0.0)
(1.1)
(0.6)
(0.0)
(3.3)
(0.0)

3
52
43
59
16
46
7
...

3
47
39
54
15
34
6
...

(100.0)
(90.4)
(90.7)
(91.5)
(93.8)
(73.9)
(85.7)
...

1
1
4
2
2
-0
...

(33.3)
(2.1)
(10.3)
(3.7)
(13.3)
-(0.0)
...

0
1
0
1
0
-0
...

(0.0)
(2.1)
(0.0)
(1.9)
(0.0)
-(0.0)
...

Patients tested to at least isoniazid and rifampin
Isolates may be resistant to other drugs. Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the District
of Columbia). Counts and percentages shown only for reporting areas with information reported for >75% of cases.
3
Excludes New York City.
4
Not included in U.S. totals.
Note: Ellipses indicate data not available.
65
1
2

Table 37. Tuberculosis Cases and Percentages by HIV Status: Reporting Areas, 2011
Reporting Area

Total
Cases

Cases with Information on HIV Status1

Cases in Persons with HIV-Positive Results2
(%)

United States

10,528

No.
8,683

(%)
(82.5)

No.
672

(7.7)

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York State3
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

161
67
255
85
2,323
70
83
21
56
754
347
123
12
359
100
40
36
71
167
9
233
196
170
137
91
98
8
23
95
11
331
49
221
689
244
7
145
94
74
260
27
140
15
156
1,325
34
8
221
200
13
70
4

153
58
211
73
1,820
64
59
21
54
623
310
108
8
311
74
32
35
64
145
8
205
117
135
121
87
79
8
19
89
8
247
45
174
546
238
6
124
59
70
201
26
124
12
149
1,081
33
0
203
171
10
61
4

(95.0)
(86.6)
(82.7)
(85.9)
(78.3)
(91.4)
(71.1)
(100.0)
(96.4)
(82.6)
(89.3)
(87.8)
(66.7)
(86.6)
(74.0)
(80.0)
(97.2)
(90.1)
(86.8)
(88.9)
(88.0)
(59.7)
(79.4)
(88.3)
(95.6)
(80.6)
(100.0)
(82.6)
(93.7)
(72.7)
(74.6)
(91.8)
(78.7)
(79.2)
(97.5)
(85.7)
(85.5)
(62.8)
(94.6)
(77.3)
(96.3)
(88.6)
(80.0)
(95.5)
(81.6)
(97.1)
(0.0)
(91.9)
(85.5)
(76.9)
(87.1)
(100.0)

7
1
10
4
100
3
7
0
9
113
31
1
0
22
6
1
1
6
12
0
13
10
5
3
9
6
0
2
2
1
26
3
11
58
12
0
6
1
4
21
2
12
0
20
95
1
0
9
6
0
0
0

(4.6)
(1.7)
(4.7)
(5.5)
(5.5)
(4.7)
(11.9)
(0.0)
(16.7)
(18.1)
(10.0)
(0.9)
(0.0)
(7.1)
(8.1)
(3.1)
(2.9)
(9.4)
(8.3)
(0.0)
(6.3)
(8.5)
(3.7)
(2.5)
(10.3)
(7.6)
(0.0)
(10.5)
(2.2)
(12.5)
(10.5)
(6.7)
(6.3)
(10.6)
(5.0)
(0.0)
(4.8)
(1.7)
(5.7)
(10.4)
(7.7)
(9.7)
(0.0)
(13.4)
(8.8)
(3.0)
.
(4.4)
(3.5)
(0.0)
(0.0)
(0.0)

3
140
78
149
27
50
8
...

3
117
48
88
19
40
8
...

(100.0)
(83.6)
(61.5)
(59.1)
(70.4)
(80.0)
(100.0)
...

0
0
0
1
0
9
1
...

(0.0)
(0.0)
(0.0)
(1.1)
(0.0)
(22.5)
(12.5)
...

American Samoa4
Fed. States of Micronesia4
Guam4
Marshall Islands4
N. Mariana Islands4
Puerto Rico4
Republic of Palau4
U.S. Virgin Islands4

Includes only those cases in persons with negative, positive, or indeterminate HIV test results.
Counts and percentages shown only for reporting areas with information reported for >75% of cases. All 2011 Vermont cases are missing HIV status because these HIV data were not available at time of publication.
3
Excludes New York City.
4
Not included in U.S. totals.
Note: Ellipses indicate data not available.
See Technical Notes.
1
2

66

Table 38. Tuberculosis Cases and Percentages by Type of Health Care Provider:
Reporting Areas, 20091

Reporting Area
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York State3
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

Cases with Information on
Type of Health Care Provider

Total
Cases

Cases in
Persons
Alive at
Diagnosis

11,528

11,282

No.
11,028

168
37
232
82
2,467
85
95
19
41
822
412
117
18
418
119
42
64
75
192
9
218
242
144
161
121
79
8
32
106
16
405
48
246
759
250
5
180
102
89
236
24
164
18
202
1,501
37
6
271
256
19
67
2

164
36
227
76
2,425
84
92
19
39
795
407
116
18
408
117
41
61
74
184
9
212
239
135
161
117
78
8
31
103
16
401
41
240
743
244
5
177
98
88
230
24
158
17
199
1,473
36
6
269
254
19
66
2

164
36
209
75
2,388
83
92
19
39
790
381
116
18
405
117
41
61
73
184
9
207
232
132
161
117
0
8
30
99
16
401
41
239
709
244
0
169
98
88
230
24
158
17
199
1,459
36
6
269
254
19
65
1

Percentage of Cases by
Type of Health Care Provider2

(%)
(97.7)

Health
Department
(70.7)

Private/
Other
(22.9)

Both Health
Department and
Private/Other
(6.4)

(100.0)
(100.0)
(92.1)
(98.7)
(98.5)
(98.8)
(100.0)
(100.0)
(100.0)
(99.4)
(93.6)
(100.0)
(100.0)
(99.3)
(100.0)
(100.0)
(100.0)
(98.6)
(100.0)
(100.0)
(97.6)
(97.1)
(97.8)
(100.0)
(100.0)
(0.0)
(100.0)
(96.8)
(96.1)
(100.0)
(100.0)
(100.0)
(99.6)
(95.4)
(100.0)
(0.0)
(95.5)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(99.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(98.5)
(50.0)

(96.3)
(52.8)
(77.5)
(80.0)
(50.6)
(89.2)
(15.2)
(100.0)
(92.3)
(69.7)
(74.3)
(73.3)
(50.0)
(85.2)
(95.7)
(19.5)
(95.1)
(86.3)
(87.5)
(0.0)
(93.2)
(73.7)
(81.8)
(55.3)
(97.4)
-(75.0)
(56.7)
(97.0)
(12.5)
(81.0)
(73.2)
(72.8)
(44.6)
(95.1)
-(79.3)
(99.0)
(48.9)
(81.3)
(95.8)
(88.6)
(64.7)
(89.9)
(76.9)
(100.0)
(83.3)
(85.5)
(89.4)
(73.7)
(72.3)
--

(3.7)
(8.3)
(22.5)
(20.0)
(34.9)
(10.8)
(30.4)
(0.0)
(7.7)
(30.3)
(25.7)
(26.7)
(50.0)
(14.8)
(4.3)
(80.5)
(4.9)
(13.7)
(12.5)
(100.0)
(6.8)
(18.1)
(18.2)
(44.7)
(2.6)
-(25.0)
(43.3)
(3.0)
(87.5)
(19.0)
(26.8)
(27.2)
(19.2)
(4.9)
-(20.7)
(1.0)
(29.5)
(18.7)
(4.2)
(11.4)
(35.3)
(10.1)
(23.1)
(0.0)
(16.7)
(14.5)
(10.6)
(26.3)
(27.7)
--

(0.0)
(38.9)
(0.0)
(0.0)
(14.4)
(0.0)
(54.3)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(8.2)
(0.0)
(0.0)
(0.0)
-(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(36.2)
(0.0)
-(0.0)
(0.0)
(21.6)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
--

American Samoa4
4
4
3
(75.0)
(100.0)
(0.0)
(0.0)
Fed. States of Micronesia4
190
190
136
(71.6)
---Guam4
102
100
94
(94.0)
(94.7)
(5.3)
(0.0)
Marshall Islands4
125
125
56
(44.8)
---N. Mariana Islands4
32
32
30
(93.8)
(100.0)
(0.0)
(0.0)
Puerto Rico4
63
58
58
(100.0)
(89.7)
(8.6)
(1.7)
Republic of Palau4
18
18
7
(38.9)
---U.S. Virgin Islands4
...
...
...
...
...
...
...
1
Most recent year for which data are available.
2
Health Department: All outpatient care provided by the state or local health department; Private/Other: All care (except contact investigation and dispensing of medication) provided by non–health department providers; Both Health Department and Private/Other: Both
sectors involved in the care of the patient. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of
Columbia). Percentages shown only for reporting areas with information reported for >75% of cases.
3
Excludes New York City.
4
Not included in U.S. totals.
Note: Ellipses indicate data not available.

67

Table 39. Tuberculosis Cases and Percentages by Directly Observed Therapy (DOT):
Reporting Areas, 20091

Reporting Area
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York State4
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

Total
Cases
11,528
168
37
232
82
2,467
85
95
19
41
822
412
117
18
418
119
42
64
75
192
9
218
242
144
161
121
79
8
32
106
16
405
48
246
759
250
5
180
102
89
236
24
164
18
202
1,501
37
6
271
256
19
67
2

Cases with
Initial Drug
Regimen
Prescribed2
11,153
164
36
213
76
2,391
84
91
19
39
790
400
115
18
407
116
41
61
73
184
9
212
227
133
161
117
77
8
31
103
16
400
41
239
723
242
5
176
85
88
229
24
158
17
199
1,467
36
6
268
251
19
66
2

Cases with Information on
Directly Observed Therapy

Percentage of Cases by
Directly Observed Therapy3

No.
11,031

(%)
(98.9)

DOT Only
(59.5)

164
36
203
76
2,320
84
91
19
39
789
396
114
18
402
116
41
61
70
184
9
209
225
130
161
117
76
8
30
103
16
399
41
239
721
242
5
174
84
88
229
24
158
17
199
1,459
36
6
268
251
18
64
2

(100.0)
(100.0)
(95.3)
(100.0)
(97.0)
(100.0)
(100.0)
(100.0)
(100.0)
(99.9)
(99.0)
(99.1)
(100.0)
(98.8)
(100.0)
(100.0)
(100.0)
(95.9)
(100.0)
(100.0)
(98.6)
(99.1)
(97.7)
(100.0)
(100.0)
(98.7)
(100.0)
(96.8)
(100.0)
(100.0)
(99.8)
(100.0)
(100.0)
(99.7)
(100.0)
(100.0)
(98.9)
(98.8)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(99.5)
(100.0)
(100.0)
(100.0)
(100.0)
(94.7)
(97.0)
(100.0)

(39.0)
(91.7)
(73.9)
(30.3)
(51.9)
(82.1)
(42.9)
(47.4)
(94.9)
(40.2)
(79.3)
(32.5)
(27.8)
(46.0)
(87.1)
(70.7)
(93.4)
(61.4)
(72.8)
(100.0)
(78.0)
(44.4)
(50.8)
(88.8)
(59.8)
(36.8)
(75.0)
(73.3)
(76.7)
(87.5)
(58.9)
(87.8)
(18.4)
(6.7)
(97.1)
(0.0)
(72.4)
(91.7)
(83.0)
(69.4)
(25.0)
(93.0)
(41.2)
(96.5)
(76.7)
(100.0)
(50.0)
(92.5)
(70.1)
(72.2)
(54.7)
(50.0)

Both DOT and
Self-Administered
(30.3)
(61.0)
(8.3)
(17.7)
(13.2)
(31.4)
(14.3)
(29.7)
(52.6)
(0.0)
(54.8)
(17.9)
(50.9)
(50.0)
(38.3)
(10.3)
(9.8)
(6.6)
(31.4)
(15.2)
(0.0)
(18.2)
(32.9)
(49.2)
(11.2)
(40.2)
(50.0)
(25.0)
(16.7)
(22.3)
(12.5)
(19.5)
(12.2)
(77.0)
(69.1)
(2.9)
(80.0)
(10.3)
(6.0)
(14.8)
(21.0)
(75.0)
(5.1)
(58.8)
(3.5)
(22.1)
(0.0)
(50.0)
(5.2)
(15.5)
(16.7)
(43.8)
(50.0)

American Samoa5
4
4
4
(100.0)
(0.0)
(100.0)
Fed. States of Micronesia5
190
190
189
(99.5)
(77.2)
(20.1)
5
Guam
102
100
95
(95.0)
(96.8)
(2.1)
5
Marshall Islands
125
125
122
(97.6)
(93.4)
(6.6)
N. Mariana Islands5
32
32
29
(90.6)
(100.0)
(0.0)
Puerto Rico5
63
58
42
(72.4)
--Republic of Palau5
18
18
2
(11.1)
--U.S. Virgin Islands5
...
...
...
...
...
...
1
Most recent year for which data are available.
2
Includes persons alive at diagnosis with an initial drug regimen of one or more drugs prescribed.
3
Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the District of Columbia). Percentages shown only for
reporting areas with information reported for >75% of cases.
4
Excludes New York City.
5
Not included in U.S. totals.
Note: Ellipses indicate data not available.

68

Table 40. Tuberculosis Cases and Percentages by Completion of Tuberculosis Therapy
(COT): Reporting Areas, 20091
Reporting Area
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York State6
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
American Samoa7
Fed. States of Micronesia7
Guam7
Marshall Islands7
N. Mariana Islands7
Puerto Rico7
Republic of Palau7
U.S. Virgin Islands7

Therapy <1 Year Indicated2,3,4

Total
Cases
11,528

No.
9854

168
37
232
82
2,467
85
95
19
41
822
412
117
18
418
119
42
64
75
192
9
218
242
144
161
121
79
8
32
106
16
405
48
246
759
250
5
180
102
89
236
24
164
18
202
1,501
37
6
271
256
19
67
2

146
32
178
59
2145
69
82
18
32
695
348
96
17
364
106
39
55
62
170
7
191
207
114
146
106
74
7
29
94
15
349
32
204
665
221
5
147
83
79
202
23
137
17
176
1228
28
5
244
232
16
56
2

(93.2)
(84.4)
(82.6)
(86.4)
(83.2)
(94.2)
(86.6)
(77.8)
(81.3)
(93.2)
(83.6)
(83.3)
(94.1)
(87.4)
(90.6)
(87.2)
(100.0)
(91.9)
(86.5)
(100.0)
(88.5)
(83.1)
(89.5)
(91.8)
(88.7)
(81.1)
(100.0)
(86.2)
(87.2)
(93.3)
(92.6)
(90.6)
(82.4)
(92.2)
(93.2)
(60.0)
(91.2)
(89.2)
(97.5)
(83.7)
(87.0)
(92.0)
(88.2)
(93.8)
(87.6)
(100.0)
(80.0)
(87.7)
(91.4)
(68.8)
(82.1)
(50.0)

4
190
102
125
32
63
18
0

3
175
93
108
28
51
15
0

(100.0)
(82.9)
(96.8)
(88.9)
(96.4)
(86.3)
(26.7)
--

COT <1 Year(%) COT(%)
(87.7)
(95.3)

Therapy >1 Year Indicated3,5

All Drug Therapy3

No.
629

COT(%)
(63.0)

No.
10487

COT(%)
(93.3)

(98.6)
(87.5)
(87.1)
(93.2)
(91.9)
(100.0)
(98.8)
(88.9)
(96.9)
(98.3)
(92.8)
(99.0)
(94.1)
(97.0)
(97.2)
(97.4)
(100.0)
(96.8)
(95.3)
(100.0)
(96.3)
(96.6)
(94.7)
(97.3)
(96.2)
(91.9)
(100.0)
(89.7)
(97.9)
(100.0)
(97.4)
(100.0)
(91.2)
(97.1)
(99.5)
(100.0)
(95.2)
(96.4)
(100.0)
(95.5)
(95.7)
(97.1)
(94.1)
(98.3)
(95.4)
(100.0)
(100.0)
(96.7)
(97.0)
(81.3)
(96.4)
(100.0)

8
2
29
7
66
10
3
0
4
39
26
7
1
25
9
1
3
1
3
1
13
14
12
13
5
3
0
1
6
0
30
3
14
27
6
0
9
1
6
11
1
9
0
11
156
5
1
11
12
1
3
0

(75.0)
(100.0)
(37.9)
(28.6)
(78.8)
(60.0)
(33.3)
...
(75.0)
(56.4)
(57.7)
(57.1)
(0.0)
(64.0)
(77.8)
(0.0)
(100.0)
(100.0)
(66.7)
(0.0)
(84.6)
(71.4)
(58.3)
(61.5)
(100.0)
(66.7)
...
(100.0)
(50.0)
...
(60.0)
(66.7)
(85.7)
(81.5)
(66.7)
...
(88.9)
(0.0)
(83.3)
(81.8)
(0.0)
(88.9)
...
(81.8)
(51.9)
(100.0)
(0.0)
(63.6)
(33.3)
(0.0)
(66.7)
...

154
34
207
66
2212
79
85
18
36
734
374
103
18
389
115
40
58
63
173
8
204
221
126
159
111
77
7
30
100
15
379
35
221
692
227
5
156
84
85
213
24
146
17
187
1384
33
6
255
244
17
59
2

(97.4)
(88.2)
(80.2)
(86.4)
(91.5)
(94.9)
(96.5)
(88.9)
(94.4)
(96.0)
(90.4)
(96.1)
(88.9)
(94.9)
(95.7)
(95.0)
(100.0)
(96.8)
(94.8)
(87.5)
(95.6)
(95.0)
(91.3)
(94.3)
(96.4)
(90.9)
(100.0)
(90.0)
(95.0)
(100.0)
(94.5)
(97.1)
(89.6)
(96.5)
(98.7)
(100.0)
(94.9)
(95.2)
(98.8)
(94.8)
(91.7)
(96.6)
(94.1)
(97.3)
(90.5)
(100.0)
(83.3)
(95.3)
(93.9)
(76.5)
(94.9)
(100.0)

(100.0)
(91.4)
(96.8)
(91.7)
(100.0)
(86.3)
(26.7)
--

0
10
4
4
1
1
1
0

...
(80.0)
(50.0)
(75.0)
(0.0)
(100.0)
(0.0)
...

3
186
97
112
29
52
16
0

(100.0)
(90.3)
(94.8)
(91.1)
(96.6)
(86.5)
(25.0)
--

Most recent year for which data are available.
Initial isolate susceptible to rifampin (n=7,258) or susceptibility unknown (n=187); culture negative (n=2,008); culture status unknown (n=401).
3
Number of cases in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed, who did not die during therapy. Percentage for U.S.
based on 52 reporting areas (50 states, New York City, and the District of Columbia). Percentages shown only for reporting areas with information reported
for >90% of cases.
4
Excludes initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or positive blood culture,
and those who moved out of country during treatment.
5
Initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or positive blood culture.
6
Excludes New York City.
7
Not included in U.S. totals.
Note: Ellipses indicate data not available. See Technical Notes for description of Completion of Therapy calculation (page 9).
1
2

69

70

Cases with
Initial Drug
Regimen
Prescribed2

11,153

164
36
213
76
2,391
84
91
19
39
790
400
115
18
407
116
41
61
73
184
9
212
227
133
161
117
77
8
31
103
16
400
41

Reporting Area

United States

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico

150
30
166
57
2,025
75
82
16
34
705
338
99
16
369
110
38
58
61
164
7
195
210
115
150
107
70
7
27
95
15
358
34

9,790

No.

(91.5)
(83.3)
(77.9)
(75.0)
(84.7)
(89.3)
(90.1)
(84.2)
(87.2)
(89.2)
(84.5)
(86.1)
(88.9)
(90.7)
(94.8)
(92.7)
(95.1)
(83.6)
(89.1)
(77.8)
(92.0)
(92.5)
(86.5)
(93.2)
(91.5)
(90.9)
(87.5)
(87.1)
(92.2)
(93.8)
(89.5)
(82.9)

(87.8)

(%)

Completed
Therapy

0
0
1
0
3
0
0
1
0
1
1
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0

20

No.

Adverse
Event

(0.0)
(0.0)
(0.5)
(0.0)
(0.1)
(0.0)
(0.0)
(5.3)
(0.0)
(0.1)
(0.3)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.5)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)

(0.2)

(%)

0
1
0
0
90
0
0
0
0
0
1
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

99

No.

(0.0)
(2.8)
(0.0)
(0.0)
(3.8)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.3)
(0.0)
(0.0)
(0.0)
(0.0)
(2.4)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)

(0.9)

(%)

Moved3

2
0
7
0
23
0
3
0
0
9
17
4
1
15
1
1
0
0
7
0
7
1
5
0
0
0
0
2
3
0
16
0

192

No.

Lost

(1.2)
(0.0)
(3.3)
(0.0)
(1.0)
(0.0)
(3.3)
(0.0)
(0.0)
(1.1)
(4.3)
(3.5)
(5.6)
(3.7)
(0.9)
(2.4)
(0.0)
(0.0)
(3.8)
(0.0)
(3.3)
(0.4)
(3.8)
(0.0)
(0.0)
(0.0)
(0.0)
(6.5)
(2.9)
(0.0)
(4.0)
(0.0)

(1.7)

(%)

1
3
0
2
17
1
0
0
0
4
2
0
0
3
3
0
0
0
0
0
2
2
1
2
0
0
0
0
0
0
1
0

83

No.

(0.6)
(8.3)
(0.0)
(2.6)
(0.7)
(1.2)
(0.0)
(0.0)
(0.0)
(0.5)
(0.5)
(0.0)
(0.0)
(0.7)
(2.6)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.9)
(0.9)
(0.8)
(1.2)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.3)
(0.0)

(0.7)

(%)

Refused

Table 41. Tuberculosis Cases and Percentages by Reason Therapy Stopped: Reporting Areas, 20091

10
2
6
10
179
5
6
1
3
56
26
12
0
18
1
1
3
10
11
1
8
6
7
2
6
0
1
1
3
1
21
6

666

No.

(6.1)
(5.6)
(2.8)
(13.2)
(7.5)
(6.0)
(6.6)
(5.3)
(7.7)
(7.1)
(6.5)
(10.4)
(0.0)
(4.4)
(0.9)
(2.4)
(4.9)
(13.7)
(6.0)
(11.1)
(3.8)
(2.6)
(5.3)
(1.2)
(5.1)
(0.0)
(12.5)
(3.2)
(2.9)
(6.3)
(5.3)
(14.6)

(6.0)

(%)

Died4

1
0
33
7
54
3
0
1
2
15
15
0
1
2
1
0
0
2
1
1
0
8
5
7
4
7
0
1
2
0
4
1

303

No.

(0.6)
(0.0)
(15.5)
(9.2)
(2.3)
(3.6)
(0.0)
(5.3)
(5.1)
(1.9)
(3.8)
(0.0)
(5.6)
(0.5)
(0.9)
(0.0)
(0.0)
(2.7)
(0.5)
(11.1)
(0.0)
(3.5)
(3.8)
(4.3)
(3.4)
(9.1)
(0.0)
(3.2)
(1.9)
(0.0)
(1.0)
(2.4)

(2.7)

(%)

Unknown5

71

6

3
169
92
102
28
45
4
...

201
668
224
5
148
80
84
202
22
141
16
182
1,253
33
5
243
229
13
56
2

239
723
242
5
176
85
88
229
24
158
17
199
1,467
36
6
268
251
19
66
2

4
190
100
125
32
58
18
...

No.

(75.0)
(88.9)
(92.0)
(81.6)
(87.5)
(77.6)
(22.2)
...

(84.1)
(92.4)
(92.6)
(100.0)
(84.1)
(94.1)
(95.5)
(88.2)
(91.7)
(89.2)
(94.1)
(91.5)
(85.4)
(91.7)
(83.3)
(90.7)
(91.2)
(68.4)
(84.8)
(100.0)

(%)

0
0
0
0
0
0
0
...

0
0
0
0
0
1
0
1
0
2
0
0
3
0
0
0
3
2
0
0

No.
(%)

(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
...

(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(1.2)
(0.0)
(0.4)
(0.0)
(1.3)
(0.0)
(0.0)
(0.2)
(0.0)
(0.0)
(0.0)
(1.2)
(10.5)
(0.0)
(0.0)

Adverse
Event

0
0
0
0
0
0
0
...

0
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

No.

(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
...

(0.0)
(0.8)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)

(%)

Moved3

0
1
0
7
0
1
0
...

4
6
0
0
4
1
0
6
0
3
0
2
38
0
0
3
1
0
0
0

No.

Lost

(0.0)
(0.5)
(0.0)
(5.6)
(0.0)
(1.7)
(0.0)
...

(1.7)
(0.8)
(0.0)
(0.0)
(2.3)
(1.2)
(0.0)
(2.6)
(0.0)
(1.9)
(0.0)
(1.0)
(2.6)
(0.0)
(0.0)
(1.1)
(0.4)
(0.0)
(0.0)
(0.0)

(%)

0
7
0
0
0
2
0
...

3
7
1
0
2
1
0
1
1
0
1
1
12
0
0
4
4
1
0
0

No.

(0.0)
(3.7)
(0.0)
(0.0)
(0.0)
(3.4)
(0.0)
...

(1.3)
(1.0)
(0.4)
(0.0)
(1.1)
(1.2)
(0.0)
(0.4)
(4.2)
(0.0)
(5.9)
(0.5)
(0.8)
(0.0)
(0.0)
(1.5)
(1.6)
(5.3)
(0.0)
(0.0)

(%)

Refused

1
4
3
13
3
6
2
...

18
31
15
0
20
1
3
16
0
12
0
12
83
3
0
13
7
2
7
0

No.

(%)

(25.0)
(2.1)
(3.0)
(10.4)
(9.4)
(10.3)
(11.1)
...

(7.5)
(4.3)
(6.2)
(0.0)
(11.4)
(1.2)
(3.4)
(7.0)
(0.0)
(7.6)
(0.0)
(6.0)
(5.7)
(8.3)
(0.0)
(4.9)
(2.8)
(10.5)
(10.6)
(0.0)

Died4

0
9
5
3
1
4
12
...

13
5
2
0
2
1
1
3
1
0
0
2
78
0
1
5
7
1
3
0

No.

(0.0)
(4.7)
(5.0)
(2.4)
(3.1)
(6.9)
(66.7)
...

(5.4)
(0.7)
(0.8)
(0.0)
(1.1)
(1.2)
(1.1)
(1.3)
(4.2)
(0.0)
(0.0)
(1.0)
(5.3)
(0.0)
(16.7)
(1.9)
(2.8)
(5.3)
(4.5)
(0.0)

(%)

Unknown5

2

1

Most recent year for which data are available.
Number of cases in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed. Percentage for U.S. based on 52 reporting areas (50 states, New York City, and the
District of Columbia).
3
Moved variable was utilized by the following reporting areas: Alaska, California, Georgia, Iowa, and New York City
4
Died = Died of any cause.
5
Includes cases reported as Other, Missing, or Unknown.
6
Excludes New York City.
7
Not included in U.S. totals.
Note: Ellipses indicate data not available.

American Samoa7
Fed. States of Micronesia7
Guam7
Marshall Islands7
N. Mariana Islands7
Puerto Rico7
Republic of Palau7
U.S. Virgin Islands7

New York State
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

Reporting Area

Completed
Therapy

Cases with
Initial Drug
Regimen
Prescribed2

Table 41. Tuberculosis Cases and Percentages by Reason Therapy Stopped: Reporting Areas, 20091

72

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey

United States

Reporting Area

146
32
178
59
2145
69
82
18
32
695
348
96
17
364
106
39
55
62
170
7
191
207
114
146
106
74
7
29
94
15
349

Total
Cases3
9854
24
0
77
9
799
30
25
7
6
175
74
1
8
93
23
5
13
10
10
0
32
39
20
14
7
10
0
11
22
1
106

No.
2821
(79.2)
...
(79.2)
(100.0)
(81.0)
(96.7)
(96.0)
(85.7)
(83.3)
(96.0)
(75.7)
(100.0)
(87.5)
(84.9)
(91.3)
(100.0)
(100.0)
(90.0)
(90.0)
...
(87.5)
(82.1)
(80.0)
(92.9)
(85.7)
(80.0)
...
(90.9)
(90.9)
(0.0)
(94.3)

(%)
(87.7)

Hispanic4

0
20
13
0
1
1
0
0
0
1
0
0
0
1
0
1
0
0
1
0
0
0
0
1
0
0
1
0
2
0
0

No.
74
...
(80.0)
(84.6)
...
(100.0)
(100.0)
...
...
...
(100.0)
...
...
...
(100.0)
...
(0.0)
...
...
(100.0)
...
...
...
...
(100.0)
...
...
(100.0)
...
(100.0)
...
...

(%)
(85.1)

American Indian
or Alaska Native

9
9
43
3
968
17
20
1
3
65
59
71
2
113
21
13
19
5
17
0
67
60
24
39
4
24
3
4
39
8
124

No.
2784
(100.0)
(88.9)
(93.0)
(100.0)
(85.3)
(94.1)
(75.0)
(100.0)
(66.7)
(93.8)
(86.4)
(78.9)
(100.0)
(90.3)
(90.5)
(76.9)
(100.0)
(100.0)
(82.4)
...
(91.0)
(80.0)
(100.0)
(92.3)
(75.0)
(75.0)
(100.0)
(75.0)
(87.2)
(100.0)
(91.1)

(%)
(87.4)

Asian

65
1
20
19
166
11
17
4
19
291
153
2
1
110
31
2
12
13
87
4
81
65
49
74
74
20
1
12
12
4
76

No.
2502
(93.8)
(100.0)
(85.0)
(78.9)
(80.1)
(100.0)
(76.5)
(75.0)
(84.2)
(93.1)
(84.3)
(100.0)
(100.0)
(86.4)
(93.5)
(100.0)
(100.0)
(92.3)
(86.2)
(100.0)
(86.4)
(83.1)
(87.8)
(90.5)
(87.8)
(85.0)
(100.0)
(83.3)
(75.0)
(100.0)
(90.8)

(%)
(87.9)

Black

0
0
1
9
11
0
0
0
0
2
0
17
0
0
0
2
1
0
1
0
0
0
0
0
0
0
0
0
1
0
0

67
...
...
(100.0)
(100.0)
(90.9)
...
...
...
...
(50.0)
...
(94.1)
...
...
...
(100.0)
(100.0)
...
(0.0)
...
...
...
...
...
...
...
...
...
(0.0)
...
...

(89.6)

Native Hawaiian
or Other Pacific
Islander
(%)
No.

Non-Hispanic

48
2
24
19
183
10
20
6
4
161
62
4
6
47
31
16
10
33
53
3
11
42
21
18
21
20
2
1
18
2
40

No.
1547
(97.9)
(100.0)
(70.8)
(78.9)
(84.2)
(80.0)
(95.0)
(66.7)
(75.0)
(90.7)
(88.7)
(100.0)
(100.0)
(87.2)
(87.1)
(93.8)
(100.0)
(93.9)
(88.7)
(100.0)
(90.9)
(88.1)
(90.5)
(94.4)
(95.2)
(85.0)
(100.0)
(100.0)
(94.4)
(100.0)
(95.0)

(88.1)

(%)

White

0
0
0
0
5
0
0
0
0
0
0
1
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
1
0
0
3

No.
34
...
...
...
...
(80.0)
...
...
...
...
...
...
(100.0)
...
...
...
...
...
(0.0)
(100.0)
...
...
...
...
...
...
...
...
(100.0)
...
...
(100.0)

(%)
(88.2)

Multiple Race

0
0
0
0
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0

...
...
...
...
(83.3)
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
...
(100.0)
...
...
...
...
...
...
...
...
...

Unknown or
Missing
No.
(%)
25
(84.0)

Table 42. Completion of Tuberculosis Therapy (COT) Cases and Percentages1 by Hispanic Ethnicity and Non-Hispanic Race:
Reporting Areas, 20092

73

32
204
665
221
5
147
83
79
202
23
137
17
176
1228
28
5
244
232
16
56
2

3
175
93
108
28
51
15
0

Reporting Area

New Mexico
New York State5
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

American Samoa6
Fed. States of Micronesia6
Guam6
Marshall Islands6
N. Mariana Islands6
Puerto Rico6
Republic of Palau6
U.S. Virgin Islands6

0
1
1
0
0
51
---

20
61
210
47
0
23
12
26
22
6
37
1
25
584
11
1
40
31
1
12
0

No.

(%)

...
(0.0)
(100.0)
...
...
(86.3)
---

(95.0)
(85.2)
(95.7)
(93.6)
...
(91.3)
(83.3)
(100.0)
(95.5)
(83.3)
(91.9)
(100.0)
(100.0)
(90.4)
(100.0)
(100.0)
(87.5)
(93.5)
(100.0)
(75.0)
...
0
0
0
0
0
0
---

5
0
1
5
1
0
9
0
0
0
0
5
2
0
0
0
0
3
0
0
0

No.

...
...
...
...
...
...
---

(100.0)
...
(100.0)
(100.0)
(100.0)
...
(88.9)
...
...
...
...
(60.0)
(100.0)
...
...
...
...
(66.7)
...
...
...

(%)

American Indian
or Alaska Native

1
2
44
0
12
0
---

No.
2
64
230
25
3
30
11
21
64
9
16
1
25
204
9
2
97
91
6
19
1

(%)

(100.0)
(50.0)
(97.7)
...
(91.7)
...
---

(100.0)
(78.1)
(89.1)
(100.0)
(66.7)
(93.3)
(100.0)
(90.5)
(79.7)
(100.0)
(100.0)
(100.0)
(96.0)
(88.2)
(100.0)
(50.0)
(87.6)
(93.4)
(50.0)
(89.5)
(100.0)

Asian

0
0
0
0
0
0
---

2
33
161
97
1
53
13
5
65
2
69
4
69
277
3
1
87
51
2
10
1

No.

(%)

...
...
...
...
...
...
---

(50.0)
(84.8)
(91.9)
(91.8)
(0.0)
(92.5)
(76.9)
(100.0)
(80.0)
(100.0)
(91.3)
(100.0)
(89.9)
(84.8)
(100.0)
(100.0)
(90.8)
(88.2)
(100.0)
(100.0)
(0.0)

Black

2
170
46
106
14
0
---

0
0
1
0
0
0
4
4
0
0
0
0
0
0
3
0
0
10
0
0
0
(100.0)
(84.1)
(95.7)
(89.6)
(100.0)
...
---

...
...
(100.0)
...
...
...
(100.0)
(100.0)
...
...
...
...
...
...
(100.0)
...
...
(80.0)
...
...
...

Native Hawaiian
or Other Pacific
Islander
(%)
No.

0
0
0
1
0
0
---

3
43
54
45
0
39
28
23
47
6
15
5
54
162
2
1
18
42
7
15
0

No.

...
...
...
(100.0)
...
...
---

(66.7)
(81.4)
(94.4)
(91.1)
...
(89.7)
(89.3)
(100.0)
(87.2)
(66.7)
(86.7)
(100.0)
(94.4)
(81.5)
(100.0)
(100.0)
(77.8)
(92.9)
(71.4)
(66.7)
...

(%)

White

0
0
1
1
0
0
---

0
0
2
2
0
0
6
0
4
0
0
1
1
1
0
0
2
3
0
0
0

No.

...
...
(100.0)
(0.0)
...
...
---

...
...
(50.0)
(100.0)
...
...
(100.0)
...
(100.0)
...
...
(100.0)
(100.0)
(100.0)
...
...
(50.0)
(100.0)
...
...
...

(%)

Multiple Race

0
2
1
0
2
0
---

0
3
6
0
0
2
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0

...
(50.0)
(100.0)
...
(100.0)
...
---

...
(100.0)
(83.3)
...
...
(50.0)
...
...
...
...
...
...
...
...
...
...
...
(100.0)
...
...
...

Unknown or
Missing
No.
(%)

2

1

Percentages shown only for reporting areas with information reported for >90% of cases, and indicate the percentage of those who completed therapy within 1 year.
Most recent year for which data are available.
3
Therapy < 1 year indicated in persons alive at diagnosis with an initial regimen of one or more drugs prescribed, who did not die during therapy. Excludes persons with initial isolate rifampin
resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or positive blood culture, and those who moved out of country during treatment.
4
Persons of Hispanic or Latino origin may be of any race.
5
Excludes New York City.
6
Not included in U.S. totals.
Note: Case counts and percentage for race categories do not include persons of Hispanic ethnicity. Ellipses indicate data not available. See Technical Notes for description of Completion of
Therapy calculation (page 9).

Total
Cases3

Hispanic4

Non-Hispanic

Table 42. (Cont’d) Completion of Tuberculosis Therapy (COT) Cases and Percentages1 by Hispanic Ethnicity and Non-Hispanic
Race: Reporting Areas, 20092

Table 43. Tuberculosis Cases and Percentages in Persons Completing Therapy for Whom
Therapy Was Indicated for One Year or Less: Reporting Areas, 2005–20091
Year
2005

2009

2008

2007

(%)3

No.2

(%)3

No.2

(%)3

No.2

(%)3

United States

12349

(83.2)

12032

(84.1)

11759

(84.8)

11388

(85.2)

9854

(87.7)

Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York State4
New York City
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

194
57
245
103
2541
85
87
24
49
968
449
95
21
524
133
52
57
104
218
16
249
235
201
183
84
91
8
29
106
4
423
26
266
844
290
6
231
118
95
270
41
231
13
267
1342
26
7
321
227
24
69
0

(89.7)
(93.0)
(83.7)
...
(81.3)
(96.5)
(83.9)
(87.5)
(87.8)
(88.6)
(82.0)
(74.7)
(76.2)
(80.0)
(91.0)
(84.6)
(86.0)
(87.5)
...
(75.0)
(89.2)
(78.7)
(80.1)
(92.9)
(84.5)
(85.7)
(87.5)
(75.9)
...
(75.0)
(86.5)
(80.8)
(87.6)
(82.0)
(85.9)
(50.0)
(87.0)
(85.6)
(93.7)
...
(82.9)
(87.4)
(53.8)
(88.8)
(82.3)
(96.2)
(100.0)
(83.2)
(83.3)
(58.3)
(84.1)
...

166
63
272
89
2398
108
77
24
64
919
445
101
18
500
116
37
73
75
178
13
226
239
200
200
97
92
10
23
82
15
463
37
271
823
339
10
205
129
71
290
24
194
12
239
1363
32
6
292
227
18
63
4

(86.7)
(88.9)
(79.8)
(89.9)
(81.4)
(88.9)
(88.3)
(83.3)
(70.3)
(89.4)
(82.5)
(79.2)
(77.8)
(82.2)
(90.5)
(86.5)
(93.2)
(84.0)
(77.0)
(100.0)
(90.7)
(85.8)
(79.5)
(90.0)
(85.6)
(78.3)
(90.0)
(100.0)
(90.2)
(93.3)
(84.9)
(81.1)
(85.6)
(84.4)
(87.3)
(60.0)
(82.9)
(81.4)
(91.5)
(83.4)
(79.2)
(86.1)
(50.0)
(88.3)
(83.1)
(84.4)
(83.3)
(85.3)
(81.9)
(77.8)
(88.9)
(100.0)

149
43
242
96
2424
91
96
18
51
884
422
109
8
455
118
36
53
108
196
18
246
205
186
225
118
106
11
24
82
10
411
43
228
792
312
4
221
131
88
249
40
188
11
202
1340
35
3
292
264
16
57
2

(91.9)
(88.4)
(71.1)
(92.7)
(79.6)
(97.8)
(82.3)
(94.4)
(70.6)
(90.2)
(85.1)
(77.1)
(75.0)
(84.6)
(89.0)
(88.9)
(83.0)
(89.8)
(79.6)
(88.9)
(89.4)
(81.0)
(81.2)
(88.9)
(95.8)
(76.4)
(100.0)
(95.8)
(86.6)
(90.0)
(85.2)
(90.7)
(87.3)
(90.7)
(91.7)
(100.0)
(87.3)
(81.7)
(90.9)
(84.3)
(90.0)
(89.4)
(100.0)
(86.6)
(81.9)
(94.3)
(33.3)
(88.4)
(88.6)
(100.0)
(77.2)
(50.0)

150
45
195
74
2386
94
88
22
49
826
413
115
11
408
102
47
54
88
210
8
248
235
146
199
96
100
5
30
89
17
379
48
275
798
304
3
189
86
70
333
34
160
15
247
1319
23
5
269
197
22
57
5

(90.0)
(88.9)
(72.8)
(79.7)
(83.9)
(92.6)
(90.9)
(81.8)
(79.6)
(89.6)
(87.9)
(77.4)
(90.9)
(86.8)
(91.2)
(89.4)
(92.6)
(80.7)
(79.5)
(87.5)
(89.1)
(80.9)
(82.9)
(90.5)
(92.7)
(86.0)
(100.0)
(80.0)
(83.1)
(82.4)
(87.6)
(91.7)
(85.8)
(88.7)
(90.8)
(33.3)
(85.7)
(76.7)
(97.1)
(81.1)
(85.3)
(85.0)
(93.3)
(88.7)
(79.5)
(95.7)
(60.0)
(83.6)
(90.4)
(95.5)
(73.7)
(80.0)

146
32
178
59
2145
69
82
18
32
695
348
96
17
364
106
39
55
62
170
7
191
207
114
146
106
74
7
29
94
15
349
32
204
665
221
5
147
83
79
202
23
137
17
176
1228
28
5
244
232
16
56
2

(93.2)
(84.4)
(82.6)
(86.4)
(83.2)
(94.2)
(86.6)
(77.8)
(81.3)
(93.2)
(83.6)
(83.3)
(94.1)
(87.4)
(90.6)
(87.2)
(100.0)
(91.9)
(86.5)
(100.0)
(88.5)
(83.1)
(89.5)
(91.8)
(88.7)
(81.1)
(100.0)
(86.2)
(87.2)
(93.3)
(92.6)
(90.6)
(82.4)
(92.2)
(93.2)
(60.0)
(91.2)
(89.2)
(97.5)
(83.7)
(87.0)
(92.0)
(88.2)
(93.8)
(87.6)
(100.0)
(80.0)
(87.7)
(91.4)
(68.8)
(82.1)
(50.0)

5
71
58
63
54
86
10
0

...
...
(79.3)
...
...
(87.2)
(100.0)
...

2
76
52
33
44
89
9
0

(100.0)
...
(86.5)
...
...
(96.6)
(66.7)
...

3
126
90
124
38
81
12
0

...
...
(91.1)
...
(84.2)
(97.5)
...
...

3
157
84
115
34
69
14
4

(100.0)
...
(92.9)
(80.0)
(70.6)
(95.7)
...
(50.0)

3
175
93
108
28
51
15
0

(100.0)
(82.9)
(96.8)
(88.9)
(96.4)
(86.3)
...
...

Reporting Area

1

2006

No.2

American Samoa5
Fed. States of Micronesia5
Guam5
Marshall Islands5
N. Mariana Islands5
Puerto Rico5
Republic of Palau5
U.S. Virgin Islands5

No.2

(%)3

Most recent year for which data are available.
Total cases for which therapy less than 1 year indicated in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed, who did not die
during therapy. Excludes persons with initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with miliary disease or
positive blood culture, and those who moved out of country during treatment.
3
Percentage of total cases in persons who completed therapy within one year for whom therapy less than 1 year was indicated.
4
Excludes New York City.
5
Not included in U.S. totals.
Note: Ellipses indicate data not available.
See Technical Notes for description of Completion of Therapy calculation.
2

74

Morbidity Tables

Cities and Metropolitan Statistical Areas, 2011

75

76

Table 44. Tuberculosis Cases in Selected Cities1: 2011 and 2010
Cases2
City

2011

2010

Albuquerque, NM
Anaheim, CA
Arlington, TX
Atlanta, GA
Austin, TX
Baltimore, MD
Birmingham, AL
Boston, MA
Buffalo, NY
Charlotte, NC
Chicago, IL
Cincinnati, OH
Cleveland, OH
Colorado Springs, CO
Columbus, OH
Corpus Christi, TX
Dallas, TX
Denver, CO
Detroit, MI
El Paso, TX
Fort Worth, TX
Fresno, CA
Honolulu, HI
Houston, TX
Indianapolis, IN
Jacksonville, FL
Kansas City, MO
Las Vegas, NV
Long Beach, CA
Los Angeles, CA
Louisville, KY
Memphis, TN
Mesa, AZ
Miami, FL
Milwaukee, WI
Minneapolis, MN
Nashville, TN
Newark, NJ
New Orleans, LA
New York, NY
Norfolk, VA
Oakland, CA
Omaha, NE
Philadelphia, PA
Phoenix, AZ
Pittsburgh, PA
Portland, OR
Sacramento, CA
St. Louis, MO
St. Paul, MN
San Antonio, TX
San Diego, CA
San Francisco, CA
San Jose, CA
Santa Ana, CA
Seattle, WA
Tampa, FL
Toledo, OH
Tucson, AZ
Virginia Beach, VA
Washington, DC
Wichita, KS

12
24
21
15
45
39
25
44
13
35
166
8
27
7
38
10
130
23
48
28
35
25
51
225
30
66
16
76
29
246
22
45
13
111
19
38
29
20
24
689
4
45
11
101
56
7
30
56
31
26
94
147
108
116
40
53
17
1
23
4
56
7

10
30
19
9
60
41
17
58
9
38
161
22
26
8
54
12
131
25
49
40
70
34
52
234
35
67
14
85
42
238
35
46
10
98
19
39
30
25
44
711
3
58
15
93
81
5
41
46
28
31
83
125
98
127
42
51
24
2
17
14
42
12

3,600

3,785

17

31

TOTAL - 62 CITIES
San Juan, PR

Historical list of cities.
2
Excludes cases known to not be within city limits. Residence within city limits was determined by the health department.
1

77

Table 45. Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan
Statistical Areas with >500,000 Population, 2011 and 2010
Case Rates

Cases
Metropolitan
Statistical Area
Akron, OH
Albany-Schenectady-Troy, NY
Albuquerque, NM
Allentown-Bethlehem-Easton, PA-NJ
Atlanta-Sandy Springs-Marietta, GA
Augusta-Richmond County, GA-SC
Austin-Round Rock, TX
Bakersfield, CA
Baltimore-Towson, MD
Baton Rouge, LA
Birmingham-Hoover, AL
Boise City-Nampa, ID
Boston-Cambridge-Quincy, MA-NH
Bridgeport-Stamford-Norwalk, CT
Buffalo-Niagara Falls, NY
Cape Coral-Fort Myers, FL
Charleston-North Charleston, SC
Charlotte-Gastonia-Concord, NC-SC
Chattanooga, TN-GA
Chicago-Naperville-Joliet, IL
Cincinnati-Middleton, OH-KY-IN
Cleveland-Elyria-Mentor, OH
Colorado Springs, CO
Columbia, SC
Columbus, OH
Dallas-Fort Worth-Arlington, TX
Dayton, OH
Denver-Aurora, CO
Des Moines-West Des Moines, IA
Detroit-Warren-Livonia, MI
Durham-Chapel Hill, NC
El Paso, TX
Fresno, CA
Grand Rapids-Wyoming, MI
Greensboro-High Point, NC
Greenville, SC
Harrisburg-Carlisle, PA
Hartford-West Hartford-East Hartford, CT
Honolulu, HI
Houston-Sugar Land-Baytown, TX
Indianapolis-Carmel, IN
Jackson, MS
Jacksonville, FL
Kansas City, MO-KS
Knoxville, TN
Lakeland, FL
Lancaster, PA
Las Vegas-Paradise, NV
Little Rock-North Little Rock-Conway, AR
Los Angeles-Long Beach-Santa Ana, CA
Louisville-Jefferson County, KY-IN
Madison, WI
McAllen-Edinburg-Mission, TX
Memphis, TN-MS-AR
Miami-Fort Lauderdale-Pompano Beach, FL
Milwaukee-Waukesha-West Allis, WI
Minneapolis-St. Paul-Bloomington, MN-WI

78

2011

2010

2
13
14
11
211
26
71
40
91
20
36
5
158
33
15
26
21
53
10
336
19
43
7
16
56
342
9
48
12
55
13
37
46
21
26
15
7
21
103
397
44
41
77
35
2
16
5
57
19
923
27
12
80
53
292
30
103

3
20
17
11
252
35
82
36
89
22
39
12
181
33
11
26
34
52
12
343
37
42
8
10
68
373
10
49
14
60
18
48
54
17
34
16
11
30
81
402
45
39
80
35
11
16
12
97
16
946
41
11
69
62
292
23
120

2011

2010

0.3
1.5
1.6
1.3
3.9
4.6
4.0
4.7
3.3
2.5
3.2
0.8
3.4
3.6
1.3
4.1
3.1
3.0
1.9
3.5
0.9
2.1
1.1
2.1
3.0
5.2
1.1
1.8
2.1
1.3
2.5
4.5
4.9
2.7
3.6
2.3
1.3
1.7
10.7
6.5
2.5
7.5
5.7
1.7
0.3
2.6
1.0
2.9
2.7
7.1
2.1
2.1
10.0
4.0
5.1
1.9
3.1

0.4
2.3
1.9
1.3
4.8
6.3
4.7
4.3
3.3
2.7
3.5
1.9
4.0
3.6
1.0
4.2
5.1
2.9
2.3
3.6
1.7
2.0
1.2
1.3
3.7
5.8
1.2
1.9
2.4
1.4
3.6
6.0
5.8
2.2
4.7
2.5
2.0
2.5
8.5
6.7
2.6
7.2
5.9
1.7
1.6
2.7
2.3
5.0
2.3
7.4
3.2
1.9
8.8
4.7
5.2
1.5
3.7

Population
Estimates
2011
701,456
871,478
898,642
824,916
5,359,205
561,858
1,783,519
851,710
2,729,110
808,242
1,132,264
627,664
4,591,112
925,899
1,134,039
631,330
682,121
1,795,472
533,372
9,504,753
2,138,038
2,068,283
660,319
777,116
1,858,464
6,526,548
845,388
2,599,504
580,255
4,285,832
512,979
820,790
942,904
779,604
730,966
647,401
552,911
1,213,255
963,607
6,086,538
1,778,568
545,394
1,360,251
2,052,676
704,500
609,492
523,594
1,969,975
709,901
12,944,801
1,294,849
576,467
797,810
1,325,605
5,670,125
1,562,216
3,318,486

Table 45. (Cont’d) Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan
Statistical Areas with >500,000 Population, 2011 and 2010
Cases

Case Rates

2011

2010

2011

2010

Population
Estimates
2011

Modesto, CA
Nashville-Davidson-Murfreesboro-Franklin, TN
New Haven-Milford, CT
New Orleans-Metairie-Kenner, LA
New York-Northern New Jersey-Long Island, NY-NJ-PA
Ogden-Clearfield, UT
Oklahoma City, OK
Omaha-Council Bluffs, NE-IA
Orlando-Kissimmee, FL
Oxnard-Thousand Oaks-Ventura, CA
Palm Bay-Melbourne-Titusville, FL
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
Phoenix-Mesa-Scottsdale, AZ
Pittsburgh, PA
Portland-South Portland-Biddeford, ME
Portland-Vancouver-Beaverton, OR-WA
Poughkeepsie-Newburgh-Middletown, NY
Providence-New Bedford-Fall River, RI-MA
Provo-Orem, UT
Raleigh-Cary, NC
Richmond, VA
Riverside-San Bernardino-Ontario, CA
Rochester, NY
Sacramento-Arden Arcade-Roseville, CA
St. Louis, MO-IL
Salt Lake City, UT
San Antonio, TX
San Diego-Carlsbad-San Marcos, CA
San Francisco-Oakland-Fremont, CA
San Jose-Sunnyvale-Santa Clara, CA
Sarasota-Bradenton-Venice, FL
Scranton-Wilkes-Barre, PA
Seattle-Tacoma-Bellevue, WA
Springfield, MA
Stockton, CA
Syracuse, NY
Tampa-St. Petersburg-Clearwater, FL
Toledo, OH
Tucson, AZ
Tulsa, OK
Virginia Beach-Norfolk-Newport News, VA-NC
Washington-Arlington-Alexandria, DC-VA-MD-WV
Wichita, KS
Worchester, MA
Youngstown-Warren-Boardman, OH-PA

9
55
19
61
1092
4
34
12
80
35
9
196
171
30
3
60
12
34
4
31
30
121
26
85
49
17
104
263
372
184
24
9
155
16
44
8
82
3
28
24
20
333
8
14
3

16
56
15
82
1191
6
31
16
82
33
10
202
203
16
6
80
14
37
.
44
43
134
19
75
56
13
96
222
388
194
29
5
156
16
46
13
125
3
19
15
34
314
12
18
6

1.7
3.4
2.2
5.1
5.7
0.7
2.7
1.4
3.7
4.2
1.7
3.3
4.0
1.3
0.6
2.7
1.8
2.1
0.7
2.7
2.4
2.8
2.5
3.9
1.7
1.5
4.7
8.4
8.5
9.9
3.4
1.6
4.4
2.3
6.3
1.2
2.9
0.5
2.8
2.5
1.2
5.8
1.3
1.7
0.5

3.1
3.5
1.7
7.0
6.3
1.1
2.5
1.8
3.8
4.0
1.8
3.4
4.8
0.7
1.2
3.6
2.1
2.3
.
3.9
3.4
3.2
1.8
3.5
2.0
1.2
4.5
7.1
8.9
10.5
4.1
0.9
4.5
2.3
6.7
2.0
4.5
0.5
1.9
1.6
2.0
5.6
1.9
2.3
1.1

518,522
1,617,142
861,113
1,191,089
19,015,900
555,916
1,278,053
877,110
2,171,360
831,771
543,566
5,992,414
4,263,236
2,359,746
515,807
2,262,605
672,871
1,600,224
540,834
1,163,515
1,269,380
4,304,997
1,055,278
2,176,235
2,817,355
1,145,905
2,194,927
3,140,069
4,391,037
1,865,450
709,355
563,223
3,500,026
693,204
696,214
662,553
2,824,724
650,266
989,569
946,962
1,679,894
5,703,948
625,526
801,227
562,739

Total - 102 Areas

8274

8799

4.0

4.3

205,086,431

13

4

0.5

0.2

2,468,598

Metropolitan
Statistical Area

San Juan-Caguas-Guaynabo, PR

Note: 2011 and 2010 population case counts and rates updated using U.S. Census Annual Estimates of the Resident Population for
Counties: April 1, 2000 to July 1, 2009 (http://www.census.gov/popest/data/counties/totals/2009/CO-EST2009-01.html) and (http://www.
census.gov/popest/data/counties/totals/2011/files/CO-EST2011-Alldata.csv) (accessed August 8, 2012).
See Technical Notes for definition of MSA.

79

Table 46. Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with
>500,000 Population, 2011
Metropolitan
Statistical Area
Akron, OH
Albany-Schenectady-Troy, NY
Albuquerque, NM
Allentown-Bethlehem-Easton, PA-NJ
Atlanta-Sandy Springs-Marietta, GA
Augusta-Richmond County, GA-SC
Austin-Round Rock, TX
Bakersfield, CA
Baltimore-Towson, MD
Baton Rouge, LA
Birmingham-Hoover, AL
Boise City-Nampa, ID
Boston-Cambridge-Quincy, MA-NH
Bridgeport-Stamford-Norwalk, CT
Buffalo-Niagara Falls, NY
Cape Coral-Fort Myers, FL
Charleston-North Charleston, SC
Charlotte-Gastonia-Concord, NC-SC
Chattanooga, TN-GA
Chicago-Naperville-Joliet, IL
Cincinnati-Middleton, OH-KY-IN
Cleveland-Elyria-Mentor, OH
Colorado Springs, CO
Columbia, SC
Columbus, OH
Dallas-Fort Worth-Arlington, TX
Dayton, OH
Denver-Aurora, CO
Des Moines-West Des Moines, IA
Detroit-Warren-Livonia, MI
Durham-Chapel Hill, NC
El Paso, TX
Fresno, CA
Grand Rapids-Wyoming, MI
Greensboro-High Point, NC
Greenville, SC
Harrisburg-Carlisle, PA
Hartford-West Hartford-East Hartford, CT
Honolulu, HI
Houston-Sugar Land-Baytown, TX
Indianapolis-Carmel, IN
Jackson, MS
Jacksonville, FL
Kansas City, MO-KS
Knoxville, TN
Lakeland, FL
Lancaster, PA
Las Vegas-Paradise, NV
Little Rock-North Little Rock-Conway, AR
Los Angeles-Long Beach-Santa Ana, CA
Louisville-Jefferson County, KY-IN
Madison, WI
McAllen-Edinburg-Mission, TX
Memphis, TN-MS-AR
Miami-Fort Lauderdale-Pompano Beach, FL
Milwaukee-Waukesha-West Allis, WI
Minneapolis-St. Paul-Bloomington, MN-WI

80

Total
Cases
2
13
14
11
211
26
71
40
91
20
36
5
158
33
15
26
21
53
10
336
19
43
7
16
56
342
9
48
12
55
13
37
46
21
26
15
7
21
103
397
44
41
77
35
2
16
5
57
19
923
27
12
80
53
292
30
103

Under 5

5–14

15 –24

25–44

45–64

0
0
0
1
6
0
3
5
2
2
3
0
6
2
0
1
1
2
1
5
0
2
1
0
1
10
0
2
0
0
0
2
3
0
1
1
1
0
1
18
1
1
1
1
0
0
0
6
0
32
1
0
7
2
10
4
2

0
1
0
0
10
0
3
1
2
0
3
1
0
0
0
0
0
0
0
11
0
0
0
0
3
10
0
3
0
1
1
0
2
0
1
1
0
1
0
6
1
0
3
3
0
0
0
2
0
16
0
0
2
3
5
1
5

0
1
1
1
26
1
6
2
5
3
2
1
19
4
4
3
2
3
2
25
2
1
1
2
11
34
0
5
1
4
1
3
1
6
6
3
1
2
10
47
6
4
10
7
1
0
0
3
2
72
1
3
8
11
24
2
20

0
5
2
5
78
15
25
16
45
5
14
2
59
14
2
6
6
21
3
101
10
11
2
7
22
134
5
17
6
11
5
14
7
8
6
1
1
7
20
131
12
12
17
6
1
2
2
15
5
242
6
5
28
14
98
5
42

2
1
6
1
65
10
26
12
22
7
10
1
39
7
5
12
5
20
2
109
4
11
2
4
9
108
2
14
3
16
2
6
20
6
5
4
3
9
38
129
12
21
34
11
0
8
2
18
5
305
15
2
22
16
104
12
22

Unknown
or
>65
Missing
0
0
5
0
5
0
3
0
26
0
0
0
8
0
4
0
15
0
3
0
4
0
0
0
35
0
6
0
4
0
4
0
7
0
7
0
2
0
85
0
3
0
18
0
1
0
3
0
10
0
46
0
2
0
7
0
2
0
23
0
4
0
12
0
13
0
1
0
7
0
5
0
1
0
2
0
34
0
66
0
12
0
3
0
12
0
7
0
0
0
6
0
1
0
13
0
7
0
256
0
4
0
2
0
13
0
7
0
51
0
6
0
12
0

Table 46. (Cont’d) Tuberculosis Cases by Age Group: Metropolitan Statistical Areas with
>500,000 Population, 2011
Metropolitan
Statistical Area

Total
Cases

Under 5

5–14

15 –24

25–44

45–64

>65

Unknown
or
Missing

Modesto, CA
Nashville-Davidson-Murfreesboro-Franklin, TN
New Haven-Milford, CT
New Orleans-Metairie-Kenner, LA
New York-Northern New Jersey-Long Island, NY-NJ-PA
Ogden-Clearfield, UT
Oklahoma City, OK
Omaha-Council Bluffs, NE-IA
Orlando-Kissimmee, FL
Oxnard-Thousand Oaks-Ventura, CA
Palm Bay-Melbourne-Titusville, FL
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
Phoenix-Mesa-Scottsdale, AZ
Pittsburgh, PA
Portland-South Portland-Biddeford, ME
Portland-Vancouver-Beaverton, OR-WA
Poughkeepsie-Newburgh-Middletown, NY
Providence-New Bedford-Fall River, RI-MA
Provo-Orem, UT
Raleigh-Cary, NC
Richmond, VA
Riverside-San Bernardino-Ontario, CA
Rochester, NY
Sacramento-Arden Arcade-Roseville, CA
St. Louis, MO-IL
Salt Lake City, UT
San Antonio, TX
San Diego-Carlsbad-San Marcos, CA
San Francisco-Oakland-Fremont, CA
San Jose-Sunnyvale-Santa Clara, CA
Sarasota-Bradenton-Venice, FL
Scranton-Wilkes-Barre, PA
Seattle-Tacoma-Bellevue, WA
Springfield, MA
Stockton, CA
Syracuse, NY
Tampa-St. Petersburg-Clearwater, FL
Toledo, OH
Tucson, AZ
Tulsa, OK
Virginia Beach-Norfolk-Newport News, VA-NC
Washington-Arlington-Alexandria, DC-VA-MD-WV
Wichita, KS
Worchester, MA
Youngstown-Warren-Boardman, OH-PA

9
55
19
61
1092
4
34
12
80
35
9
196
171
30
3
60
12
34
4
31
30
121
26
85
49
17
104
263
372
184
24
9
155
16
44
8
82
3
28
24
20
333
8
14
3

0
1
0
2
21
0
3
1
1
2
0
4
3
1
0
0
0
3
0
3
0
3
1
1
2
1
10
7
12
4
0
0
4
1
3
1
3
0
2
5
0
10
0
0
0

0
0
0
2
14
0
0
1
3
1
1
1
2
1
0
2
0
0
0
0
1
0
1
2
0
1
3
8
12
2
0
0
7
0
1
0
7
0
3
2
4
5
0
0
0

1
6
4
5
123
0
2
2
5
1
0
20
23
2
1
8
0
3
2
4
2
7
2
7
4
2
7
29
26
12
1
2
20
6
0
2
8
0
0
0
1
39
1
2
0

1
29
8
20
415
2
15
3
24
12
2
75
74
11
1
23
5
15
1
16
13
34
8
26
21
7
33
68
97
52
12
2
46
3
14
4
20
0
6
5
3
144
2
3
0

4
15
6
25
299
0
9
4
29
13
4
61
34
6
0
11
3
8
1
4
7
49
11
28
15
4
29
81
118
61
5
5
38
2
14
1
30
1
9
9
6
87
3
5
0

3
4
1
7
220
2
5
1
18
6
2
35
35
9
1
16
4
5
0
4
7
28
3
21
6
2
22
70
107
53
6
0
40
4
12
0
14
2
8
3
6
48
2
4
3

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Total - 102 Areas

8274

266

189

818

2736

2520

1744

1

13

1

0

1

6

3

2

0

San Juan-Caguas-Guaynabo, PR
Note: See Technical Notes for definition of MSA.

81

Table 47. Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race: Metropolitan
Statistical Areas with >500,000 Population, 2011
Metropolitan
Statistical Area
Akron, OH
Albany-Schenectady-Troy, NY
Albuquerque, NM
Allentown-Bethlehem-Easton, PA-NJ
Atlanta-Sandy Springs-Marietta, GA
Augusta-Richmond County, GA-SC
Austin-Round Rock, TX
Bakersfield, CA
Baltimore-Towson, MD
Baton Rouge, LA
Birmingham-Hoover, AL
Boise City-Nampa, ID
Boston-Cambridge-Quincy, MA-NH
Bridgeport-Stamford-Norwalk, CT
Buffalo-Niagara Falls, NY
Cape Coral-Fort Myers, FL
Charleston-North Charleston, SC
Charlotte-Gastonia-Concord, NC-SC
Chattanooga, TN-GA
Chicago-Naperville-Joliet, IL
Cincinnati-Middleton, OH-KY-IN
Cleveland-Elyria-Mentor, OH
Colorado Springs, CO
Columbia, SC
Columbus, OH
Dallas-Fort Worth-Arlington, TX
Dayton, OH
Denver-Aurora, CO
Des Moines-West Des Moines, IA
Detroit-Warren-Livonia, MI
Durham-Chapel Hill, NC
El Paso, TX
Fresno, CA
Grand Rapids-Wyoming, MI
Greensboro-High Point, NC
Greenville, SC
Harrisburg-Carlisle, PA
Hartford-West Hartford-East Hartford, CT
Honolulu, HI
Houston-Sugar Land-Baytown, TX
Indianapolis-Carmel, IN
Jackson, MS
Jacksonville, FL
Kansas City, MO-KS
Knoxville, TN
Lakeland, FL
Lancaster, PA
Las Vegas-Paradise, NV
Little Rock-North Little Rock-Conway, AR
Los Angeles-Long Beach-Santa Ana, CA
Louisville-Jefferson County, KY-IN
Madison, WI
McAllen-Edinburg-Mission, TX
Memphis, TN-MS-AR
Miami-Fort Lauderdale-Pompano Beach, FL
Milwaukee-Waukesha-West Allis, WI
Minneapolis-St. Paul-Bloomington, MN-WI

82

American
Hispanic Indian or
Total
Alaska
or
Cases Latino1
Native
2
1
0
13
1
0
14
9
0
11
2
0
211
44
0
26
3
0
71
29
0
40
23
0
91
13
0
20
3
0
36
1
0
5
0
0
158
25
0
33
8
0
15
0
0
26
8
0
21
2
0
53
14
0
10
3
0
336
95
0
19
4
0
43
0
0
7
2
0
16
6
0
56
2
0
342
109
0
9
0
0
48
14
0
12
1
0
55
3
0
13
5
0
37
35
0
46
29
0
21
5
0
26
3
0
15
2
0
7
0
0
21
2
0
103
1
0
397
172
0
44
7
0
41
5
0
77
9
0
35
7
0
2
1
0
16
4
0
5
1
0
57
21
0
19
2
0
923
381
1
27
3
0
12
3
0
80
80
0
53
3
0
292
104
1
30
3
0
103
8
0

Black
Native
or
Unknown
Hawaiian or
African Other Pacific
or
Multiple
Asian American Islander
White Race2 Missing
0
0
0
1
0
0
7
2
0
3
0
0
0
3
0
2
0
0
4
2
0
3
0
0
46
98
0
23
0
0
3
18
0
2
0
0
24
9
0
9
0
0
8
6
0
3
0
0
28
33
0
17
0
0
1
8
0
7
1
0
6
24
0
5
0
0
2
2
0
0
1
0
58
45
0
25
1
4
9
0
5
0
0
11
3
6
0
6
0
0
6
5
0
7
0
0
1
13
0
5
0
0
9
19
0
10
1
0
2
2
0
3
0
0
108
87
0
46
0
0
7
3
0
5
0
0
14
21
0
8
0
0
2
2
1
0
0
0
2
5
0
3
0
0
11
25
0
18
0
0
73
105
1
54
0
0
0
1
1
0
7
0
15
11
0
8
0
0
5
5
0
1
0
0
23
11
0
16
0
2
2
4
0
2
0
0
2
0
0
0
0
0
15
1
0
1
0
0
7
4
1
3
0
1
8
10
0
5
0
0
6
2
0
5
0
0
2
1
0
4
0
0
8
4
0
7
0
0
82
1
18
1
0
0
83
90
0
52
0
0
11
8
0
18
0
0
3
30
0
3
0
0
11
45
1
11
0
0
9
13
1
5
0
0
1
0
0
0
0
0
1
5
0
6
0
0
1
1
0
2
0
0
18
8
1
9
0
0
1
11
0
5
0
0
421
48
3
65
0
4
3
9
0
12
0
0
7
2
0
0
0
0
0
0
0
0
0
0
4
38
0
7
1
0
20
123
5
39
0
0
13
9
0
5
0
0
34
57
0
4
0
0

Table 47. (Cont’d) Tuberculosis Cases by Hispanic Ethnicity and Non-Hispanic Race: Metropolitan
Statistical Areas with >500,000 Population, 2011
Metropolitan
Statistical Area

American
Hispanic Indian or
Total
Alaska
or
Cases Latino1
Native

Black
Native
or
Unknown
Hawaiian or
Multiple
or
African Other Pacific
White Race2 Missing
Asian American Islander

Modesto, CA
Nashville-Davidson-Murfreesboro-Franklin, TN
New Haven-Milford, CT
New Orleans-Metairie-Kenner, LA
New York-Northern New Jersey-Long Island, NY-NJ-PA
Ogden-Clearfield, UT
Oklahoma City, OK
Omaha-Council Bluffs, NE-IA
Orlando-Kissimmee, FL
Oxnard-Thousand Oaks-Ventura, CA
Palm Bay-Melbourne-Titusville, FL
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
Phoenix-Mesa-Scottsdale, AZ
Pittsburgh, PA
Portland-South Portland-Biddeford, ME
Portland-Vancouver-Beaverton, OR-WA
Poughkeepsie-Newburgh-Middletown, NY
Providence-New Bedford-Fall River, RI-MA
Provo-Orem, UT
Raleigh-Cary, NC
Richmond, VA
Riverside-San Bernardino-Ontario, CA
Rochester, NY
Sacramento-Arden Arcade-Roseville, CA
St. Louis, MO-IL
Salt Lake City, UT
San Antonio, TX
San Diego-Carlsbad-San Marcos, CA
San Francisco-Oakland-Fremont, CA
San Jose-Sunnyvale-Santa Clara, CA
Sarasota-Bradenton-Venice, FL
Scranton-Wilkes-Barre, PA
Seattle-Tacoma-Bellevue, WA
Springfield, MA
Stockton, CA
Syracuse, NY
Tampa-St. Petersburg-Clearwater, FL
Toledo, OH
Tucson, AZ
Tulsa, OK
Virginia Beach-Norfolk-Newport News, VA-NC
Washington-Arlington-Alexandria, DC-VA-MD-WV
Wichita, KS
Worchester, MA
Youngstown-Warren-Boardman, OH-PA

9
55
19
61
1092
4
34
12
80
35
9
196
171
30
3
60
12
34
4
31
30
121
26
85
49
17
104
263
372
184
24
9
155
16
44
8
82
3
28
24
20
333
8
14
3

5
14
4
10
329
1
11
1
17
15
1
34
94
2
0
7
4
7
2
3
4
61
3
12
2
4
76
127
49
21
6
3
8
2
17
0
13
0
11
1
0
76
1
0
0

0
0
0
0
0
0
3
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
1
0
0
0
0
0
2
3
0
0
0
0
0

3
11
8
14
396
1
10
2
18
15
0
75
38
10
1
30
4
11
0
12
10
38
3
44
12
9
13
94
239
142
8
1
77
12
25
4
16
1
2
4
3
119
3
7
0

0
14
3
22
230
1
1
4
28
1
3
59
12
8
1
10
2
7
0
13
6
7
9
15
23
2
9
13
32
7
2
1
41
0
0
3
28
0
7
5
10
114
4
3
0

0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
0
2
0
0
0
0
2
0
0
0
3
16
1
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0

0
16
4
15
121
1
6
4
17
4
5
26
24
10
1
11
2
8
0
3
10
15
11
10
11
2
6
25
29
11
8
3
25
2
2
1
25
2
6
9
7
22
0
3
3

0
0
0
0
2
0
0
0
0
0
0
2
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
3
1
0
1
0
0
0
0
0
0
0
0
0
2
0
0
0

1
0
0
0
14
0
3
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
2
1
0
0
0
3
1
0
0
0
0
0
0
0
0
0
2
0
0
0
1
0

Total - 102 Areas

8274

2379

16

2798

1864

61

1099

17

40

San Juan-Caguas-Guaynabo, PR
13
13
0
0
0
0
0
0
0
Persons of Hispanic or Latino origin may be of any race or multiple race.
2
Indicates two or more races reported for a person.
Note: Case counts for race categories (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other Pacific Islander, and White) are mutually exclusive and do not include persons of Hispanic ethnicity or multiple race. Multiple Race does not include persons
of Hispanic ethnicity.
See Technical Notes for definition of MSA and Hispanic ethnicity and non-Hispanic race.
1

83

Table 48. Tuberculosis Cases and Percentages, U.S.-born Persons and Foreign-born
Persons1: Metropolitan Statistical Areas with >500,000 Population, 2011
Metropolitan
Statistical Area
Akron, OH
Albany-Schenectady-Troy, NY
Albuquerque, NM
Allentown-Bethlehem-Easton, PA-NJ
Atlanta-Sandy Springs-Marietta, GA
Augusta-Richmond County, GA-SC
Austin-Round Rock, TX
Bakersfield, CA
Baltimore-Towson, MD
Baton Rouge, LA
Birmingham-Hoover, AL
Boise City-Nampa, ID
Boston-Cambridge-Quincy, MA-NH
Bridgeport-Stamford-Norwalk, CT
Buffalo-Niagara Falls, NY
Cape Coral-Fort Myers, FL
Charleston-North Charleston, SC
Charlotte-Gastonia-Concord, NC-SC
Chattanooga, TN-GA
Chicago-Naperville-Joliet, IL
Cincinnati-Middleton, OH-KY-IN
Cleveland-Elyria-Mentor, OH
Colorado Springs, CO
Columbia, SC
Columbus, OH
Dallas-Fort Worth-Arlington, TX
Dayton, OH
Denver-Aurora, CO
Des Moines-West Des Moines, IA
Detroit-Warren-Livonia, MI
Durham-Chapel Hill, NC
El Paso, TX
Fresno, CA
Grand Rapids-Wyoming, MI
Greensboro-High Point, NC
Greenville, SC
Harrisburg-Carlisle, PA
Hartford-West Hartford-East Hartford, CT
Honolulu, HI
Houston-Sugar Land-Baytown, TX
Indianapolis-Carmel, IN
Jackson, MS
Jacksonville, FL
Kansas City, MO-KS
Knoxville, TN
Lakeland, FL
Lancaster, PA
Las Vegas-Paradise, NV
Little Rock-North Little Rock-Conway, AR
Los Angeles-Long Beach-Santa Ana, CA
Louisville-Jefferson County, KY-IN
Madison, WI
McAllen-Edinburg-Mission, TX
Memphis, TN-MS-AR
Miami-Fort Lauderdale-Pompano Beach, FL
Milwaukee-Waukesha-West Allis, WI
Minneapolis-St. Paul-Bloomington, MN-WI

84

Total
Cases
2
13
14
11
211
26
71
40
91
20
36
5
158
33
15
26
21
53
10
336
19
43
7
16
56
342
9
48
12
55
13
37
46
21
26
15
7
21
103
397
44
41
77
35
2
16
5
57
19
923
27
12
80
53
292
30
103

U.S.-born Persons
No.

(%)

1
3
8
4
93
20
28
16
32
17
24
1
28
6
8
14
17
24
5
118
5
25
1
7
19
167
4
13
2
16
5
10
11
4
9
9
4
9
26
181
23
32
55
18
0
8
3
21
14
176
21
0
28
42
89
13
10

(50.0)
(23.1)
(57.1)
(36.4)
(44.1)
(76.9)
(39.4)
(40.0)
(35.2)
(85.0)
(66.7)
(20.0)
(17.7)
(18.2)
(53.3)
(53.8)
(81.0)
(45.3)
(50.0)
(35.1)
(26.3)
(58.1)
(14.3)
(43.8)
(33.9)
(48.8)
(44.4)
(27.1)
(16.7)
(29.1)
(38.5)
(27.0)
(23.9)
(19.0)
(34.6)
(60.0)
(57.1)
(42.9)
(25.2)
(45.6)
(52.3)
(78.0)
(71.4)
(51.4)
(0.0)
(50.0)
(60.0)
(36.8)
(73.7)
(19.1)
(77.8)
(0.0)
(35.0)
(79.2)
(30.5)
(43.3)
(9.7)

Foreign-born
Persons
No.
1
10
6
7
118
6
43
24
59
3
12
4
130
27
7
12
4
29
5
218
14
18
6
9
37
175
5
35
10
38
8
27
34
17
17
6
3
12
77
216
21
9
22
17
2
8
2
36
5
737
6
12
52
11
203
17
93

Unknown

(%)

No.

(%)

(50.0)
(76.9)
(42.9)
(63.6)
(55.9)
(23.1)
(60.6)
(60.0)
(64.8)
(15.0)
(33.3)
(80.0)
(82.3)
(81.8)
(46.7)
(46.2)
(19.0)
(54.7)
(50.0)
(64.9)
(73.7)
(41.9)
(85.7)
(56.3)
(66.1)
(51.2)
(55.6)
(72.9)
(83.3)
(69.1)
(61.5)
(73.0)
(73.9)
(81.0)
(65.4)
(40.0)
(42.9)
(57.1)
(74.8)
(54.4)
(47.7)
(22.0)
(28.6)
(48.6)
(100.0)
(50.0)
(40.0)
(63.2)
(26.3)
(79.8)
(22.2)
(100.0)
(65.0)
(20.8)
(69.5)
(56.7)
(90.3)

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
0
0
0
0
0
0
0

(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(1.8)
(0.0)
(0.0)
(2.2)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(1.1)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)

Table 48. (Cont’d) Tuberculosis Cases and Percentages, U.S.-born Persons and Foreign-born
Persons1: Metropolitan Statistical Areas with >500,000 Population, 2011
Metropolitan
Statistical Area

Total
Cases

Modesto, CA
Nashville-Davidson-Murfreesboro-Franklin, TN
New Haven-Milford, CT
New Orleans-Metairie-Kenner, LA
New York-Northern New Jersey-Long Island, NY-NJ-PA
Ogden-Clearfield, UT
Oklahoma City, OK
Omaha-Council Bluffs, NE-IA
Orlando-Kissimmee, FL
Oxnard-Thousand Oaks-Ventura, CA
Palm Bay-Melbourne-Titusville, FL
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
Phoenix-Mesa-Scottsdale, AZ
Pittsburgh, PA
Portland-South Portland-Biddeford, ME
Portland-Vancouver-Beaverton, OR-WA
Poughkeepsie-Newburgh-Middletown, NY
Providence-New Bedford-Fall River, RI-MA
Provo-Orem, UT
Raleigh-Cary, NC
Richmond, VA
Riverside-San Bernardino-Ontario, CA
Rochester, NY
Sacramento-Arden Arcade-Roseville, CA
St. Louis, MO-IL
Salt Lake City, UT
San Antonio, TX
San Diego-Carlsbad-San Marcos, CA
San Francisco-Oakland-Fremont, CA
San Jose-Sunnyvale-Santa Clara, CA
Sarasota-Bradenton-Venice, FL
Scranton-Wilkes-Barre, PA
Seattle-Tacoma-Bellevue, WA
Springfield, MA
Stockton, CA
Syracuse, NY
Tampa-St. Petersburg-Clearwater, FL
Toledo, OH
Tucson, AZ
Tulsa, OK
Virginia Beach-Norfolk-Newport News, VA-NC
Washington-Arlington-Alexandria, DC-VA-MD-WV
Wichita, KS
Worchester, MA
Youngstown-Warren-Boardman, OH-PA
Total - 102 Areas
San Juan-Caguas-Guaynabo, PR

U.S.-born Persons

Foreign-born
Persons

Unknown

No.

(%)

No.

(%)

No.

(%)

9
55
19
61
1092
4
34
12
80
35
9
196
171
30
3
60
12
34
4
31
30
121
26
85
49
17
104
263
372
184
24
9
155
16
44
8
82
3
28
24
20
333
8
14
3

0
23
2
38
237
1
21
6
35
8
7
61
43
15
0
13
4
8
1
12
14
35
16
28
28
2
59
79
67
18
9
5
31
3
12
1
50
1
12
20
15
79
1
2
2

(0.0)
(41.8)
(10.5)
(62.3)
(21.7)
(25.0)
(61.8)
(50.0)
(43.8)
(22.9)
(77.8)
(31.1)
(25.1)
(50.0)
(0.0)
(21.7)
(33.3)
(23.5)
(25.0)
(38.7)
(46.7)
(28.9)
(61.5)
(32.9)
(57.1)
(11.8)
(56.7)
(30.0)
(18.0)
(9.8)
(37.5)
(55.6)
(20.0)
(18.8)
(27.3)
(12.5)
(61.0)
(33.3)
(42.9)
(83.3)
(75.0)
(23.7)
(12.5)
(14.3)
(66.7)

9
32
17
23
854
3
13
6
45
26
2
135
128
15
3
47
8
26
3
19
16
85
10
55
21
15
45
184
305
161
15
4
124
13
32
7
32
2
16
4
5
254
7
12
1

(100.0)
(58.2)
(89.5)
(37.7)
(78.2)
(75.0)
(38.2)
(50.0)
(56.3)
(74.3)
(22.2)
(68.9)
(74.9)
(50.0)
(100.0)
(78.3)
(66.7)
(76.5)
(75.0)
(61.3)
(53.3)
(70.2)
(38.5)
(64.7)
(42.9)
(88.2)
(43.3)
(70.0)
(82.0)
(87.5)
(62.5)
(44.4)
(80.0)
(81.3)
(72.7)
(87.5)
(39.0)
(66.7)
(57.1)
(16.7)
(25.0)
(76.3)
(87.5)
(85.7)
(33.3)

0
0
0
0
1
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
2
0
0
0
0
0
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

(0.0)
(0.0)
(0.0)
(0.0)
(0.1)
(0.0)
(0.0)
(0.0)
(0.0)
(2.9)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.8)
(0.0)
(2.4)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(2.7)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)

8274

2671

(32.3)

5581

(67.5)

22

(0.3)

13

7

(53.8)

6

(46.2)

0

(0.0)

Includes persons born outside the United States, American Samoa, the Federated States of Micronesia, Guam, the Republic of the
Marshall Islands, Midway Island, the Commonwealth of the Northern Mariana Islands, Puerto Rico, the Republic of Palau, the U.S. Virgin
Islands, and U.S. minor and outlying Pacific islands.
Note: See Technical Notes for definition of MSA.

1

85

Table 49. Tuberculosis Cases and Percentages by Homeless Status,1 Age >15:
Metropolitan Statistical Areas with >500,000 Population, 2011
Metropolitan
Statistical Area
Akron, OH
Albany-Schenectady-Troy, NY
Albuquerque, NM
Allentown-Bethlehem-Easton, PA-NJ
Atlanta-Sandy Springs-Marietta, GA
Augusta-Richmond County, GA-SC
Austin-Round Rock, TX
Bakersfield, CA
Baltimore-Towson, MD
Baton Rouge, LA
Birmingham-Hoover, AL
Boise City-Nampa, ID
Boston-Cambridge-Quincy, MA-NH
Bridgeport-Stamford-Norwalk, CT
Buffalo-Niagara Falls, NY
Cape Coral-Fort Myers, FL
Charleston-North Charleston, SC
Charlotte-Gastonia-Concord, NC-SC
Chattanooga, TN-GA
Chicago-Naperville-Joliet, IL
Cincinnati-Middleton, OH-KY-IN
Cleveland-Elyria-Mentor, OH
Colorado Springs, CO
Columbia, SC
Columbus, OH
Dallas-Fort Worth-Arlington, TX
Dayton, OH
Denver-Aurora, CO
Des Moines-West Des Moines, IA
Detroit-Warren-Livonia, MI
Durham-Chapel Hill, NC
El Paso, TX
Fresno, CA
Grand Rapids-Wyoming, MI
Greensboro-High Point, NC
Greenville, SC
Harrisburg-Carlisle, PA
Hartford-West Hartford-East Hartford, CT
Honolulu, HI
Houston-Sugar Land-Baytown, TX
Indianapolis-Carmel, IN
Jackson, MS
Jacksonville, FL
Kansas City, MO-KS
Knoxville, TN
Lakeland, FL
Lancaster, PA
Las Vegas-Paradise, NV
Little Rock-North Little Rock-Conway, AR
Los Angeles-Long Beach-Santa Ana, CA
Louisville-Jefferson County, KY-IN
Madison, WI
McAllen-Edinburg-Mission, TX
Memphis, TN-MS-AR
Miami-Fort Lauderdale-Pompano Beach, FL
Milwaukee-Waukesha-West Allis, WI
Minneapolis-St. Paul-Bloomington, MN-WI

86

Total
Cases
2
13
14
11
211
26
71
40
91
20
36
5
158
33
15
26
21
53
10
336
19
43
7
16
56
342
9
48
12
55
13
37
46
21
26
15
7
21
103
397
44
41
77
35
2
16
5
57
19
923
27
12
80
53
292
30
103

Cases with Information on
Homeless Status

Cases Reported as Being
Homeless2

No.

(%)

No.

(%)

2
13
14
11
209
26
71
39
90
20
36
5
157
33
14
26
21
53
10
333
16
43
7
16
56
342
9
48
12
54
13
37
46
20
26
15
7
19
92
397
44
41
77
35
2
16
5
57
19
916
27
12
80
53
292
30
103

(100.0)
(100.0)
(100.0)
(100.0)
(99.1)
(100.0)
(100.0)
(97.5)
(98.9)
(100.0)
(100.0)
(100.0)
(99.4)
(100.0)
(93.3)
(100.0)
(100.0)
(100.0)
(100.0)
(99.1)
(84.2)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(98.2)
(100.0)
(100.0)
(100.0)
(95.2)
(100.0)
(100.0)
(100.0)
(90.5)
(89.3)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(99.2)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)

0
0
2
0
20
1
3
1
3
0
3
0
7
0
1
3
2
4
0
33
0
1
0
0
0
34
1
3
2
0
1
2
3
0
0
1
0
0
10
10
5
7
17
4
1
1
0
2
3
58
6
0
0
3
20
0
2

(0.0)
(0.0)
(14.3)
(0.0)
(9.5)
(3.8)
(4.2)
(2.5)
(3.3)
(0.0)
(8.3)
(0.0)
(4.4)
(0.0)
(6.7)
(11.5)
(9.5)
(7.5)
(0.0)
(9.8)
(0.0)
(2.3)
(0.0)
(0.0)
(0.0)
(9.9)
(11.1)
(6.3)
(16.7)
(0.0)
(7.7)
(5.4)
(6.5)
(0.0)
(0.0)
(6.7)
(0.0)
(0.0)
(9.7)
(2.5)
(11.4)
(17.1)
(22.1)
(11.4)
(50.0)
(6.3)
(0.0)
(3.5)
(15.8)
(6.3)
(22.2)
(0.0)
(0.0)
(5.7)
(6.8)
(0.0)
(1.9)

Table 49. (Cont’d) Tuberculosis Cases and Percentages by Homeless Status,1 Age >15:
Metropolitan Statistical Areas with >500,000 Population, 2011
Metropolitan
Statistical Area

Total
Cases

Modesto, CA
Nashville-Davidson-Murfreesboro-Franklin, TN
New Haven-Milford, CT
New Orleans-Metairie-Kenner, LA
New York-Northern New Jersey-Long Island, NY-NJ-PA
Ogden-Clearfield, UT
Oklahoma City, OK
Omaha-Council Bluffs, NE-IA
Orlando-Kissimmee, FL
Oxnard-Thousand Oaks-Ventura, CA
Palm Bay-Melbourne-Titusville, FL
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD
Phoenix-Mesa-Scottsdale, AZ
Pittsburgh, PA
Portland-South Portland-Biddeford, ME
Portland-Vancouver-Beaverton, OR-WA
Poughkeepsie-Newburgh-Middletown, NY
Providence-New Bedford-Fall River, RI-MA
Provo-Orem, UT
Raleigh-Cary, NC
Richmond, VA
Riverside-San Bernardino-Ontario, CA
Rochester, NY
Sacramento-Arden Arcade-Roseville, CA
St. Louis, MO-IL
Salt Lake City, UT
San Antonio, TX
San Diego-Carlsbad-San Marcos, CA
San Francisco-Oakland-Fremont, CA
San Jose-Sunnyvale-Santa Clara, CA
Sarasota-Bradenton-Venice, FL
Scranton-Wilkes-Barre, PA
Seattle-Tacoma-Bellevue, WA
Springfield, MA
Stockton, CA
Syracuse, NY
Tampa-St. Petersburg-Clearwater, FL
Toledo, OH
Tucson, AZ
Tulsa, OK
Virginia Beach-Norfolk-Newport News, VA-NC
Washington-Arlington-Alexandria, DC-VA-MD-WV
Wichita, KS
Worchester, MA
Youngstown-Warren-Boardman, OH-PA
Total - 102 Areas
San Juan-Caguas-Guaynabo, PR

Cases with Information on
Homeless Status

Cases Reported as Being
Homeless2

No.

(%)

No.

(%)

9
55
19
61
1092
4
34
12
80
35
9
196
171
30
3
60
12
34
4
31
30
121
26
85
49
17
104
263
372
184
24
9
155
16
44
8
82
3
28
24
20
333
8
14
3

9
55
19
61
1077
4
33
12
79
35
9
196
138
30
3
60
12
34
4
30
30
121
25
75
45
17
104
263
371
181
24
9
155
16
43
8
81
2
28
23
20
333
8
14
3

(100.0)
(100.0)
(100.0)
(100.0)
(98.6)
(100.0)
(97.1)
(100.0)
(98.8)
(100.0)
(100.0)
(100.0)
(80.7)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)
(96.8)
(100.0)
(100.0)
(96.2)
(88.2)
(91.8)
(100.0)
(100.0)
(100.0)
(99.7)
(98.4)
(100.0)
(100.0)
(100.0)
(100.0)
(97.7)
(100.0)
(98.8)
(66.7)
(100.0)
(95.8)
(100.0)
(100.0)
(100.0)
(100.0)
(100.0)

0
4
0
4
22
0
4
1
5
2
1
7
11
0
1
4
0
2
1
2
0
1
0
6
0
1
3
15
20
4
0
0
5
1
7
0
11
0
1
3
0
11
0
1
0

(0.0)
(7.3)
(0.0)
(6.6)
(2.0)
(0.0)
(11.8)
(8.3)
(6.3)
(5.7)
(11.1)
(3.6)
(6.4)
(0.0)
(33.3)
(6.7)
(0.0)
(5.9)
(25.0)
(6.5)
(0.0)
(0.8)
(0.0)
(7.1)
(0.0)
(5.9)
(2.9)
(5.7)
(5.4)
(2.2)
(0.0)
(0.0)
(3.2)
(6.3)
(15.9)
(0.0)
(13.4)
(0.0)
(3.6)
(12.5)
(0.0)
(3.3)
(0.0)
(7.1)
(0.0)

8274

8166

(98.7)

441

(5.3)

13

13

(100.0)

0

(0.0)

Homeless within past 12 months of TB diagnosis.
Percent of those with known status.
Note: See Technical Notes for definition of MSA.

1
2

87

This page intentionally left blank

88

United States Affiliated
Pacific Islands, 2011

89

90

Tuberculosis in the U.S.-affiliated Pacific Island Jurisdictions (USAPI), 2011
The US-affiliated Pacific Islands consist of six jurisdictions that cover an area within the Pacific
Ocean that is larger than the continental United States. Three are U.S. flag territories: American
Samoa, the Commonwealth of the Northern Mariana Islands (CNMI), and Guam. The other three
— Federated States of Micronesia (FSM), Republic of the Marshall Islands (RMI), and Republic of
Palau – are independent countries but are also freely associated with the United States. These independent countries have Compacts of Free Association with the United States; under these compacts,
the countries are fully sovereign in domestic and foreign affairs, but give responsibility for their
health, education, defense, and other essential operations to the United States. Through these agreements, citizens residing in these three countries are able to immigrate to the United States without
the usual overseas screening for health conditions that is required of those permanently resettling
from other foreign countries.
As a result of their affiliations with the United States, the USAPIs are among the recipients of U.S.
federal government funding, including CDC cooperative agreement funding for domestic TB control
program activities.

How do the USAPI TB programs differ from the 50 U.S. state programs?
•	 Geographically, the USAPI constitutes a total land area equivalent to two-thirds of Rhode
Island (1,545 square miles). While there are 10 population centers, many Pacific Islanders
live on surrounding islands, creating challenges for diagnosis and treatment of TB. Across
these jurisdictions, basic infrastructure needs are not uniformly available; several of these
jurisdictions are in close proximity to countries with higher rates of endemic TB.
•	 There is a consistent shortage of health care providers in all job classes, and continuing
education opportunities are limited, often requiring staff to travel off-island for significant
amounts of time. These challenges impact the delivery of health care.
•	 The region grapples with health problems common to developed countries (diabetes, obesity,
cancer) as well as those common to developing countries; infant mortality rates in this region
exceed the national average, in some areas as much as 5 times greater.
•	 While case counts in this region are similar to low-incidence states, the burden of disease
is much greater when compared to U.S. areas with similar case counts. The burden of
disease in the region far exceeds that of any metropolitan statistical area with a population
of 500,000 or greater. The USAPI regional TB case rate (87.7/100,000) is almost10 times
greater than that of the State of Hawaii (8.9/100,000) and 26 times greater than the U.S.
national rate (3.4/100,000).

91

Table 1. Tuberculosis Cases and Case Rates for USAPIs, Hawaii, and the United States, 2010
Jurisdiction

Cases

Rate

Population

USAPI Regional Total

405

87.7

461,939

American Samoa
Northern Mariana Islands
Federated States of Micronesia
Guam
Marshall Islands
Palau

3
27
140
78
149
8

5.4
51.8
131
48.9
221.8
38.2

55,198
52,167
106,836
159,600
67,182
20,956

123
10,528

8.9
3.4

1,374,810
311,591,917

Hawaii1
United States1
1

Not included in USAPI regional total.

USAPI TB Surveillance Data Highlights, 2011 (N=405)
•	
•	
•	
•	
•	
•	
•	
•	

94 (23%) age less than 15 years
99 (24%) age 25–44 years
221 (55%) male
84 (21%) not born in the USAPI jurisdictions or the United States
o	 50 (60%) of these emigrating from the Republic of the Philippines
272 (67%) diagnosed with pulmonary disease only
180 (44%) positive culture for Mycobacterium tuberculosis
2 (<1%) with MDR TB; no cases of XDR TB
137 (34%) were unemployed

The data reported here reflect cases reported to the CDC National TB Surveillance System using
the Report of Verified Case of Tuberculosis (RVCT). Denominators for computing 2011 rates for
the United States and Hawaii were obtained from Annual Estimates of the Population for the United
States and States, and for Puerto Rico; for all other areas, from IDB Summary Demographic Data
(http://www.census.gov/population/international/data/idb/informationGateway.php) accessed August
10, 2012.

92

93

Surveillance Slide #1 - USAPI

94

Surveillance Slide #2 - USAPI

95

Surveillance Slide #3 - USAPI

96

Surveillance Slide #4 - USAPI

97

Surveillance Slide #5 - USAPI

This page intentionally left blank

98

Slide Narratives for US Affiliated Pacific Islands:
Slide 1 - USAPI. Map of U.S.-Affiliated Pacific Islands by TB Case Rates, 2011. This map of the
Pacific region shows the case rates by jurisdiction.
Slide 2 - TB Case rates, U.S.-Affiliated Pacific Islands, 2011. This bar chart shows TB rates for
the U.S. Pacific Islands for reported cases in 2011. These case rates from 5.4 per 100,000 in American Samoa to 221.8 per 100,000 in the Republic of the Marshall Islands. The overall case rate for
the United States (3.4 per 100,000) and for Hawaii (8.9 per 100,000) are also shown.
Slide 2 - USAPI. Reported TB Cases by Age Group, U.S.-Affiliated Pacific Islands, 2011. This
pie chart shows the age distribution of persons reported with TB in the U.S. Pacific Islands in 2011.
Twenty three percent were children under 15 years of age and 16% were among 15 to 24 year-olds,
whereas 25% were among 25 to 44 years of age, 29% were among 45 to 64 year-olds, and 7% were
among those at least 65 years old.
Slide 3 - USAPI. TB Case Rates by Age Group and Sex, U.S.-Affiliated Pacific Islands, 2011.
This slide graphs the rates in 2011 of persons reported with TB in the U.S. Pacific Islands in 2011
by age group and sex. Children under 15 years old had a rate of approximately 48 per 100,000 for
females and approximately 45 per 100,000 for males. In those between the ages of 25-44 years old
females accounted for 47 per 100,000 and males were approximately 52 per 100,000.
Slide 4 - USAPI. Anti-TB Drug Susceptibility, U.S.- Affiliated Pacific Islands, 2011. This pie
chart shows the level of drug susceptibility for culture positive cases for in the U.S. Pacific Islands
in 2011. Data were available for 92.2% of culture-positive cases for which drug susceptibility testing was available for 2011. Any isoniazid resistance that was not multi-drug resistance was 4.2%.
Resistance to at least isoniazid and rifampin, known as multidrug-resistant TB (MDR TB), was
1.2%. Other resistance (Not MDR or INH resistant) or missing testing to at least one first-line drug
was 2.4%.

99

This page intentionally left blank

100

Surveillance Slide Set
2011

101

102

103

Division of Tuberculosis Elimination

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention

National Tuberculosis Surveillance System
Highlights from 2011

Tuberculosis in the United States

Surveillance Slide #1

104

No. of Cases

*Updated as of June 25, 2012.

0

5,000

10,000

15,000

20,000

25,000

30,000

Year

Reported TB Cases
United States, 1982–2011*

Surveillance Slide #2

105

13,727
13,278
12,895
11,528
11,171
10,528

2006

2007

2008

2009

2010

2011

*Cases per 100,000. Updated as of June 25, 2012.

No.

Year

3.4

3.6

3.8

4.2

4.4

4.6

Rate*

TB Morbidity
United States, 2006–2011

Surveillance Slide #3

106

*Cases per 100,000.

D.C.

>3.4

< 3.4 (2011 national average)

TB Case Rates,* United States, 2011

Surveillance Slide #4

107

0.0

5.0

10.0

15.0

1995

1994

1993

* Updated as of June 25, 2012.

Cases per 100,000

20.0

TB Case Rates* by Age Group
United States, 1993–2011

1997

1996
0- 14

2000

1999
15 - 24

2003

2002

25 - 44

2006

2005

45-65

2008

2007

>65

2010

2009

Surveillance Slide #5

2011

2004

2001

1998

108

45-64 yrs
(31%)

≥ 65 yrs
(21%)

<15 yrs
(5%)

24-44 yrs
(32%)

15-24 yrs
(10%)

Reported TB Cases by Age Group,
United States, 2011

Surveillance Slide #6

109

Cases per 100,000

0.0

1.0

2.0

3.0

4.0

5.0

6.0

7.0

8.0

Under 5

5 - 14

15 - 24
Male

24 - 44
45-64
Female

TB Case Rates by Age Group and Sex,
United States, 2011

≥65

Surveillance Slide #7

110

Cases per 100,000

2003

2004

2005

2006

*All races are non-Hispanic.
**Updated as of June 25, 2012.

Hispanic or Latino
Asian
Native Hawaiian or Other Pacific Islander

0.0

5.0

10.0

15.0

20.0

25.0

30.0

35.0

2007

2009

2010

2011
American Indian or Alaska Native
Black or African American
White

2008

TB Case Rates by Race/Ethnicity*
United States, 2003–2011**

Surveillance Slide #8

111

Cases per 100,000

5 - 14

15 - 24

Hispanic or Latino
Asian
Native Hawaiian or Other Pacific Islander

Under 5

45-64
American Indian or Alaska Native
Black or African American
White

24 - 44

*All races are non-Hispanic. Persons reporting two or more races accounted for less than 1% of all cases.

0.0

10.0

20.0

30.0

40.0

50.0

60.0

≥65

TB Case Rates by Age Group and Race/Ethnicity*
United States, 2011

Surveillance Slide #9

112

Asian
(30%)

White
(16%)

Native Hawaiian
or Other Pacific
Islander
(1%)

Hispanic or
Latino
(29%)

*All races are non-Hispanic. Persons reporting two or more races accounted for less than 1% of all cases.

American Indian
or Alaska Native
(1%)

Black or African
American
(23%)

Reported TB Cases by Race/Ethnicity*
United States, 2011

Surveillance Slide #10

113

No. of Cases

1994

1993

*Updated as of June 25, 2012.

0

5,000

10,000

15,000

20,000

Number of TB Cases in
U.S.-born vs. Foreign-born Persons
United States, 1993–2011*

2000

1999

1998
U.S.-born

2005

2004

2003

2002

Foreign-born

2010

2009

Surveillance Slide #11

2011

2008

2007

2006

2001

1997

1996

1995

114

*Updated as of June 25, 2012.

10,000
9,000
8,000
7,000
6,000
5,000
4,000
3,000
2,000
1,000
0

No. of Cases

Number of Cases

Percentage of Total Cases

Trends in TB Cases in Foreign-born Persons
United States, 1990 – 2011*

0

10

20

30

40

50

60

70

Percentage

Surveillance Slide #12

115

Black or
African
American
(39%)

Asian
(3%)

Hispanic or
Latino
(19%) American
Indian or
Alaska
Native
(3%)
Black or
African
American
(13%)

Asian
(46%)

White
(5%)

Foreign-born**

*All races are non-Hispanic. Persons reporting two or more races accounted for less than 1% of all cases.
** American Indian or Alaska Native and Native Hawaiian or Other Pacific Islander accounted for less than 1% of
foreign-born cases and are not shown.

Native
Hawaiian
or Other
Pacific
Islander
(2%)

White
(33%)

U.S.-born

Hispanic or
Latino
(34%)

Reported TB Cases by Origin and Race/Ethnicity,*
United States, 2011

Surveillance Slide #13

116

*Updated as of June 25, 2012.

2001

DC

>50%
25%–49%
<25%

2011

Percentage of TB Cases Among
Foreign-born Persons, United States*

DC

Surveillance Slide #14

117

Cases per 100,000

1995

1994

1993

*Updated as of June 25, 2012.

0.0

5.0

10.0

15.0

20.0

25.0

30.0

35.0

40.0

1999

1998

1997

1996
U.S. Overall

2003

2002

2001

U.S.-born

2007

2006

2005

2004

Foreign-born

2010

2009

2008

2000

TB Case Rates in U.S.-born vs. Foreign-born Persons,
United States, 1993 – 2011*

Surveillance Slide #15

2011

1999

1998

1997

1996
U.S. Overall

2003

2001

U.S.-born

2002

2000

1995

1994

1993

*Includes the same data as slide 15, but rates presented on a logarithmic scale.
**Updated as of June 25, 2012.

1.0

10.0

100.0

2007

2006

2005

2004

Foreign-born

2010

2009

2008

TB Case Rates in U.S.-born vs. Foreign-born Persons,
United States*, 1993 – 2011**

Surveillance Slide #16

2011

118

Cases per 100,000

119

(3%)
Guatemala China
(3%)
(6%)

Haiti

Other Countries
39%

(8%)

India

(11%)

(8%)

Vietnam

Philippines

(22%)

Mexico

Countries of Birth of Foreign-born Persons Reported
with TB, United States, 2011

Surveillance Slide #17

120

Mexico
Unknown*

<1 year

Philippines

1-4 years

Vietnam

≥5 years

All Foreign-born

*Foreign-born TB patients for whom information on length of residence in the U.S. prior to diagnosis is unknown or
missing

0

20

40

60

80

100

Percent of Foreign-born with TB by Time of Residence
in U.S. Prior to Diagnosis, 2011

Surveillance Slide #18

121

% Resistant

Isoniazid

MDR TB

*Updated as of June 25, 2012.
Note: Based on initial isolates from persons with no prior history of TB. Multidrug resistant TB (MDR TB) is defined
as resistance to at least isoniazid and rifampin

0

5

10

Primary Anti-TB Drug Resistance
United States, 1993 – 2011*

Surveillance Slide #19

2001

2000

1999
No. of Cases

2006

2005

2004

2003

Percentage

2008

2002

1998

1997

1996

1995

1994

1993

*Updated as of June 25, 2012.
Note: Based on initial isolates from persons with no prior history of TB. MDR TB defined as resistance to at least
isoniazid and rifampin.

0

100

200

300

400

500

2007

0

1

2

3

Percentage

2010

No. of Cases

Primary MDR TB
United States, 1993 – 2011*

2009

Surveillance Slide #20

2011

122

123

% Resistant

U.S.-born

*Updated as of June 25, 2012.
Note: Based on initial isolates from persons with no prior history of TB.

0

2

4

6

8

10

12

14

Foreign-born

Primary Isoniazid Resistance in
U.S.-born vs. Foreign-born Persons
United States, 1993 – 2011*

Surveillance Slide #21

124

% Resistant

U.S.-born

Foreign-born

*Updated as of June 25, 2012.
Note: Based on initial isolates from persons with no prior history of TB. MDR TB defined as resistance to at least
isoniazid and rifampin.

0

1

2

3

Primary MDR TB in
U.S.-born vs. Foreign-born Persons
United States, 1993 – 2011*

Surveillance Slide #22

125

Case Count

Year of Diagnosis

* Drug susceptibility test
** Updated as of June 25, 2012.
Note: Extensively drug-resistant TB (XDR TB) is defined as resistance to isoniazid and rifampin, plus resistance to any fluoroquinolone and at
least one of three injectable second-line anti-TB drugs

0

2

4

6

8

10

12

XDR TB Case Count Defined on Initial DST*
by Year, 1993 – 2011**

Surveillance Slide #23

2000

1999
All Ages

2004

2003

2002

Aged 25 - 44

2007

2006

2005

2001

1998

1997

1996

1995

1994

1993

*Updated as of June 25, 2012.
Note: Includes TB patients with positive, negative, or indeterminate HIV test results. HIV test results not reported from
California after 2004. HIV test results not reported from Rhode Island for years 1993-1997. HIV test results not reported from
Vermont after 2007.

100
90
80
70
60
50
40
30
20
10
0

Reporting of HIV Test Results
in Persons with TB by Age Group
United States, 1993 – 2011*

2010

2009

2008

Surveillance Slide #24

2011

126

% with Test Results

127

% Coinfection

Aged 25-44

All Ages

*Updated as of June 25, 2012
Note: Minimum estimates based on reported HIV-positive status among all TB cases in the age group

0

5

10

15

20

25

30

Estimated HIV Coinfection in Persons
Reported with TB, United States, 1993 – 2011*

Surveillance Slide #25

1999

1998

1997
No. of Cases

2000

1996

1995

1994

1993

*Updated as of June 25, 2012
Note: Resident of correctional facility at time of TB diagnosis

0

200

400

600

800

1000

1200

TB Cases by Residence in Correctional Facilities,
Age ≥15, United States, 1993-2011*

2008

2007

2006

2005

2004

2003

2002

Percent of Total Cases

0.0%

1.0%

2.0%

3.0%

4.0%

5.0%

6.0%

Surveillance Slide #26

2011

2010

2009

2001

128

129

2000

1998

1997
No. of Cases

1999

1996

1995

1994

1993

*Updated as of June 25, 2012
Note: Homeless within past 12 months of TB diagnosis

0

200

400

600

800

1000

1200

1400

1600

TB Cases Reported as Homeless in the
12 Months Prior to Diagnosis,
Age ≥15, United States, 1993-2011*

2008

2007

2006

2005

2004

2003

2002

Percent of Total Cases

2010

0.0%

1.0%

2.0%

3.0%

4.0%

5.0%

6.0%

7.0%

8.0%

Surveillance Slide #27

2011

2009

2001

130

Percentage**

DOT only

DOT + SA

SA only

*Updated as of June 25, 2012. Data available through 2009 only.
**Percentage of total cases in persons alive at diagnosis, with an initial regimen of one or more drugs prescribed, and excluding cases with
unknown mode of treatment administration.
Directly observed therapy (DOT); Self-administered therapy (SA)

0

20

40

60

80

100

Mode of Treatment Administration
in Persons Reported with TB
United States, 1993 – 2009*

Surveillance Slide #28

131

Percentage

Completed

Completed in 1 year or less

* Updated as of June 25, 2012. Data available through 2009 only.
Note: Includes persons alive at diagnosis, with initial drug regimen of one or more drugs prescribed, who did not die during
therapy. Excludes persons with initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged
<15) with miliary disease or positive blood culture.

0

20

40

60

80

100

Completion of TB Therapy
United States, 1993 – 2009*

Surveillance Slide #29

Tuberculosis in the United States
National Tuberculosis Surveillance System Highlights from 2011
Slide 1 (title slide). Tuberculosis in the United States—National Tuberculosis Surveillance System, Highlights
from 2011. This slide set was prepared by the Division of Tuberculosis Elimination, Centers for Disease Control
and Prevention (CDC), Department of Health and Human Services (DHHS). It provides trends for the recent past
and highlights data collected through the National Tuberculosis Surveillance System for 2011. Since 1953, through
the cooperation of state and local health departments, CDC has collected information on newly reported cases of
tuberculosis (TB) disease in the United States. The data presented here were collected via the revised TB case
report introduced in 2009. Currently, each individual TB case report (Report of Verified Case of Tuberculosis or
RVCT) is submitted electronically to CDC. The data for this slide set are based on updates received by CDC as of
June 25, 2012. All case counts and rates for years 1993–2011 have been updated.
Slide 2. Reported TB Cases, United States, 1982–2011. The resurgence of TB in the mid-1980s was marked by
several years of increasing case counts until its peak in 1992. Case counts began decreasing again in 1993, and
2011 marked the nineteenth year of decline in the total number of TB cases reported in the United States since the
peak of the resurgence. From 1992 until 2002, the total number of TB cases decreased 5%–7% annually. From
2002 to 2003, however, the total number of TB cases decreased by only 1.4%. An unprecedented decrease occurred in 2009, when the total number of TB cases decreased by more than 10% from 2008 to 2009. In 2011, a total
of 10,528 cases were reported from the 50 states and the District of Columbia (DC). This represents a decline of
5.8% from 2011 and approximately 60.5% from 1992.
Slide 3. TB Morbidity, United States, 2005-2011. This slide provides the total number of reported U.S. TB cases
and the associated rates for each of the past 6 years. Rate is defined as cases per 100,000 population. The number
of TB cases decreased from 13,727 in 2006 to 10,528 in 2011, and the TB rate decreased from 4.6 in 2006 to 3.4 in
2011.
Slide 4. TB Case Rates, United States, 2011. This map shows TB rates for 2011. Thirty-seven states reported
a rate less than 3.4TB cases per 100,000, the 2011 national average. Thirteen states and DC reported a rate above
3.4 TB cases per 100,000; these accounted for 67% of the national total in 2011 and have experienced substantial
overall decreases in cases and rates from 1992 through 2011.
Slide 5. TB Case Rates by Age Group, United States, 1993–2011. This slide shows the last 19 years’ declining trend in TB rates by age group. Starting in 2011, case rates in all age groups have declined by more than
50%:persons 65 years and older (from 17.7 per 100,000 in 1993 to 5.4in 2011); adults aged 45 to 64 years (from
12.4 to 4.0); adults aged 25 to 44 years (from 11.5 to 4.1); those 15 to 24 years of age (from 5.0 to 2.4); and in
children under 15 years of age (from 2.9 to 0.9)
Slide 6. Reported TB Cases by Age Group, United States, 2011. This pie chart shows the age distribution of
persons reported with TB in 2011. Five percent were children under 15 years of age, 10% were age 15 to 24, 32%
were age 25 to 44, 31% were age 45 to 64, and 21% were at least 65 years old.
Slide 7. TB Case Rates by Age Group and Sex, United States, 2011. This slide graphs the TB rates in 2011 by
age group and sex. It shows that rates tended to increase with age, ranging from a low of less than 1 per 100,000
in children aged 5 - 14 to a high of 7.4 per 100,000 in men 65 years and older. As age increased, the case rate in
men increased faster than women; the rates in men 45 years and older were approximately more than twice those in
same-age women.
Slide 8. TB Case Rates by Race/Ethnicity, United States, 2003–2011. This slide shows the declining trend in
TB rates by race/ethnicity during the last 9 years. Asians had the highest TB rates, which declined from 29.9 per
100,000 in 2003 to 20.9 in 2011, and had a percent decline over the time period of 30%. Rates also declined in
the following racial/ethnic groups: among non-Hispanic blacks or African-Americans, from 11.7 in 2003 to 6.3 in
2011 (-46%); among Hispanics, from 10.3 to 5.8 (-44%); among American Indians and Alaska Natives, from 8.2 to
5.6 (-32%); and among non-Hispanic whites, from 1.4 to 0.8 (-43%). Ratesdecreased among Native Hawaiian or
Other Pacific Islanders after two years of increase since 2008, from 16.2 in 2003 to 15.9 in 2011 (-2%).

132

Several important factors likely contribute to the disproportionate burden of TB in minorities. In persons
who were born in countries where TB is common, TB disease may result from infection acquired in the country of
origin. Unequal distribution of TB risk factors, such as HIV infection, may also contribute to increased exposure to
TB or to an increased risk of developing TB once infected with M. tuberculosis.
Slide 9. TB Case Rates by Age Group and Race/Ethnicity, United States, 2011. This slide presents TB rates
in 2011 by age group and race/ethnicity. After infancy (age under 5), risk typically increased with age across all
racial and ethnic groups. Rates were consistently higher in minority racial and ethnic groups than in non-Hispanic
whites. Rates were the highest in Asians and Native Hawaiians and Other Pacific Islanders, particularly in adult
age groups. The impact of foreign birth is a consideration in interpreting rate variations by race/ethnicity. For example, 96% of cases in the Asian group occurred in foreign-born persons, compared with 74% of cases in Hispanics and 36% of cases in non-Hispanic blacks or African-Americans. Persons reporting two or more races totaled
less than 1% of all cases.
Slide 10. Reported TB Cases by Race/Ethnicity, United States, 2011. In 2011, 84% of all reported TB cases
occurred in racial and ethnic minorities (29% in Hispanics, 30% in Asians, 23% in non-Hispanic blacks or AfricanAmericans, 1% in American Indians or Alaska Natives, and 1% in Native Hawaiians or Other Pacific Islanders),
whereas 16% of cases occurred in non-Hispanic whites. Persons reporting two or more races totaled less than 1%
of all cases. This is the first year that Asians have constituted the single largest percentage of TB cases among all
racial/ethnic groups; Hispanics had previously held the largest TB percentage for seven years. Non-Hispanic blacks
or African Americans have remained the third largest racial/ethnic group for four years now.
Slide 11. Number of TB Cases in U.S.-born vs. Foreign-born Persons, United States, 1993–2011. This graph
plots the number of U.S.-born vs. foreign-born persons reported with TB each year, from 1993 through 2011. It
illustrates the increase in the percentage of cases occurring in foreign-born persons during this period, from 29% in
1993 to 62% in 2011. Overall, the number of cases in foreign-born persons remained virtually level, with approximately 7,000–8,000 cases each year before 2009, until 2009 when the number dropped to 6,854. That decreasing
trend continued in 2011 with the number of foreign-born cases dropping to 6,510. The number in U.S.-born persons
decreased from more than 17,000 in 1993 to 3,981 in 2011.
Slide 12. Trends in TB Cases in Foreign-born Persons, United States, 1991–2011. This slide shows trends in
the past 20 years of TB cases in foreign-born persons in the United States from 1991 through 2011. The percentage
of TB cases accounted for by foreign-born persons increased from 28% in 1990 to 62% in 2011.
Slide 13. Reported TB Cases by Origin and Race/Ethnicity, United States, 2011. Among U.S.-born persons
with TB in 2011, 39% were non-Hispanic black or African-American, 33% were non-Hispanic white, 19% were
Hispanic or Latino, 3% were Asian, 3% were American Indian or Alaska Native, and 2% were Native Hawaiian or
Other Pacific Islander. Among the foreign-born, 46% were Asian, 34% were Hispanic or Latino, 13% were nonHispanic black or African-American, and 5% were non-Hispanic white. Cases among American Indians or Alaska
Natives and among Native Hawaiians or Other Pacific Islanders constituted less than 1%, respectively, of the cases
among the foreign-born and are not shown. Persons reporting two or more races totaled less than 1% of all cases.
Slide 14. Percentage of TB Cases Among Foreign-born Persons, United States, 2001 and 2011. The percentage range of the total number of TB cases that occurred in foreign-born persons in each state is highlighted for
2001 and 2011 in these side-by-side maps. The number of states with less than 25% of their TB cases among the
foreign-born decreased from 13 states in 2001 to 6 states in 2011. The number of states with at least 25-49% of
cases among the foreign-born decreased from 14 states in 2001 to 11 states in 2011. However, the number of states
that had 50% or more of their cases among the foreign-born increased from 23 states in 2001 to 34 states in 2011.
Slide 15. TB Case Rates in U.S.-born vs. Foreign-born Persons, United States, 1993–2011. TB rates in
foreign-born persons remain higher than those in the U.S.-born population. From 1993 through 2011, the rates in
U.S.-born persons decreased from 7.4 per 100,000 to 1.5, whereas the rates in foreign-born persons decreased from
34.0 per 100,000 to 17.2.
Slide 16. TB Case Rates in U.S.-born vs. Foreign-born Persons, United States, 1993–2011. This is the same as
Slide 15, but the rates are presented on a logarithmic scale to better illustrate the trend in TB rates among the U.S.-

133

born and foreign-born. The lines show a greater rate of decline among the U.S.-born compared with the foreignborn during this period.
Slide 17. Countries of Birth of Foreign-born Persons Reported with TB, United States, 2011. This slide shows
the overall distribution of the countries of birth of foreign-born persons reported with TB in 2011, with the top
seven highlighted. The list of countries has remained relatively constant since 1986, when information on country of birth was first reported by all areas submitting reports to CDC. In 2011 the seven top countries accounted
for 61% of the total cases, with Mexico accounting for 22%; the Philippines, 11.6%; Vietnam, 8.4%; India, 7.7%;
China, 5.8%; Haiti, 2.9%; and Guatemala, 2.5%.Persons from more than 135 other countries each accounted for
2% or less of the total, but altogether accounted for 39% of foreign-born persons reported with TB.
Slide 18. Percent of Foreign-born with TB by Time of Residence in U.S. Prior to Diagnosis, 2011. The length
of U.S. residence among foreign-born persons prior to their TB diagnosis in 2011 is shown in these stacked bars.
Overall, 14% had been in the United States for less than 1 year, 17% between 1 and 4 years, and 59% for at least
5 years. The distribution is also shown for the top three countries of birth: Mexico, the Philippines, and Vietnam.
Among persons born in Mexico, 9% had been in the United States for less than 1 year, 11% between 1 and 4 years,
and 66% for at least 5 years. Among persons born in the Philippines, 15% had been in the United States for less
than 1 year, 13% between 1 and 4 years, and 61% for at least 5 years. Among persons born in Vietnam, 10% had
been in the United States for less than 1 year, 12% between 1 and 4 years, and 62% for at least 5 years.
Slide 19. Primary Anti-TB Drug Resistance, United States, 1993–2011. Primary drug resistance is shown
for the past 19 years. The graph starts in 1993, the year in which the individual TB case reports submitted to the
national surveillance system began collecting information on initial susceptibility test results for patients with
culture-positive TB. Data were available for more than 85% of culture-positive cases for each year. Primary resistance was calculated by using data from persons with no reported prior TB episode. Resistance to at least isoniazid
remained between 7.0% and 8.6% between 1993 and 2010, however in 2011, this increased to 9.2%. Resistance to
at least isoniazid and rifampin, known as multidrug-resistant TB (MDR TB), decreased from 2.5% in 1993 to 1.1%
in 1997, and remained at approximately 1.0 % until 2009 and 2010 when it increased to 1.1% and 1.2%, respectively. In 2011, it increased again to 1.3%.
Slide 20. Primary MDR TB, United States, 1993–2011. This graph focuses on trends in primary MDR TB
(based on initial isolates from persons with no prior history of TB) in the United States from 1993 through 2011.
The number of primary MDR TB cases, represented by bars, steadily declined from 407 in 1993 to 115 in 2001.
Since then, the total number of primary MDR TB cases has fluctuated from 86 to 132 cases, with 98 cases reported
for 2011. Primary MDR TB, shown by the line, decreased from 2.5% in 1993 to approximately 1.1% in 1997, and
has fluctuated around 1.0% since then. In 2011, the percentage increased to 1.3%.
Slide 21. Primary Isoniazid Resistance in U.S.-born vs. Foreign-born Persons, United States, 1993–2011.
This graph shows primary isoniazid resistance in U.S.-born vs. foreign-born persons. Based on initial isolates from
persons with no prior history of TB, the percentage of isoniazid resistance was approximately two times higher
among foreign-born persons than among U.S.-born persons. In foreign-born persons, the percentage declined from
12.4% in 1993 to 10.7% in 2011. In U.S.-born persons, the percentagedecreased from 6.8% in 1993 to 4.2% in
2007, but has increased since then to 6.5% in 2011.
Slide 22. Primary MDR TB in U.S.-born vs. Foreign-born Persons, United States, 1993–2011. This graph
highlights primary MDR TB in U.S.-born versus foreign-born persons. The percentage with primary MDR TB
has declined among both groups since 1993, although the decline in the U.S.-born has been greater. As a result,
the proportion of primary MDR TB cases in the US that are attributed to foreign-born persons increased from approximately 25% in 1993 to 83% in 2011 (not shown on slide). Among the U.S.-born, the percentage with primary
MDR TB remained between 0.4% and 0.7% from 1999 through 2010 and was 0.6% in 2011. The percentage
among foreign-born persons has fluctuated year by year, while averaging approximately 1.5% from 1999 through
2010. In 2011, the percentage of primary MDR TB among foreign-born persons was 1.7%
Slide 23. Extensively Drug Resistant (XDR) TB, as Defined on Initial Drug Susceptibility Testing (DST),
United States, 1993–2011. This graph shows the annual number of counted XDR TB cases as defined on initial

134

DST from 1993-2011, reported as of June 25,2012 ; XDR TB is defined as resistance to isoniazid and rifampin,
plus resistance to any fluoroquinolone and at least one of three injectable second-line anti-TB drugs. Six cases
of XDR TB were reported in 2011. The most reported in a single year was 10 in 1993, while there were no cases
reported in 2003 and 2009. There is no apparent trend in the number of cases over time.
Slide 24. Reporting of HIV Test Results in Persons with TB by Age Group, United States, 1993–2011. This
slide shows the completeness of reporting of HIV test results in persons with TB by age group from 1993 through
2011. The percentage of TB patients for whom test results were reported increased from 30% among all ages in
1993 to 82% in 2011. Among adults aged 25–44 years, the percentage increased from 46% in 1993 to 90% in
2011. California began reporting HIV test results to CDC in 2011; this accounts for the substantial percentage
increase for that year.
Slide 25. Estimated HIV Coinfection in Persons Reported with TB, United States, 1993–2011. This slide provides minimum estimates of HIV coinfection among persons reported with TB from 1993 through 2011. Since the
addition of the request for HIV status to the individual TB case report in 1993, incomplete reporting has provided a
challenge to calculating reliable estimates. Results from the cross-matching of TB and AIDS registries have been
used to supplement reported HIV test results. For all ages, the estimated percentage of HIV coinfection in persons
reported with TB decreased from 15% to 6% overall and from 29% to 10% in persons aged 25 to 44 years during
this period.
Slide 26. TB Cases by Residence in Correctional Facilities, Age ≥15, United States, 1993-2011. This graph
highlights the number of cases that were a resident of any type of correctional facility at the time of TB diagnosis. Cases must have been 15 years of age or greater. The number of cases residing in a correctional facility has
decreased from 1,117 cases in 1994 to 424 cases in 2011. Between the years 2000 and 2010, the number of cases
residing in a correctional facility has fluctuated between 587 (in 2000) to as low as 460 (in 2002). The first year
to drop below this range was 2011, to 424 cases. Of total cases, the percentage of cases residing in a correctional
facility has ranged from 5.1% in 1994 to 3.3% in 2002. The 1990s saw a decreasing trend in percentage until 2002.
Since 2002, the trend has showed an increase; in 2010 the percentage of total cases was 4.7%. In 2011, this percentage decreased to 4.3%, only the second decrease since 2002.
Slide 27. TB Cases by Homeless Status, Age ≥15, United States, 1993-2011. This graph shows the number of
TB cases reported to be homeless within twelve months prior to their TB diagnosis from 1993 through 2011. Cases
must have been above 14 years of age. The number of homeless cases has decreased from a high of 1379 cases in
1994 to 565 in 2011 and parallels the overall decline in cases during this time. This category has seen a continuous
decrease in cases since 1994; the years 2003, 2006, and 2010 have been exceptions with a small increase in cases.
Of total cases, 6.8% were homeless in 1994 and percentages have ranged between 7.5% in 1993 and 5.4% in 2009.
Since 2009 there has been a small increase in 2010 (5.7%) and in 2011 (5.8%).
Slide 28. Mode of Treatment Administration in Persons Reported with TB, United States, 1993–2009. In
1993, the reporting areas began providing information about mode of treatment administration on the individual TB
case report form. Treatment administered as only directly observed therapy (DOT) increased from 21.7% in 1993
to 59.5% in 2009, the latest year with available data. The proportion of patients who received at least some portion
of their treatment as DOT (based on combining the percentage of patients who received only DOT and the percentage for whom some portion was self-administered) remained the same in 2009 as it was in 2008. In 2009, 89.8% of
patients received at least some portion of their treatment as DOT.
Slide 29. Completion of TB Therapy, United States, 1993–2009. The reporting areas began providing information on completion of therapy in 1993 through the individual TB case report form. The calculations exclude
persons with initial isolate rifampin resistant, or patient with meningeal disease, or pediatric patient (aged <15) with
miliary disease or positive blood culture. Overall completion of therapy had remained at approximately 92-93%
from 1998 through 2008, but increased to 95% in 2009.. Completion in 1 year or less increased from 64% in 1993
to 88% in 2009, the latest year with available data. The current DHHS Healthy People 2020 objective is completion of therapy in 1 year or less in 93% of patients. CDC is working with state and local health departments to
determine and evaluate reasons for apparently delayed completion of therapy, which may vary by jurisdiction.

135

This page intentionally left blank

136

Appendices

137

138

Appendix A

Tuberculosis Case Definition for Public Health Surveillance1
(Revised May 13, 2009)
Clinical description
A chronic bacterial infection caused by Mycobacterium tuberculosis, usually characterized pathologically by the formation of granulomas. The most common site of infection is the lung, but other
organs may be involved.
Clinical case definition
A case that meets all of the following criteria:
•	 A positive tuberculin skin test result or positive interferon gamma release assay for M. tuberculosis
•	 Other signs and symptoms compatible with tuberculosis (TB) (e.g., abnormal chest radiograph, abnormal chest computerized tomography scan or other chest imaging study, or clinical evidence of current disease)
•	 Treatment with two or more anti-TB medications
•	 A completed diagnostic evaluation
Laboratory criteria for diagnosis
•	 Isolation of M. tuberculosis complex from a clinical specimen,*
or
•	 Demonstration of M. tuberculosis complex from a clinical specimen by nucleic acid amplification test,†
or
•	 Demonstration of acid-fast bacilli in a clinical specimen when a culture has not been or cannot be obtained or is falsely negative or contaminated.
Case classification
Confirmed: a case that meets the clinical case definition or is laboratory confirmed
Comment
A case should not be counted twice within any consecutive 12-month period. However, a case occurring in a patient who had previously had verified TB disease should be reported and counted
again if more than 12 months have elapsed since the patient completed therapy. A case should also
be reported and counted again if the patient was lost to supervision for greater than 12 months and
TB disease can be verified again. Mycobacterial diseases other than those caused by M. tuberculosis
complex should not be counted in tuberculosis morbidity statistics unless there is concurrent tuberculosis.
Use of rapid identification techniques for M. tuberculosis (e.g., DNA probes and mycolic acid high-pressure liquid
chromatography performed on a culture from a clinical specimen) are acceptable under this criterion.
†Nucleic acid amplification (NAA) tests must be accompanied by culture for mycobacteria species for clinical purposes.
A culture isolate of M. tuberculosis complex is required for complete drug susceptibility testing and also genotyping.
However, for surveillance purposes, CDC will accept results obtained from NAA tests approved by the Food and Drug
Administration (FDA) and used according to the approved product labeling on the package insert, or a test produced
and validated in accordance with applicable FDA and Clinical Laboratory Improvement Amendments (CLIA) regulations.
*

139

Appendix B
Recommendations for Counting Reported Tuberculosis Cases
(Revised May 13, 2009)
Since publication of the “Recommendations for Counting Reported Tuberculosis Cases”1 in July
1997, numerous changes have occurred, and many issues have been raised within the field of tuberculosis (TB) surveillance. This current version updates and supersedes the previous version.
A distinction should be made between reporting TB cases to a health department and counting
TB cases for determining incidence of disease. Throughout each year, TB cases and suspected
cases are reported to public health authorities by sources such as clinics, hospitals, laboratories,
and health care providers. From these reports, the state or local TB control officer must determine which cases meet the current surveillance definition for TB disease and whether the case
is countable. These countable TB cases are then reported to the Centers for Disease Control and
Prevention (CDC).
Beginning in 2009, state and local TB control officers may also report to CDC those TB cases
that are verified but not countable for morbidity statistics, as a measure of programmatic and case
management burden. The noncountable report can include persons with TB disease recurring
within a consecutive 12-month period after the patient completed TB therapy.
I.	

Reporting TB Cases. CDC recommends that health care providers and laboratories be
required to report all TB cases or suspected cases to state and local health departments
based on the current “Tuberculosis Case Definition for Public Health Surveillance” (Appendix A). This notification is essential in order for TB programs to
•	
•	
•	
•	
•	

Ensure case supervision
Ensure completion of appropriate therapy
Ensure completion of contact investigations
Evaluate program effectiveness
Assess trends and characteristics of TB morbidity

TB Surveillance. For purposes of surveillance, a case of TB is defined on the basis of
II.	
laboratory or clinical evidence of active disease due to M. tuberculosis complex.*
________________________________

* Because most laboratories use tests that do not routinely distinguish Mycobacterium tuberculosis from very closely related species,
these laboratories report culture results as being positive or negative for “Mycobacterium tuberculosis complex.” Although in almost
all cases of human disease, isolates in the M. tuberculosis complex are, in fact, M. tuberculosis, other species are possible. Other species in the Mycobacterium tuberculosis complex include M. bovis, M. africanum, M. microti, M. canetii, M. caprae, M. pinnipedii, and
M. mungi; the inclusion of these species in M. tuberculosis complex should not impact public health laboratories or programs, because
only a few laboratories identify to the species level. These seven species are almost identical in DNA homology studies. In terms of
their ability to cause clinical disease or be transmissible from person to person, M. bovis, M. africanum, M. microti, M. canetii, M. pinnipedii, and M. mungi behave like M. tuberculosis; therefore, disease caused by any of the organisms should be reported as TB, using
the Report of Verified Case of Tuberculosis (RVCT). The only exception is the BCG strain of M. bovis, which may be isolated from
persons who have received the vaccine for protection against TB or as cancer immunotherapy; disease caused by the BCG strain of M.
bovis should not be reported as TB.

140

a.	 Laboratory Case Definition
•	 Isolation of M. tuberculosis complex from a clinical specimen. The use of rapid identification techniques for M. tuberculosis performed on a culture from a clinical specimen,
such as DNA probes and high-pressure liquid chromatography (HPLC), is acceptable
under this criterion.
OR
•	 Demonstration of M. tuberculosis from a clinical specimen by nucleic acid amplification (NAA) test. NAA tests must be accompanied by cultures of mycobacterial species.
However, for surveillance purposes, CDC will accept results obtained from NAA tests
approved by the Food and Drug Administration (FDA) and used according to the approved product labeling on the package insert, or a test produced and validated in accordance with applicable FDA and Clinical Laboratory Improvement Amendments (CLIA)
regulations.
OR
•	 Demonstration of acid-fast bacilli (AFB) in a clinical specimen when a culture has not
been or cannot be obtained or is falsely negative or contaminated; historically this criterion has been most commonly used to diagnose TB in the postmortem setting.		
b. Clinical Case Definition. In the absence of laboratory confirmation of M. tuberculosis complex after a diagnostic process has been completed, persons must have all of the following
criteria for clinical TB:
•	 Evidence of TB infection based on a positive tuberculin skin test result or positive interferon gamma release assay for M. tuberculosis
•	 Current treatment with two or more anti-TB medications
AND
•	 One of the following:
(1) Signs and symptoms compatible with current TB disease, such as an abnormal chest
radiograph or abnormal chest computerized tomography scan or other chest imaging study,
OR
(2) Clinical evidence of current disease (e.g., fever, night sweats, cough, weight loss,
hemoptysis)
NOTE: The software for TB surveillance developed by CDC includes a calculated variable called “Vercrit,”
for which one of the values is “Provider Diagnosis.” “Provider Diagnosis” is selected when the user chooses
to override a “Suspect” default value in the case verification screen as “Verified by Provider Diagnosis.” Thus,
“Provider Diagnosis” is not a component of the case definition for TB in the current “Tuberculosis Case Definition for Public Health Surveillance” (Appendix A). CDC’s national morbidity reports have traditionally included
all TB cases that are considered verified by the reporting areas, without a requirement that cases meet the published case definition.

141

III.	

Counting TB Cases. Cases that meet the current CDC surveillance case definition for
verified TB are counted by 52 reporting areas with count authority (50 states, District of
Columbia, and New York City) to determine annual incidence for the United States. The
remaining 8 reporting areas (American Samoa, Federated States of Micronesia, Guam,
Marshall Islands, Northern Mariana Islands, Puerto Rico, Republic of Palau, and U.S.
Virgin Islands) report cases to CDC but are not included in the annual incidence for the
United States. The laboratory and clinical case definitions are the two diagnostic categories used in the CDC “Tuberculosis Case Definition for Public Health Surveillance.”
Most verified TB cases are accepted for counting based on laboratory confirmation
of M. tuberculosis complex from a clinical specimen.
A person may have more than one discrete (separate and distinct) episode of TB. If
disease recurs in a person within any 12-consecutive-month period after the patient
completed therapy, count only one episode as a case. However, if TB disease recurs
in a person, and if more than 12 months have elapsed since the person completed
TB therapy or was lost to supervision, the TB case is considered a separate episode
and should be counted as a new case.
Mycobacterial diseases other than those caused by M. tuberculosis complex should
not be counted in TB morbidity statistics unless there is concurrent TB.

a.	 Verified TB Cases
COUNT
Count only verified TB cases that meet the laboratory or clinical case definitions
(see Section II). The diagnosis of TB must be verified by the TB control officer
or designee. The current CDC surveillance case definition for TB describes and
defines the criteria to be used in the case definition for TB disease.
DO NOT COUNT
If diagnostic procedures have not been completed, do not count; wait for confirmation of disease. Do not count as a case the patient for which two or more anti-TB
medications have been prescribed for preventive therapy for exposure to multidrugresistant (MDR) TB, or while the diagnosis is still pending
b.	 Nontuberculous Mycobacterial Diseases (NTM)
COUNT
An episode of TB disease diagnosed concurrently with another nontuberculous mycobacterial disease should be counted as a TB case.
DO NOT COUNT
Disease attributed to or caused by nontuberculous mycobacteria alone should not be
counted as a TB case.

142

c.	 TB Cases Reported at Death
COUNT
TB cases first reported to the health department at the time of a person’s death are
counted as incident cases, provided the person had current disease at the time of
death. The TB control officer should verify the diagnosis of TB.
DO NOT COUNT
Do not count as a case of TB if there is no evidence of current disease at the time of
death or at autopsy.
d.	 Immigrants, Refugees, Permanent Resident Aliens, Border Crossers,* and Foreign Visi3
tors
COUNT
Immigrants and refugees who are examined after arriving in the United States and
diagnosed with clinically active TB requiring anti-TB medications should be reported and counted by the locality of their current residence at the time of diagnosis
regardless of citizenship status.
Border crossers* who are diagnosed with TB and plan to receive anti-TB therapy
from a locality in the United States for 90 days or more should be reported and
counted by the locality where they receive anti-TB therapy.
Foreign visitors (e.g., students, commercial representatives, and diplomatic personnel) who are diagnosed with TB, are receiving anti-TB therapy, and have been,
or plan to remain in, the United States for 90 days or more should be reported and
counted by the locality of current residence.
*Border crosser — defined, by the U.S. Citizenship and Immigration Services
(USCIS)2 as “an alien resident of the United States reentering the country after an
absence of less than six months in Canada or Mexico, or a nonresident alien entering the United States across the Canadian border for stays of no more than six
months, or across the Mexican border for stays of no more than 72 hours.” Border
crossers may go back and forth across the border many times in a short period.
DO NOT COUNT
Any person who was diagnosed and started on anti-TB drugs in another country
should not be counted as a new case but should be reported as a verified noncountable TB case.
Border crossers* and foreign visitors who are diagnosed with TB and receive antiTB therapy from a locality in the United States for less than 90 days but plan to
return to their native country to continue therapy should not be reported or counted
by the locality where they receive anti-TB therapy.

143

e.	 Out-of-State or Out-of-Area Residents
COUNT	
A person’s TB case should be counted by the locality in which he or she resides at
the time of diagnosis. TB in a person who has no address should be counted by the
locality that diagnosed and is treating the TB. The TB control officer should notify
the appropriate out-of-state or out-of-area TB control officer of the person’s home
locality to (1) determine whether the case has already been counted to avoid “double counting,” and (2) agree on which TB control office should count the case if it
has not yet been counted.
DO NOT COUNT
Do not count a case in a newly diagnosed TB patient who is an out-of-area resident
and whose TB has already been counted by the out-of-area TB control office.
f.	 Migrants and Other Transients
COUNT
Persons without any fixed U.S. residence are considered to be the public health
responsibility of their present locality and their TB case should be reported and
counted where diagnosed.
DO NOT COUNT
Cases in transient TB patients should not be counted when there is evidence that
they have already been counted by another locality.
g.	 Federal Facilities (e.g., Military and Veterans Administration Facilities)
COUNT
Cases in military personnel, dependents, or veterans should be reported and counted
by the locality where the persons are residing in the United States at the time of
diagnosis and initiation of treatment.
However, if military personnel or dependents are discovered to have TB at a military base outside the United States but are referred elsewhere for treatment (e.g., a
military base located within the United States), the TB case should be reported and
counted where treated and not where the diagnosis was made.
DO NOT COUNT
Do not count if the case was already counted by another locality in the United
States.
h.	 Indian Health Service
COUNT
TB should be reported to the local health authority (e.g., state or county) and counted where diagnosed and treatment initiated. However, for a specific group such as
144

the Navajo Nation, which is geographically located in multiple states, health departments should discuss each case and determine which locality should count the case.
DO NOT COUNT
Do not count if the case was already counted by another locality.
i.	 Correctional Facilities (e.g., Local, State, Federal, and Military)
COUNT
Persons who reside in local, state, federal, or military correctional facilities may
frequently be transferred or relocated within and/or between various correctional
facilities. TB in these persons should be reported to the local health authority and
counted by the locality where the diagnosis was made and treatment plans were
initiated.
DO NOT COUNT
Do not count correctional facility residents’ TB cases that were counted elsewhere
by another locality or correctional facility, even if treatment continues at another
locale or correctional facility.
j.	 Peace Corps, Missionaries, and Other Citizens Residing Outside the United States
DO NOT COUNT
TB in persons diagnosed outside the United States should not be counted. TB in
these persons should be counted by the country in which they are residing, regardless of their plans to return to the United States for further work-up or treatment.
IV.	 Suggested Administrative Practices
To promote uniformity in TB case counting, the following administrative procedures
are recommended:
(a)	 All TB cases verified by the 52 reporting areas with count authority (50 states, District
of Columbia, and New York City) during the calendar year (by December 31) will be
included in the annual U.S. incidence count for that year. All tuberculosis cases verified
during the calendar year by a reporting area with count authority from one of the remaining 8 reporting areas (American Samoa, Federated States of Micronesia, Guam, Marshall
Islands, Northern Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin Islands) are also counted but are not included in the annual incidence for the United States.
Cases for which bacteriologic results are pending or for which confirmation of disease is
questionable for any other reason should not be counted until their status is clearly determined; they should be counted at the time they meet the criteria for counting. This means
that a case reported in one calendar year could be included in the morbidity count for the
following year. The reporting area with count authority should ensure that there is agreement between final local and state TB figures reported to CDC. Currently, some reporting
areas may not use this suggested protocol. Some of these areas may wait until the beginning of the following year when they have received and processed all of the TB cases

145

for inclusion in the annual case count for the previous year. If reporting areas decide to
revise their protocols, they should be aware that their TB trends may change.
(b)	TB is occasionally reported to health departments over the telephone, by letter or fax, or
on forms other than the Report of Verified Case of Tuberculosis (RVCT). Such information should be accepted as an official morbidity report if sufficient details are provided;
otherwise, the notification should be used as an indicator of a possible TB case (suspect)
which should be investigated promptly for confirmation.
V.	 TB Surveillance Definitions
Case - an episode of TB disease in a person meeting the laboratory or clinical
criteria for TB as defined in the document “Tuberculosis Case Definition for Public
Health Surveillance” (see Section II for criteria).
Suspect - a person for whom there is a high index of suspicion for active TB (e.g.,
a known contact to an active TB case or a person with signs or symptoms consistent
with TB) who is currently under evaluation for TB disease.
Verification of a TB case - the process whereby a TB case, after the diagnostic
evaluation is complete, is reviewed at the local level (e.g., state or county) by a TB
control official who is familiar with TB surveillance definitions; if all the criteria for
a TB case are met, the TB case is then verified and eligible for counting.
Counting of a TB case - the process whereby a reporting area with count authority evaluates verified TB cases against count criteria (e.g., assesses for case duplication). These cases are then counted for morbidity in that locality (e.g., state or
county) and reported to CDC for national morbidity counting. Noncountable, verified cases may also be sent to CDC.
Mycobacterium tuberculosis complex (M. tuberculosis complex) - Because most
laboratories use tests that do not routinely distinguish Mycobacterium tuberculosis
from very closely related species, these laboratories report culture results as being
positive or negative for “Mycobacterium tuberculosis complex.” Although in almost
all cases of human disease, isolates in the M. tuberculosis complex are, in fact, M.
tuberculosis, other species are possible. For example, one study in San Diego found
that 6% of human tuberculosis was caused by Mycobacterium bovis; cultures from
these cases would be reported by most laboratories as being positive for M. tuberculosis complex. Other species in the Mycobacterium tuberculosis complex include
M. africanum, M. microti, M. canetii, M. caprae, and M. pinnipedii. Although M.
microti, M. canetii, M. caprae, and M. pinnipedii are newly described species, their
inclusion in M. tuberculosis complex should not impact public health laboratories or
programs because only a few laboratories identify to the species level. These seven
species are almost identical in DNA homology studies. In terms of their ability to
cause clinical disease or be transmissible from person to person, M. bovis, M. africanum, M. microti, M. canetti, M. caprae, and M. pinnipedii behave like M. tuberculosis; therefore, disease caused by any of the organisms should be reported as TB,
146

	

using the Report of Verified Case of Tuberculosis (RVCT). The only exception is
the BCG strain of M. bovis, which may be isolated from persons who have received
the vaccine for protection against TB or as cancer immunotherapy; disease caused
by the BCG strain of M. bovis should not be reported as TB.
Nontuberculous mycobacteria (NTM) - mycobacteria other than Mycobacterium
tuberculosis complex that can cause human infection or disease. Common nontuberculous mycobacteria include M. avium complex or MAC (M. avium, M. intracellulare), M. kansasii, M. marinum, M. scrofulaceum, M. chelonae, M. fortuitum, and
M. simiae. Other terms have been used to represent NTM, including MOTT (mycobacteria other than TB) and “atypical” mycobacteria.
Reporting area - areas responsible for counting and reporting verified TB cases to
CDC. Currently there are 60 reporting areas: the 50 states, District of Columbia,
New York City, American Samoa, Federated States of Micronesia, Guam, Marshall
Islands, Northern Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin
Islands. The annual incidence of tuberculosis for the United States is based on 52
reporting areas (the 50 states, District of Columbia, and New York City).
2

Alien - defined by the U.S. Citizenship and Immigration Services (USCIS) as “any
person not a citizen or national of the United States.”
Border crosser - defined, by the U.S. Citizenship and Immigration Services
(USCIS)2 as “an alien resident of the United States reentering the country after an
absence of less than six months in Canada or Mexico, or a nonresident alien entering the United States across the Canadian border for stays of no more than six
months, or across the Mexican border for stays of no more than 72 hours.” Border
crossers may go back and forth across the border many times in a short period.
Class A TB with waiver3
All applicants who have tuberculosis disease and have been granted a waiver.
Class B1 TB, Pulmonary3
	
	 No treatment
•	 Applicants who have medical history, physical exam, HIV, or CXR findings
suggestive of pulmonary TB but have negative AFB sputum smears and
cultures and are not diagnosed with TB or can wait to have TB treatment
started after immigration.
Completed treatment
•	 Applicants who were diagnosed with pulmonary TB and successfully
completed directly observed therapy prior to immigration. The cover sheet
should indicate if the initial sputum smears and cultures were positive and if
drug susceptibility testing results are available.

147

Class B1 TB, Extrapulmonary3
Applicants with evidence of extrapulmonary TB. Document the anatomic site of
infection.
Class B2 TB, Latent TB Infection (LTBI) Evaluation3
	
Applicants who have a tuberculin skin test ≥10 mm but otherwise have a negative
evaluation for TB. The size of the TST reaction, the applicant’s status with respect
to LTBI treatment, and the medication(s) used should be documented. For applicants who had more than one TST, whether the applicant converted the TST should
be documented (i.e., initial TST <10 mm but subsequent TST ≥10 mm).
Class B3 TB, Contact Evaluation3
	
Applicants who are a recent contact of a known tuberculosis case. The size of the
applicant’s TST reaction should be documented. Information about the source case,
name, alien number, relationship to contact, and type of tuberculosis should also be
documented.
Immigrant - defined by the USCIS2 as “an alien admitted to the United States as
a lawful permanent resident. Immigrants are those persons lawfully accorded the
privilege of residing permanently in the United States. They may be issued immigrant visas by the Department of State overseas or adjusted to permanent resident
status by the USCIS of the United States.”
Permanent Resident Alien - see Immigrant.
Waivers3 - A provision allows applicants undergoing pulmonary or laryngeal
tuberculosis treatment to petition for a Class A TB with waiver. Waivers should be
pursued for any immigrant or refugee who has a complicated clinical course and
would benefit from receiving treatment of their tuberculosis in the United States.
Applicants diagnosed with tuberculosis disease who are both smear- and culturenegative and will be traveling to the United States prior to start of treatment do not
need to complete the waiver process.
References
1.	 Recommendations for Counting Reported TB Cases. Atlanta: CDC, July 1997.
2.	 U.S. Department of Homeland Security, U.S. Citizenship and Immigration Services;
http://uscis.gov. Accessed September 2010.
3.	 2007 Technical Instructions for Tuberculosis Screening and Treatment for Panel Physicians. Atlanta: CDC, Division of Global Migration and Quarantine. http://www.cdc.
gov/immigrantrefugeehealth/exams/ti/panel/tuberculosis-panel-technical-instructions.
html. Accessed September 2010.

148

Appendix C
National Surveillance for Severe Adverse Events Associated with Treatment for
Latent Tuberculosis Infection - Reporting Information
This information is included to alert our public health partners of the importance of reporting severe (i.e., hospitalization or death) adverse events associated with treatment for latent TB infection (LTBI). Data on severe adverse events (SAEs) among persons receiving treatment for LTBI
are needed to serve as a basis for periodic evaluation of guidelines for treatment of LTBI.
In April 2000, after the publication of updated Guidelines for Targeted Tuberculin Testing and
1
Treatment of Latent Tuberculosis Infection , DTBE began receiving reports of SAEs related to the
use of a 2-month course of rifampin and pyrazinamide (RZ) for treatment of LTBI. In response,
DTBE requested and received reports and conducted on-site investigations of liver injury in persons
on treatment for LTBI, and treatment guidelines were revised to recommend against the general use
2, 3
of rifampin and pyrazinamide to treat LTBI. In January 2004, DTBE implemented the National
Surveillance System for Severe Adverse Events Associated with Treatment for LTBI, which collects
reports about SAEs associated with any treatment regimen for LTBI, to quantify the frequency of
4
SAEs and to characterize the clinical features of affected patients.
Local medical providers should report possible LTBI-treatment associated SAEs to their respective
local/state health departments. State health departments should report SAEs that occurred on or after
January 1, 2004 to DTBE (e-mail: [email protected]).
References
1. ATS/CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir
Crit Care Med 2000;161:S221-S247.
2. American Thoracic Society/CDC. Update: Adverse event data and revised American Thoracic
Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent
tuberculosis infection—United States, 2003. MMWR 2003;52(31):735-9.
3. ATS. An official ATS statement: hepatoxicity of antituberculosis therapy. Am J Respir Crit Care
Med 2006;174:935–52.
4. CDC. Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection — United States, 2004–2008. MMWR 2010;59(8):224–9.

149

This page intentionally left blank

150

Index

151

152

Index
A
Age group, 18, 24, 29-32, 42, 80
Appendices
	
A, 139
	
B, 140
	
C, 149
Alcohol use, 62
B
B (appendix), 140
C
C (appendix), 149
Case verification criterion, 21
Cities and metropolitan statistical areas, 77-86
	
Areas with >500,000 population, 78-86
	
Selected cities, 77
Completion of therapy (COT), 24, 69, 72, 74
Correctional facilities, 57
Country of origin, 34
D
Deaths, 15
Death rates, 15
Directly observed therapy (DOT), 24, 68
District of Columbia, 40
Drug susceptibility results, 65
Drug use
	
Injecting drug use, 60
	
Noninjecting drug use, 61
E
Executive commentary, 3
Extrapulmonary disease, 51, 52
F
Foreign-born persons
	
Adult, 20
	
Cities and metropolitan statistical areas, 	
	
84
	
Country of origin, 48
	
States, 46, 48
	
Top 30 countries of origin of birth, 19, 20
	
Years in the U.S. before TB diagnosis, 20
	
Morbidity, 50

H
Health care provider (type), 67
HIV
	
By age group, 24, 66
	
Coinfection, 24
	
Status, 66
	
Test results, 24
Hispanic, 16, 29-32, 44, 72, 83
	
Cases by race, sex, age group, 29
		
Foreign-born, 32
		
U.S.-born, 31
	
Case rates by race, sex, and age group, 30
	
Reporting areas, 44
Homeless status, 58, 86
I
INH resistance, 22, 65
Initial drug regimen, 24, 64
L
Long-term care facilities, 59
M
Morbidity
	
Cities and metropolitan statistical areas, 	
	
77-86
	
Foreign-born persons, 50
	
Reporting areas, 57-74
	
States, 39-52
	
Trend, 15-25
Multidrug resistance, 23, 65
N
Non-Hispanic, 16, 29-32, 44, 72, 83
	
Cases by race, sex, age group, 29
		
Foreign-born, 32
		
U.S.-born, 31
	
Case rates by race, sex, and age group, 30
	
Reporting areas, 44
O
Occupation, 63
Origin of birth, 17-20, 22, 23

153

Index
P
Persons with no previous history of TB, 22, 23
Persons with previous history of TB, 22, 23
Preface, ix
Previous statistical reports in this series, xi
Pulmonary disease, 21, 51,
R
Race, 17, 29-32
Reason TB therapy stopped, 25, 70
Reporting areas (morbidity), 42, 44, 51, 52, 5774
	
Completion of therapy (COT), 69, 72, 74
	
Directly observed therapy (DOT), 68
	
Drug susceptibility results, 65
	
Excess alcohol use, 62
	
HIV status, 66
	
Homeless status, 58
	
Initial drug regimen, 64
	
Injecting drug use, 60
	
Multidrug resistance, 65
	
Noninjecting drug use, 61
	
Occupation, 63
	
Reason therapy stopped, 70
	
Residence in correctional facilities, 57
	
Residence in long-term care facilities, 59
	
Resistance to INH, 65
	
Type of health care provider, 67
Resistance to INH, 22, 65
S
Sex, 29-32
Site of disease, 21, 52
Sputum culture, 21
Sputum smear, 21
State TB statistics on the internet, xii
States (morbidity), 39-52
	
Age group, 42
	
Cases and case rates, 39
	
Reporting areas, 42	
Surveillance slide set, 91
	
Slides, 103-131
	
Narrative, 132

154

T
Technical notes, 9
Trend (morbidity), 15-25
	
Age group, 18, 24
	
Case verification criterion, 21
	
Completion of therapy, 24
	
Death and death rates, 15
	
Directly observed therapy, 24
	
Foreign-born persons, 19-20
	
HIV coinfection, 24
	
HIV test results, 24
	
Hispanic/Non-Hispanic, 16
	
Multidrug resistance, 23
	
No previous history of TB, 22, 23
	
Origin of birth, 18, 22, 23
	
Previous history of TB, 22, 23
	
Race, 17
	
Reason TB therapy stopped, 25
	
Resistance to INH, 22
	
Site of disease, 21
	
Sputum culture/sputum smear, 21
Type of health care provider, 67
	
U
USAPI supplement section, 91
U.S.-born
	
Cities and metropolitan statistical areas, 	
	
84
	
Hispanic/Non-Hispanic, 31
	
States, 46

detropeR
sisolucrebuT
eht ni
setatS detinU
1102

CS-221670
File Type	application/pdf
File Modified	2012-10-16
File Created	2012-09-14